{"meta":{"query_hash":"e12ef9ce158e","filters":{"venue":"Expert Opinion on Biological Therapy"},"cohort_total":145,"direct_labels_cover":1,"predictions_cover":145,"exported":145,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/e12ef9ce158e","api":"https://metacan.xera.ac/api/v1/cohort?venue=Expert+Opinion+on+Biological+Therapy"},"results":[{"id":"W1596505224","doi":"10.1517/14712598.2015.1057564","title":"Cell therapy in muscular dystrophies: many promises in mice and dogs, few facts in patients","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University; Centre hospitalier de l'Université Laval","funders":"","keywords":"Myocyte; Clinical trial; Medicine; Cell therapy; Transplantation; Cell; Skeletal muscle; Bioinformatics; Stem cell; Pathology; Immunology; Internal medicine; Biology; Genetics","score_opus":0.07396828387614951,"score_gpt":0.34510738124797535,"score_spread":0.27113909737182584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1596505224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15954234,0.8389478,0.0000010135068,0.000029979137,0.00018708495,0.0011111624,0.000015873333,0.000009674446,0.00015508369],"genre_scores_gemma":[0.028127668,0.9702441,0.00003226883,0.000442227,0.000114754715,0.00033695553,0.00066282577,0.000031358024,0.000007857053],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99738795,0.00069529004,0.0005303928,0.000870887,0.00011327968,0.00040220126],"domain_scores_gemma":[0.9993156,0.000053832435,0.00017580208,0.0003294191,0.000030776864,0.00009453679],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028110892,0.0005279743,0.0010597642,0.00017892603,0.000033078755,0.0000161532,0.00034022317,0.00096759415,0.000026081812],"category_scores_gemma":[0.00004816321,0.0003463752,0.00018629736,0.00020071905,0.00015055251,0.000006005018,0.000093796305,0.00035237253,0.000008935609],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017618677,0.0019500349,0.0021708524,0.0001589844,0.000059996844,0.000006483645,0.00018848672,0.000004489507,0.001343722,0.00003993277,0.00081417325,0.991501],"study_design_scores_gemma":[0.0035838718,0.0026197284,0.004522776,0.00051069696,3.2548542e-7,8.3525356e-7,0.000036085803,7.7861415e-7,0.00012993747,0.00010260265,0.9879909,0.00050142297],"about_ca_topic_score_codex":0.000059356,"about_ca_topic_score_gemma":0.0000054801194,"teacher_disagreement_score":0.9909996,"about_ca_system_score_codex":0.000043979337,"about_ca_system_score_gemma":0.00008175428,"threshold_uncertainty_score":0.99989885},"labels":[],"label_agreement":null},{"id":"W1827097600","doi":"10.1517/14712598.2015.1065248","title":"Subcutaneous abatacept in rheumatoid arthritis: current update","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Abatacept; Medicine; Rheumatoid arthritis; Clinical trial; Immunogenicity; Biologic Agents; Adverse effect; Safety profile; Intensive care medicine; Internal medicine; Oncology; Immunology; Antigen; Antibody","score_opus":0.15672135775429896,"score_gpt":0.42064719267581663,"score_spread":0.26392583492151767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1827097600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000121425066,0.9957214,0.0000064759447,0.00029584274,0.0011960588,0.0019270681,0.00007439604,0.0002034881,0.00045384798],"genre_scores_gemma":[0.0001022154,0.99718577,0.00008812161,0.00031017512,0.00046607014,0.0006573258,0.0010936863,0.00008749041,0.00000913597],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956286,0.00080026354,0.0010865788,0.0009902503,0.0006357971,0.0008584915],"domain_scores_gemma":[0.99811524,0.0002655197,0.0002514879,0.0007316921,0.000113448514,0.0005226132],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006669053,0.0008230535,0.0029691951,0.0004256994,0.00009897508,0.000080591584,0.00046669826,0.00064277375,0.0010454666],"category_scores_gemma":[0.00017124705,0.00050161046,0.0006903425,0.00045767028,0.00030112226,0.00007100701,0.000109065346,0.0012638038,0.0010922734],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054606557,0.0006759724,0.000010233476,0.000060399983,0.00009491723,0.00014865692,0.00009161968,7.018323e-8,0.0000024402837,0.00057407573,0.0063692695,0.9914263],"study_design_scores_gemma":[0.002331994,0.0022881192,0.000005439799,0.016786922,8.0757076e-8,0.0006405585,0.000032799067,0.0000018467529,0.0000032838286,0.00031526393,0.9770556,0.0005380693],"about_ca_topic_score_codex":0.000015719836,"about_ca_topic_score_gemma":0.0000021682183,"teacher_disagreement_score":0.99088824,"about_ca_system_score_codex":0.00024767662,"about_ca_system_score_gemma":0.00039297625,"threshold_uncertainty_score":0.99986774},"labels":[],"label_agreement":null},{"id":"W1917425892","doi":"10.1517/14712598.2015.1065249","title":"Combination therapy for the treatment of Crohn’s disease","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"UCB Pharma","keywords":"Crohn's disease; Medicine; Disease; Inflammatory bowel disease; Intensive care medicine; Gastrointestinal tract; Drug; Infliximab; Pharmacotherapy; Immunology; Internal medicine; Pharmacology","score_opus":0.14270470312422884,"score_gpt":0.4020402889959434,"score_spread":0.25933558587171457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1917425892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048827683,0.9954014,0.000063748834,0.000086911175,0.0006899883,0.0029742501,0.00022454085,0.00002176663,0.00004911167],"genre_scores_gemma":[0.0001709724,0.9946711,0.00003529834,0.00029772887,0.00086213433,0.0022254996,0.0016171952,0.000045543737,0.00007451765],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983236,0.00034981407,0.0004138333,0.00051854353,0.00015626513,0.00023793933],"domain_scores_gemma":[0.9986033,0.00013563629,0.00028885974,0.00068884535,0.00013337441,0.00015001622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022198557,0.00046331112,0.0006585227,0.000044326218,0.00010870421,0.000020762389,0.00039190557,0.00037479546,0.000043407643],"category_scores_gemma":[0.00005300691,0.00021916423,0.00085846026,0.00006348534,0.00017205148,0.0000021285373,0.00002339418,0.00005901637,0.0000111477],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021630945,0.0009909597,0.000009583216,0.000034011457,0.00024764144,0.0000035210662,0.000029054205,0.0000013640632,0.000026219239,0.00043229602,0.0025972337,0.993465],"study_design_scores_gemma":[0.0016357847,0.0025471654,0.0005264482,0.00014490535,0.0000032686726,8.30991e-7,0.000008022181,0.0000040250793,0.000055556106,0.0001103423,0.99468535,0.0002782728],"about_ca_topic_score_codex":0.0000018828066,"about_ca_topic_score_gemma":1.6055097e-7,"teacher_disagreement_score":0.9931868,"about_ca_system_score_codex":0.0000634403,"about_ca_system_score_gemma":0.00021726813,"threshold_uncertainty_score":0.89372575},"labels":[],"label_agreement":null},{"id":"W1963526807","doi":"10.1517/14712598.3.1.187","title":"AACR Special Conference in cancer research: ubiquitination in normal and cancer cells","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ubiquitin; Cancer; Proteasome; Cancer cell; Cancer research; Biology; Medicine; Cell biology; Biochemistry; Genetics; Gene","score_opus":0.18081447936761028,"score_gpt":0.4022481292485984,"score_spread":0.2214336498809881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963526807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98437816,0.010459676,0.000016272641,0.0005568165,0.00037034263,0.00035332164,0.000017317408,0.0000069922526,0.0038410926],"genre_scores_gemma":[0.8055355,0.19286777,0.00007244876,0.0006615387,0.00057630276,0.00021956452,0.000019678022,0.0000075527932,0.000039672443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985356,0.0004527689,0.0001767316,0.0003895197,0.00012559575,0.0003197995],"domain_scores_gemma":[0.99967486,0.000041129777,0.000036605164,0.00012536546,0.000057019046,0.000065023196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005333541,0.00013541903,0.00014313398,0.00007487014,0.00006054518,0.000022618839,0.00012206529,0.00023354804,0.00055000756],"category_scores_gemma":[0.000063644424,0.00010346934,0.00002939433,0.00013901237,0.00013887182,0.0000048495695,0.000036557405,0.00020495559,0.00000575649],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000505634,0.00019915678,0.004457859,0.0000018788173,0.000006365846,0.0000021881535,0.00044070242,0.00001139118,0.9328495,0.0033588528,0.0008971182,0.057269346],"study_design_scores_gemma":[0.00091838784,0.00059667014,0.004977022,0.00003090885,2.052518e-8,0.0000010087183,0.00014714435,0.000008817525,0.5909342,0.0004328748,0.4018046,0.000148337],"about_ca_topic_score_codex":0.00013547507,"about_ca_topic_score_gemma":0.00007705045,"teacher_disagreement_score":0.4009075,"about_ca_system_score_codex":0.000037378497,"about_ca_system_score_gemma":0.00007138747,"threshold_uncertainty_score":0.60221976},"labels":[],"label_agreement":null},{"id":"W1967641319","doi":"10.1517/14712598.2.5.483","title":"New developments in immunosuppressive therapy in renal transplantation","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heritage Medical Research Clinic; University of Alberta","funders":"","keywords":"Medicine; Calcineurin; Alemtuzumab; Rituximab; Tacrolimus; Adverse effect; Transplantation; Pharmacology; Monoclonal antibody; Belatacept; Monoclonal; Immunosuppression; Immunology; Internal medicine; Kidney transplantation; Antibody","score_opus":0.19644409638056642,"score_gpt":0.4155422922459468,"score_spread":0.21909819586538037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967641319","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018987393,0.99661314,0.000032272426,0.00010226614,0.0003602819,0.0016231742,0.00002648651,0.0000483338,0.0010041794],"genre_scores_gemma":[0.00018514552,0.9965622,0.00083635456,0.0005295475,0.00015941076,0.00031595575,0.0012502461,0.000041157473,0.00011997512],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99750364,0.0003218771,0.00087675516,0.0006373781,0.00028366788,0.00037667688],"domain_scores_gemma":[0.99912137,0.00026242263,0.00020771973,0.0002508325,0.000020560776,0.0001370676],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012382395,0.00059759355,0.001563248,0.0004074629,0.000042317413,0.000023063712,0.00020361823,0.000592495,0.0006708472],"category_scores_gemma":[0.000009584061,0.00034036263,0.00040833376,0.00043226744,0.00003622058,0.000056970228,0.0000072329026,0.00046720295,0.00011726719],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000900809,0.00048845477,0.00041825126,0.000106396066,0.00017045827,0.00017430694,0.00038191845,6.4873484e-7,0.000017313983,0.00006330025,0.000067550456,0.99721056],"study_design_scores_gemma":[0.007816755,0.0012245784,0.005916159,0.013842197,0.0000019933957,0.00009892987,0.000009097288,7.007846e-7,0.000076889584,0.00002835495,0.97060186,0.00038247864],"about_ca_topic_score_codex":0.000059880924,"about_ca_topic_score_gemma":0.0000017545766,"teacher_disagreement_score":0.99682814,"about_ca_system_score_codex":0.00019670546,"about_ca_system_score_gemma":0.00012673927,"threshold_uncertainty_score":0.9999048},"labels":[],"label_agreement":null},{"id":"W1968763049","doi":"10.1517/14712598.1.3.359","title":"Anticytokine gene therapy of autoimmune diseases","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Viral Infectious Diseases and Gene Expression in Insects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute on Aging; National Institutes of Health","keywords":"Genetic enhancement; Immunology; Biology; Naked DNA; DNA vaccination; Autoimmunity; Immune system; Cytokine; Medicine; Gene; Genetics","score_opus":0.10684949923676214,"score_gpt":0.390288394400051,"score_spread":0.28343889516328885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968763049","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00059358875,0.9969647,0.000058276753,0.000030520827,0.0010164399,0.000737983,0.00018797253,0.000058092217,0.00035246127],"genre_scores_gemma":[0.00074769335,0.99539804,0.00006275561,0.00046748444,0.0013915385,0.00028888727,0.0014955695,0.00007088579,0.000077117744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99739885,0.0004566817,0.00070135045,0.0008377806,0.00021718,0.0003881458],"domain_scores_gemma":[0.9983564,0.000075475844,0.00044788903,0.0008710139,0.00008521618,0.00016401052],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012076662,0.0006757521,0.0013193021,0.000113168884,0.00013384469,0.000028754652,0.0005718879,0.00074337766,0.0004587553],"category_scores_gemma":[0.00006955304,0.00040555734,0.0011633803,0.00026032038,0.0002186658,0.000003596701,0.00013490526,0.0002017454,0.000029824174],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042762145,0.0009227971,0.000033362343,0.000046389338,0.0003155212,0.000004322495,0.0000072753446,0.000002696468,0.008857142,0.0000577552,0.0081495205,0.9811756],"study_design_scores_gemma":[0.0007945218,0.0027692858,0.000092999406,0.00070185715,0.0000015492592,0.000017679791,0.00000400428,6.4127283e-7,0.002881009,0.000057348636,0.99216044,0.0005186914],"about_ca_topic_score_codex":0.00001161288,"about_ca_topic_score_gemma":7.935287e-8,"teacher_disagreement_score":0.9840109,"about_ca_system_score_codex":0.000022512899,"about_ca_system_score_gemma":0.00011627465,"threshold_uncertainty_score":0.9998396},"labels":[],"label_agreement":null},{"id":"W1970421649","doi":"10.1517/14712590903130558","title":"Fate and manipulations of endogenous neural stem cells following brain ischemia","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"L'Alliance Boviteq","funders":"","keywords":"Subgranular zone; Subventricular zone; Neural stem cell; Neuroscience; Stem cell; Neurogenesis; Biology; Endogeny; Hippocampus; Cell biology; Endocrinology","score_opus":0.3729883159791388,"score_gpt":0.38326063814457023,"score_spread":0.010272322165431447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970421649","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043631424,0.99333787,0.000042808537,0.00006596598,0.0010050043,0.00089748856,0.000043889137,0.00011695424,0.0001268922],"genre_scores_gemma":[0.006403236,0.9917891,0.000039725783,0.0014753549,0.00016579888,0.000053321823,0.000012612419,0.000044943947,0.000015900512],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99702317,0.00076273124,0.0006499555,0.0009211532,0.0002703477,0.00037265226],"domain_scores_gemma":[0.99775136,0.0013712642,0.00035629573,0.00037367965,0.000012820402,0.00013457019],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015411008,0.0005423534,0.0012977605,0.00013564294,0.00018557273,0.000048359303,0.0004269351,0.00032880603,0.000036592093],"category_scores_gemma":[0.00007063906,0.00034639347,0.00058711326,0.00027385814,0.000084471314,0.000049495517,0.000084512336,0.00031175467,0.000020207277],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031428874,0.00014534195,2.3024862e-7,0.000036589434,0.000012026574,0.000032632193,0.000024841067,0.0000014634951,0.4121583,0.0009738508,0.000062323925,0.58652097],"study_design_scores_gemma":[0.00025884726,0.00095145416,8.0024756e-7,0.00040043707,0.0000012077991,0.000060377668,0.0000030634276,0.000014433467,0.2684233,0.000021195781,0.72956663,0.00029824863],"about_ca_topic_score_codex":0.000001216854,"about_ca_topic_score_gemma":2.585374e-8,"teacher_disagreement_score":0.72950435,"about_ca_system_score_codex":0.000021535741,"about_ca_system_score_gemma":0.000027033957,"threshold_uncertainty_score":0.9998988},"labels":[],"label_agreement":null},{"id":"W1971211783","doi":"10.1517/14712598.2015.993375","title":"Glycoconjugate vaccines: an update","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child, Adolescent and Family Mental Health","funders":"","keywords":"Glycoconjugate; Vaccination; Neisseria meningitidis; Medicine; Meningococcal vaccine; Streptococcus pneumoniae; Haemophilus influenzae; Immunology; Virology; Immunization; Intensive care medicine; Biology; Microbiology; Antibiotics; Immune system; Bacteria; Bioinformatics","score_opus":0.12243014228357499,"score_gpt":0.3900100634619948,"score_spread":0.2675799211784198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971211783","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016884794,0.9921613,0.000022549653,0.00011870388,0.006092292,0.0007363901,0.000055586883,0.0003277855,0.0003165767],"genre_scores_gemma":[0.00007366089,0.9951018,0.000028641938,0.00074388535,0.001261746,0.00034792777,0.0022906533,0.000058005495,0.00009368574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99659634,0.0012795082,0.00074408745,0.0008671373,0.000019828114,0.0004931024],"domain_scores_gemma":[0.9984981,0.00026565988,0.00035939514,0.00075574307,0.00005659086,0.0000645572],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003300674,0.00074506033,0.0019824863,0.00017852947,0.0002879066,0.000057145528,0.0005848969,0.0015190009,0.0049112756],"category_scores_gemma":[0.00004557311,0.00040954936,0.0006388396,0.00019653236,0.000102726386,0.00007424073,0.0000813896,0.00058768207,0.0032646758],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015444557,0.0003050477,0.0000019836498,0.000028793691,0.00021433619,3.837335e-7,0.00001548372,4.258333e-8,0.00073619373,0.0017299112,0.005620498,0.9911929],"study_design_scores_gemma":[0.000808521,0.0017417262,0.000010554253,0.00065499754,0.0000019048539,0.000059896123,0.0000058677506,1.2511009e-7,0.00010533977,0.0001039086,0.9959377,0.00056943815],"about_ca_topic_score_codex":0.000024193741,"about_ca_topic_score_gemma":8.508195e-7,"teacher_disagreement_score":0.9906234,"about_ca_system_score_codex":0.000041900774,"about_ca_system_score_gemma":0.000044631553,"threshold_uncertainty_score":0.9998356},"labels":[],"label_agreement":null},{"id":"W1972122842","doi":"10.1517/14712590903307370","title":"Modification of mammalian reoviruses for use as oncolytic agents","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Kom op tegen Kanker","keywords":"Oncolytic virus; Reoviridae; Biology; Virology; Genome; RNA; Gene; Capsid; Reverse genetics; Virus; RNA virus; Genetic enhancement; Genetics; Rotavirus","score_opus":0.3425493463956565,"score_gpt":0.4841111118754819,"score_spread":0.1415617654798254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972122842","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019205769,0.99523413,0.00014225852,0.00007375099,0.00026912778,0.002114003,0.00013269729,0.000028746595,0.000084695756],"genre_scores_gemma":[0.0003878678,0.99517846,0.00042521025,0.0009033922,0.0006589623,0.00059598713,0.0016329655,0.00006474131,0.00015238822],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972635,0.00055337837,0.0006545382,0.00086311303,0.00024955414,0.00041592267],"domain_scores_gemma":[0.9983461,0.00016076333,0.00032926936,0.00088551274,0.00013623408,0.00014212544],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042060856,0.0005195399,0.0010238454,0.00014143666,0.000099641264,0.000038681355,0.0006800036,0.0008826696,0.00012421396],"category_scores_gemma":[0.00019739935,0.00035284765,0.000756857,0.00018479771,0.00015293983,0.000005065195,0.000055179175,0.00020057772,0.000042045882],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021789533,0.0003941813,0.0000020674158,0.00006287809,0.00014828487,7.4216115e-7,0.000011782752,0.0000027164585,0.0068974774,0.00009913785,0.002571505,0.98763025],"study_design_scores_gemma":[0.0007276463,0.013888181,0.00000764337,0.00046261522,0.0000016812916,0.000004490275,0.000006629338,0.0000038784906,0.012255456,0.000060871484,0.9721901,0.00039079948],"about_ca_topic_score_codex":0.000016033597,"about_ca_topic_score_gemma":0.0000015106115,"teacher_disagreement_score":0.9872395,"about_ca_system_score_codex":0.0000656192,"about_ca_system_score_gemma":0.00019480119,"threshold_uncertainty_score":0.99989235},"labels":[],"label_agreement":null},{"id":"W1975813747","doi":"10.1517/14712598.6.3.301","title":"Fluarix™, inactivated split-virus influenza vaccine","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Reactogenicity; Immunogenicity; Vaccination; Live attenuated influenza vaccine; Virology; Influenza vaccine; Virus; Public health; Medicine; Cornerstone; Immunology; Immune system","score_opus":0.42480656718496224,"score_gpt":0.51788247967576,"score_spread":0.09307591249079772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975813747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010158578,0.9925842,0.000006382196,0.00022959374,0.0006000774,0.002673771,0.00008664884,0.00040993223,0.0033077637],"genre_scores_gemma":[0.0000052024393,0.9918617,0.00024499572,0.0042413953,0.0019213954,0.00085859024,0.00059475796,0.000116972114,0.00015496579],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950811,0.0007167274,0.0012786358,0.0012248994,0.00070189976,0.0009966971],"domain_scores_gemma":[0.99722403,0.0007687425,0.0004174382,0.0010408504,0.00023607878,0.0003128296],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00054804125,0.0011909906,0.0036761148,0.0004948003,0.0002852627,0.00006047373,0.00054468674,0.0013257343,0.0009800955],"category_scores_gemma":[0.00049996754,0.00064427237,0.0011249072,0.0007232054,0.00023092418,0.00006932752,0.0002223288,0.0015316955,0.00086115766],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012215262,0.0007685528,0.000026137091,0.00027117968,0.0005951916,0.000040574152,0.000034854264,2.6358484e-7,0.00013302223,0.0004420926,0.025142387,0.9713242],"study_design_scores_gemma":[0.0023155755,0.0025373665,0.0002734101,0.003905007,0.0000043195455,0.00003543068,0.000010103645,0.0000012705963,0.00010341269,0.00006746245,0.99006826,0.0006783665],"about_ca_topic_score_codex":0.00013084152,"about_ca_topic_score_gemma":6.056296e-7,"teacher_disagreement_score":0.97064584,"about_ca_system_score_codex":0.000561723,"about_ca_system_score_gemma":0.0002478708,"threshold_uncertainty_score":0.99997073},"labels":[],"label_agreement":null},{"id":"W1979151040","doi":"10.1517/14712598.2.1.75","title":"The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Immune system; Antigen; Vaccinia; Biology; Vaccination; Immunology; Virology; Vector (molecular biology); Viral vector; Virus; Immunogenicity; DNA vaccination; Immunization; Genetics; Gene; Recombinant DNA","score_opus":0.06521455261899517,"score_gpt":0.3762826085574467,"score_spread":0.31106805593845155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979151040","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010815569,0.98693866,0.000006219121,0.00029033684,0.00044141812,0.0013862054,0.000044281867,0.000009167559,0.00006812547],"genre_scores_gemma":[0.035739243,0.9634477,0.000009990157,0.00017689675,0.00040197413,0.00012687354,0.000034069024,0.00003193933,0.00003131657],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997138,0.001200446,0.0005317615,0.00050690374,0.0003479405,0.00027491458],"domain_scores_gemma":[0.99807495,0.00032618482,0.00043599476,0.0010053598,0.00010777743,0.00004973926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005525759,0.00036583078,0.0005989402,0.000039343282,0.0002555508,0.000029850384,0.0010643167,0.0007449905,0.00003880962],"category_scores_gemma":[0.000102960585,0.00013698847,0.00046970468,0.00020018654,0.00018086832,0.0000015779323,0.00018133358,0.0004376462,0.000004306208],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005981674,0.00011992918,0.00002523086,0.00010246729,0.00029737546,3.636767e-7,0.000055597913,0.0000019702106,0.004592998,0.00012724033,0.0007762284,0.9933024],"study_design_scores_gemma":[0.000514425,0.0020781276,0.00063578674,0.00046842333,0.000002713662,0.000013299277,0.000029950737,0.0000086234495,0.0122512095,0.000009146801,0.983795,0.00019329609],"about_ca_topic_score_codex":0.0000047834383,"about_ca_topic_score_gemma":0.0000021039145,"teacher_disagreement_score":0.9931091,"about_ca_system_score_codex":0.000035563982,"about_ca_system_score_gemma":0.000072796036,"threshold_uncertainty_score":0.57460487},"labels":[],"label_agreement":null},{"id":"W1981785099","doi":"10.1517/14712590902841924","title":"Oligonucleotide based-strategies for allergy with special reference to siRNA","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital; Western University","funders":"","keywords":"Oligonucleotide; Allergy; Immunotherapy; Immunology; Medicine; Small interfering RNA; CpG Oligodeoxynucleotide; Disease; Immune system; Computational biology; Biology; RNA; DNA; DNA methylation; Gene; Internal medicine; Genetics","score_opus":0.1423333869808301,"score_gpt":0.3848982618277775,"score_spread":0.2425648748469474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981785099","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013316037,0.99395704,0.0012662635,0.00017267905,0.00039047777,0.0010280289,0.000089223504,0.000037038804,0.0029260581],"genre_scores_gemma":[0.0001386554,0.99095315,0.0010269125,0.00330845,0.0029825533,0.0004015656,0.0010659894,0.00004028389,0.000082427905],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979478,0.00018946786,0.00040378462,0.00090622896,0.00013768845,0.00041501914],"domain_scores_gemma":[0.9989929,0.00007297148,0.00016732431,0.0005191565,0.00009772172,0.00014991929],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016273328,0.00058921275,0.0008695985,0.000086802414,0.000101450576,0.00007588714,0.0005919743,0.000628875,0.00012935427],"category_scores_gemma":[0.000033691846,0.00034348638,0.00039779043,0.00011256382,0.00008252472,0.0000041479525,0.000044476532,0.00018276108,0.000059784477],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009542568,0.0001619169,3.220864e-7,0.000024447385,0.00011876441,0.0000025094716,0.000011292603,0.000011903101,0.0007873643,0.0007335032,0.017672474,0.9795213],"study_design_scores_gemma":[0.0003910257,0.008244705,0.00000542919,0.00078398414,8.982789e-7,0.000006396109,0.000024146837,9.574533e-7,0.00061565766,0.00006800543,0.9893066,0.00055216596],"about_ca_topic_score_codex":0.00000596356,"about_ca_topic_score_gemma":0.000004786621,"teacher_disagreement_score":0.9789691,"about_ca_system_score_codex":0.00002868738,"about_ca_system_score_gemma":0.00021539279,"threshold_uncertainty_score":0.9999017},"labels":[],"label_agreement":null},{"id":"W1983200035","doi":"10.1517/14712598.2013.748739","title":"Cell-based vasculogenic studies in preclinical models of chronic myocardial ischaemia and hibernation","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Congenital heart defects research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cardiology; Ischemia; Coronary artery disease; Internal medicine; Hibernation (computing); Population; Hibernating myocardium; Myocardial infarction; Revascularization; Computer science","score_opus":0.3619906621239243,"score_gpt":0.48590582635454393,"score_spread":0.12391516423061966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983200035","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002474074,0.9959386,0.00003356625,0.000023475399,0.0003986293,0.0009329359,0.000025055855,0.0000115871535,0.00016208689],"genre_scores_gemma":[0.027482511,0.9710455,0.000074935255,0.00006908897,0.00074195414,0.00030450142,0.00023382517,0.000032924243,0.000014778547],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974091,0.00079680554,0.00057041657,0.0006478987,0.00021194045,0.00036380813],"domain_scores_gemma":[0.998903,0.00032229268,0.00016802407,0.000429865,0.00007323032,0.00010362418],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006424943,0.0003862894,0.0011040744,0.00012523864,0.00004254005,0.000009097716,0.00026153596,0.0008014521,0.00002372384],"category_scores_gemma":[0.00009368298,0.00025316642,0.0005086816,0.00014373385,0.00030320213,0.000004633505,0.00017703958,0.0003348421,0.000009377375],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022445348,0.00035592407,0.000025782112,0.00035787647,0.00023039145,0.0000014631215,0.00003258632,0.000011616261,0.0009841614,0.00005089043,0.00014092593,0.9975839],"study_design_scores_gemma":[0.0010099894,0.0023080688,0.000022236905,0.0006926524,0.000003319447,0.0000049478526,0.000008987505,0.00004174427,0.000648014,0.00008004278,0.9948247,0.0003552593],"about_ca_topic_score_codex":0.0000064639553,"about_ca_topic_score_gemma":0.0000017530614,"teacher_disagreement_score":0.9972287,"about_ca_system_score_codex":0.000085478634,"about_ca_system_score_gemma":0.00017759312,"threshold_uncertainty_score":0.9999921},"labels":[],"label_agreement":null},{"id":"W1983435477","doi":"10.1517/14712598.2.2.211","title":"Becaplermin: recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcers","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Wound Healing and Treatments","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Wound healing; Medicine; Growth factor; Diabetic foot; Platelet-derived growth factor; Platelet-derived growth factor receptor; Surgery; Diabetes mellitus; Internal medicine; Receptor; Endocrinology","score_opus":0.34834058749933167,"score_gpt":0.43390506992427375,"score_spread":0.08556448242494208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983435477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043921385,0.9929132,0.000039170758,0.00092679396,0.0014639754,0.0038024422,0.00008529002,0.00021084148,0.000119057084],"genre_scores_gemma":[0.00020007418,0.99433357,0.0007886537,0.0007277637,0.0010821321,0.0011286468,0.0013383687,0.000103753766,0.00029701935],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969805,0.00024074533,0.0008166732,0.0010201539,0.00021869753,0.0007232546],"domain_scores_gemma":[0.9979138,0.0007136796,0.0003292579,0.00050541665,0.000054223707,0.00048365287],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010614391,0.00096930994,0.0028419488,0.00019058792,0.00023815573,0.000041122916,0.00019343576,0.000866359,0.0003811904],"category_scores_gemma":[0.00007307799,0.00051418174,0.0012904566,0.00018795229,0.000074736345,0.000023157263,0.000020094738,0.00029829523,0.00011491508],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036051948,0.0011039964,0.000014679407,0.0001829089,0.0007106907,0.00001956976,0.00018146052,6.767592e-8,0.000007005488,0.0000844042,0.0017869131,0.9955478],"study_design_scores_gemma":[0.005229273,0.012117399,0.000032613127,0.004377506,0.000013774469,0.000050640214,0.000012675898,0.000004213819,0.00008362219,0.00013948236,0.9774391,0.00049969676],"about_ca_topic_score_codex":0.00011104958,"about_ca_topic_score_gemma":6.2301825e-7,"teacher_disagreement_score":0.9950481,"about_ca_system_score_codex":0.0007485682,"about_ca_system_score_gemma":0.00023035934,"threshold_uncertainty_score":0.999731},"labels":[],"label_agreement":null},{"id":"W1988232405","doi":"10.1517/14712598.1.1.67","title":"Heat shock proteins: novel therapeutic tools for HIV-infection?","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Heat shock protein; Biology; Cytotoxic T cell; Virology; Biochemistry; In vitro","score_opus":0.24435351674959216,"score_gpt":0.44245787705115386,"score_spread":0.1981043603015617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988232405","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043318887,0.9840696,0.00801519,0.00032218065,0.0006068285,0.0062372806,0.00015984742,0.00009112064,0.0004546758],"genre_scores_gemma":[0.000041175575,0.9862623,0.0006857829,0.0008822391,0.0026056953,0.0070700925,0.0020653172,0.00012764755,0.0002597127],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99631053,0.00049453834,0.0007069464,0.0013675356,0.00030281808,0.00081765174],"domain_scores_gemma":[0.9982974,0.00024238505,0.000104789724,0.0009835501,0.00014970583,0.0002222021],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00056292245,0.000836387,0.0013071378,0.00015356847,0.00027949509,0.00014256063,0.0006888577,0.0015678145,0.000271952],"category_scores_gemma":[0.00030611717,0.000529217,0.0010946007,0.00031316822,0.00017279277,0.000009274852,0.0001534279,0.00050075946,0.00010672746],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032644803,0.0005237811,0.0000024566175,0.00011949255,0.00025200864,0.0000010935597,0.000006520705,0.0000015031942,0.009214165,0.00016135846,0.0021443951,0.98724675],"study_design_scores_gemma":[0.0010259525,0.0035173227,0.000004822033,0.00073273986,0.0000013961107,0.000037285503,0.000004832822,0.0000060699685,0.002776795,0.000033595763,0.99117035,0.000688836],"about_ca_topic_score_codex":0.000013769286,"about_ca_topic_score_gemma":8.569711e-7,"teacher_disagreement_score":0.98902595,"about_ca_system_score_codex":0.00013068882,"about_ca_system_score_gemma":0.00026918674,"threshold_uncertainty_score":0.9997284},"labels":[],"label_agreement":null},{"id":"W1988523217","doi":"10.1517/14712590903002021","title":"Novel application of lentiviral vectors towards treatment of graft-versus-host disease","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Genetic enhancement; Suicide gene; Transplantation; Graft-versus-host disease; Hematopoietic stem cell transplantation; Medicine; Gene delivery; Immunology; Disease; Stem cell; Immunogenicity; Immune system; Biology; Gene; Internal medicine","score_opus":0.16968350474709196,"score_gpt":0.4337459767547498,"score_spread":0.26406247200765787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988523217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001841402,0.99606806,0.0001808215,0.000059868613,0.0002568981,0.0012580968,0.00022663108,0.000020267427,0.00008792839],"genre_scores_gemma":[0.0036593701,0.9936024,0.00010731394,0.00006520154,0.0005212602,0.000362149,0.0016189555,0.000041719282,0.000021612499],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776673,0.0003121742,0.0005794571,0.0007474204,0.00027077447,0.00032344626],"domain_scores_gemma":[0.9984986,0.00006505107,0.00036953663,0.00082197605,0.00008862238,0.0001561678],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017441832,0.0005307797,0.0010857829,0.00012272746,0.000052859297,0.000009741444,0.00047955476,0.0004970858,0.000047334124],"category_scores_gemma":[0.00003797738,0.0003356986,0.00089304196,0.00021824935,0.00022645998,0.0000027630178,0.000049061753,0.00011111084,0.000010464277],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005961166,0.0014366711,0.000005320069,0.00004722922,0.0002755736,5.099122e-7,0.000013523277,0.0000015754562,0.031274285,0.00007153221,0.00010883061,0.9608038],"study_design_scores_gemma":[0.0015861493,0.021005204,0.00006421209,0.0002191974,0.000003794449,8.935542e-7,0.0000051365846,0.0000023592647,0.017977215,0.000010660802,0.9587941,0.00033106704],"about_ca_topic_score_codex":0.000019371137,"about_ca_topic_score_gemma":0.0000017797092,"teacher_disagreement_score":0.9604727,"about_ca_system_score_codex":0.0000833111,"about_ca_system_score_gemma":0.00021614754,"threshold_uncertainty_score":0.9999095},"labels":[],"label_agreement":null},{"id":"W1989944891","doi":"10.1517/14712598.8.7.1011","title":"Adalimumab for the treatment of Crohn's disease","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary General Hospital; University of Calgary","funders":"","keywords":"Adalimumab; Infliximab; Medicine; Crohn's disease; Monoclonal antibody; Disease; Monoclonal; Internal medicine; Inflammatory bowel disease; Clinical trial; Immunology; Antibody","score_opus":0.11658275887418404,"score_gpt":0.3832660486252241,"score_spread":0.26668328975104005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989944891","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018054788,0.9967329,0.00006611549,0.000050421637,0.0005416479,0.0020608343,0.00030345787,0.000019592813,0.000044515033],"genre_scores_gemma":[0.000071184644,0.995475,0.000057773494,0.00029041263,0.001236094,0.0017449453,0.0010162264,0.000045671844,0.00006272376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984024,0.00024038064,0.00041427536,0.0005547435,0.000119587516,0.00026860894],"domain_scores_gemma":[0.9986309,0.00017059577,0.00024315943,0.00075660844,0.00005750871,0.00014122353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000064150474,0.00048324716,0.00068230677,0.000036112113,0.00015029506,0.000011356458,0.00039796202,0.0003712557,0.00005489685],"category_scores_gemma":[0.000054797547,0.00022729747,0.0012882941,0.000053807984,0.00022953934,0.0000012391113,0.000029387755,0.000059026763,0.000012900054],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018092954,0.00063878164,0.0000055494925,0.000051202518,0.00031552746,0.00001838424,0.000020174715,0.0000020000925,0.000019795412,0.00015680007,0.0035133243,0.99344915],"study_design_scores_gemma":[0.0008450646,0.0014020745,0.00034606786,0.00020159691,0.0000034065945,0.0000036867698,0.000004998795,0.0000019552604,0.000041836243,0.000017571003,0.9968437,0.0002880707],"about_ca_topic_score_codex":0.0000017991188,"about_ca_topic_score_gemma":1.7916588e-7,"teacher_disagreement_score":0.99333036,"about_ca_system_score_codex":0.000041702242,"about_ca_system_score_gemma":0.00018353653,"threshold_uncertainty_score":0.92689216},"labels":[],"label_agreement":null},{"id":"W1991295531","doi":"10.1517/14712598.3.2.319","title":"RETRACTED: Biotherapeutic approaches to pancreatic cancer","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":18,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Pancreatic cancer; Cancer research; Medicine; Metastasis; Immunotherapy; Cancer; Angiogenesis; Monoclonal antibody; Immunology; Internal medicine; Antibody","score_opus":0.6534273310603201,"score_gpt":0.5014126272413248,"score_spread":0.1520147038189953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991295531","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009932103,0.9901764,0.00004805089,0.001122082,0.0005841279,0.0030679677,0.0000311903,0.00012316056,0.004747727],"genre_scores_gemma":[0.000018168523,0.99034095,0.0009407827,0.0046143797,0.001040348,0.0020823218,0.00017199402,0.000083071965,0.00070795935],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962688,0.00087191473,0.0007354036,0.0009871474,0.00042856665,0.00070817536],"domain_scores_gemma":[0.9978265,0.0006950419,0.00020992747,0.0007489645,0.000055473323,0.00046408558],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059535843,0.0007251515,0.0033787,0.000309285,0.00014205664,0.00003189408,0.0003544794,0.0015094874,0.0026188414],"category_scores_gemma":[0.00013468713,0.00038792932,0.00064955367,0.0006293164,0.00022575684,0.0000216683,0.000042800348,0.001049757,0.0005084899],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036208497,0.0006050416,0.0002411889,0.00023229496,0.0006634295,0.000013677275,0.00007828482,5.3502298e-8,0.000012509759,0.00048323785,0.0032784736,0.9940297],"study_design_scores_gemma":[0.0008141388,0.0027209935,0.00026597086,0.0041616545,0.000013363512,0.000058626283,0.000022046695,0.0000030798033,0.0000070628284,0.000047390888,0.99144197,0.0004437039],"about_ca_topic_score_codex":0.000027898734,"about_ca_topic_score_gemma":4.122191e-7,"teacher_disagreement_score":0.993586,"about_ca_system_score_codex":0.00038755705,"about_ca_system_score_gemma":0.0004826051,"threshold_uncertainty_score":0.99985725},"labels":[],"label_agreement":null},{"id":"W1993434776","doi":"10.1517/14712598.2013.840580","title":"Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; London Health Sciences Centre; SickKids Foundation; Western University","funders":"","keywords":"Etanercept; Medicine; Clinical trial; Adverse effect; Intensive care medicine; Arthritis; Quality of life (healthcare); Physical therapy; Internal medicine; Rheumatoid arthritis","score_opus":0.19851319863352745,"score_gpt":0.4213451919868079,"score_spread":0.22283199335328047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993434776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028986955,0.99578947,0.0000017441304,0.0004270404,0.00018589244,0.0023015167,0.0000087290255,0.000031873577,0.0009638425],"genre_scores_gemma":[0.00028945156,0.99748445,0.000020372783,0.00036078796,0.00028694133,0.0012869748,0.00017170962,0.000028862762,0.000070437505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99710464,0.00082208455,0.0009816206,0.0004277215,0.0003162395,0.0003477057],"domain_scores_gemma":[0.99872065,0.00026514888,0.0002590283,0.00064534013,0.000043499876,0.00006635444],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044271082,0.00043143868,0.0024330518,0.00016981759,0.00006441349,0.000017771303,0.00032229803,0.0005837268,0.0010603924],"category_scores_gemma":[0.00005684927,0.00018114748,0.0007368341,0.0003011149,0.00019281148,0.000025649537,0.00001950597,0.00040687446,0.00025184875],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000852872,0.0010977848,0.000009325983,0.00008185289,0.00006534864,0.000018791932,0.00044929827,4.7372865e-8,0.000019529647,0.00015877812,0.0008357997,0.99717814],"study_design_scores_gemma":[0.0013051734,0.0067729405,0.00007478722,0.0034117287,7.477294e-7,0.00003771466,0.00016100904,0.0000011809655,0.00001611684,0.00003960977,0.9879951,0.00018388027],"about_ca_topic_score_codex":0.000052662977,"about_ca_topic_score_gemma":6.255229e-7,"teacher_disagreement_score":0.99699426,"about_ca_system_score_codex":0.00013559574,"about_ca_system_score_gemma":0.0001833017,"threshold_uncertainty_score":0.9998528},"labels":[],"label_agreement":null},{"id":"W1993924959","doi":"10.1517/14712598.6.7.727","title":"American Association of Anatomists meeting on regenerative medicine","year":2006,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Anatomy and Medical Technology","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Regenerative medicine; Stem cell biology; Stem cell; Tissue engineering; Medicine; Engineering ethics; Regeneration (biology); Mesenchymal stem cell; Neuroscience; Biology; Pathology; Biomedical engineering; Engineering; Cell biology","score_opus":0.024294286003258378,"score_gpt":0.29171280744139344,"score_spread":0.26741852143813505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993924959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9111255,0.02241078,0.0017299571,0.013140626,0.0016927879,0.00057045446,0.000015033094,0.0013501678,0.04796473],"genre_scores_gemma":[0.9492136,0.049189534,0.0002603387,0.0008162034,0.00043039754,0.000028837861,0.000026478543,0.000010652985,0.00002391409],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991467,0.00008077718,0.00023967637,0.00017394629,0.00016694037,0.00019193033],"domain_scores_gemma":[0.999468,0.00024413393,0.00009377013,0.00012454005,0.000030063205,0.000039482155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019587242,0.00013884243,0.00028778287,0.00007117466,0.00003788959,0.0000021760422,0.000117254385,0.00018029993,0.00008775834],"category_scores_gemma":[0.00012836316,0.0000880287,0.000052947224,0.00020256454,0.00016145801,0.000012786791,0.000007762556,0.0001768772,0.0000094845445],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040811667,0.00043633292,0.003402209,0.0000039855236,0.00017479082,0.000007048383,0.00045344335,0.00060829474,0.10065073,0.10949502,0.07642285,0.7079372],"study_design_scores_gemma":[0.0009196341,0.0014581805,0.0035441923,0.000058813315,1.4391321e-7,7.54611e-7,0.000121807985,0.0006449613,0.08149227,0.001898772,0.9096771,0.00018339414],"about_ca_topic_score_codex":0.000040446495,"about_ca_topic_score_gemma":0.000001543561,"teacher_disagreement_score":0.8332542,"about_ca_system_score_codex":0.000093101844,"about_ca_system_score_gemma":0.0000041970347,"threshold_uncertainty_score":0.3589706},"labels":[],"label_agreement":null},{"id":"W1994672627","doi":"10.1517/14712598.4.5.627","title":"Modulation of immune responses – strategies for optimising vaccines","year":2004,"lang":"en","type":"editorial","venue":"Expert Opinion on Biological Therapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc","funders":"","keywords":"Vaccination; Immune system; Effector; Immune modulation; Immunology; Biology; Acquired immune system","score_opus":0.056115720950990954,"score_gpt":0.3477792489681049,"score_spread":0.291663528017114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994672627","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014083475,0.2726954,0.0013616106,0.00037377173,0.70917773,0.001499146,0.000415289,0.000246767,0.0001468189],"genre_scores_gemma":[0.093169145,0.698196,0.0012491365,0.000361128,0.19797176,0.00075478177,0.007042571,0.00021814115,0.0010373223],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99685407,0.00075743976,0.0010221809,0.0007075513,0.0001243462,0.0005343944],"domain_scores_gemma":[0.9950239,0.0032824492,0.00068841106,0.00064526475,0.00033962433,0.000020325766],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007491216,0.00066751486,0.0011476341,0.00028669398,0.00033476835,0.000053409003,0.00063745555,0.0024511234,0.00042686868],"category_scores_gemma":[0.0007362039,0.000465033,0.0006403451,0.00016333767,0.00035278688,0.00013259084,0.000056923855,0.00064694503,0.000035110337],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040898103,0.0006081672,0.0000023483806,0.000015810778,0.00058868836,8.0265625e-7,0.00057288975,0.00009443851,0.76412857,0.0010730986,0.16025132,0.03176578],"study_design_scores_gemma":[0.004799776,0.0049324757,0.00019668709,0.00030985379,0.0000010588869,0.0000037658258,0.00024985717,0.0000017844088,0.08935707,0.0010515157,0.8985848,0.00051135255],"about_ca_topic_score_codex":0.000095628806,"about_ca_topic_score_gemma":4.3208863e-7,"teacher_disagreement_score":0.73833346,"about_ca_system_score_codex":0.00011184385,"about_ca_system_score_gemma":0.00047514902,"threshold_uncertainty_score":0.9997801},"labels":[],"label_agreement":null},{"id":"W1995328364","doi":"10.1517/14712590802666397","title":"Aflibercept (AVE0005): an alternative strategy for inhibiting tumour angiogenesis by vascular endothelial growth factors","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Aflibercept; Angiogenesis; Cancer research; Decoy; Vascular endothelial growth factor; Tyrosine kinase; Receptor tyrosine kinase; Metastasis; Medicine; Cancer; VEGF receptors; Receptor; Internal medicine; Bevacizumab; Chemotherapy","score_opus":0.12813195382551093,"score_gpt":0.38521482393282175,"score_spread":0.2570828701073108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995328364","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020105592,0.9947994,0.0005767199,0.00002565904,0.0004478854,0.0012048369,0.0007663298,0.000054081826,0.00011453547],"genre_scores_gemma":[0.0020383284,0.9887388,0.00017893201,0.0006835135,0.0027557863,0.00047123237,0.004982376,0.000109799075,0.000041279418],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967602,0.00047028536,0.0006393617,0.0013030358,0.00022405756,0.00060307846],"domain_scores_gemma":[0.9987187,0.00012380509,0.0003948011,0.0004271523,0.00011477098,0.00022080739],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002861078,0.00089609233,0.0012862731,0.00009324139,0.00021643452,0.00007183234,0.00062614813,0.0010008734,0.00010278111],"category_scores_gemma":[0.0000642723,0.00057805935,0.0016081991,0.00013159927,0.00012588786,0.00000928504,0.000060271836,0.00016907175,0.000008161878],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017285548,0.0003703308,0.000009056844,0.0000440548,0.00039459317,0.0000012273628,0.000036357254,0.0000044371636,0.014033966,0.00015335086,0.0041360334,0.98064375],"study_design_scores_gemma":[0.00066784007,0.0032638053,0.0000127555695,0.00033316956,0.0000053757844,0.0000044338567,0.000048866284,0.0000030450858,0.015668537,0.000060035487,0.97912246,0.0008096979],"about_ca_topic_score_codex":0.00003315198,"about_ca_topic_score_gemma":0.0000010720337,"teacher_disagreement_score":0.979834,"about_ca_system_score_codex":0.00007093072,"about_ca_system_score_gemma":0.00010816578,"threshold_uncertainty_score":0.9996671},"labels":[],"label_agreement":null},{"id":"W1996102681","doi":"10.1517/14712598.2010.532786","title":"Treatment of diabetes with glucagon-like peptide-1 gene therapy","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Genetic enhancement; Gene delivery; Medicine; Bioinformatics; Computational biology; Biology; Gene; Genetics","score_opus":0.13994077343704872,"score_gpt":0.37369406287708684,"score_spread":0.23375328944003812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996102681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0055225138,0.99061835,0.0000048514294,0.00015321001,0.0008073921,0.0016220454,0.00003851371,0.00013441015,0.0010987347],"genre_scores_gemma":[0.00011843025,0.9958868,0.0006508063,0.00086731615,0.00090593816,0.00068951165,0.0006180973,0.00006645947,0.00019665973],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99774873,0.00023315263,0.00062093395,0.00069993385,0.00028208387,0.00041518398],"domain_scores_gemma":[0.9980067,0.0005314832,0.00037316195,0.00076468074,0.00008965777,0.00023429884],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000121355384,0.00077216193,0.0027441343,0.00018155051,0.00007965295,0.000017960734,0.0001844538,0.00075279735,0.0008123611],"category_scores_gemma":[0.00003551374,0.0003334622,0.00080033607,0.00026814593,0.00028227712,0.000024201261,0.0000143195775,0.00028661502,0.00008275836],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042010166,0.0014458768,0.00025516385,0.00006038374,0.00055836106,0.0000036967137,0.000054164608,4.4552532e-8,0.0010857786,0.00006213301,0.00040870268,0.9956456],"study_design_scores_gemma":[0.003067003,0.016432004,0.00015172352,0.0013446053,0.000007507146,0.000015501899,0.000011910011,0.0000011755338,0.0022091414,0.000012048772,0.9763724,0.00037492983],"about_ca_topic_score_codex":0.0000075499697,"about_ca_topic_score_gemma":7.458853e-8,"teacher_disagreement_score":0.99527067,"about_ca_system_score_codex":0.000094103,"about_ca_system_score_gemma":0.00017145224,"threshold_uncertainty_score":0.9999117},"labels":[],"label_agreement":null},{"id":"W1996623626","doi":"10.1517/14712598.2012.668517","title":"Eculizumab for treatment of asthma","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Eculizumab; Medicine; Asthma; Immunology; Paroxysmal nocturnal hemoglobinuria; Complement system; Exacerbation; Allergy; Monoclonal; Monoclonal antibody; Antibody","score_opus":0.3470602536935998,"score_gpt":0.44179609915047285,"score_spread":0.09473584545687308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996623626","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002046052,0.9944899,0.000028986087,0.000032117732,0.0022624203,0.002415354,0.0004681684,0.00007927254,0.00020329621],"genre_scores_gemma":[0.00025137974,0.9947746,0.00006024551,0.000055701053,0.0004142716,0.0018348979,0.0024797826,0.000034352935,0.00009481604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99773115,0.0006018086,0.00071046,0.0004958056,0.00003692523,0.0004238313],"domain_scores_gemma":[0.998175,0.0007856122,0.00044318498,0.0005143259,0.00004137814,0.000040492032],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013522341,0.0005480397,0.0019732825,0.000114829,0.00010341287,0.000006567183,0.00035252448,0.0006361492,0.0020313233],"category_scores_gemma":[0.000025268642,0.00029318972,0.0011572208,0.00008580481,0.00014898273,0.00001806942,0.000035744466,0.00006341969,0.0003175606],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002878707,0.0010595154,0.000004702869,0.00010444609,0.0005454528,2.2863267e-7,0.000054165328,2.285021e-8,0.00010444808,0.0013402418,0.002369717,0.9941292],"study_design_scores_gemma":[0.0014568715,0.004020461,0.000011601237,0.00084264675,0.000004159127,0.000012365392,0.000019089965,2.9707257e-8,0.00023432406,0.00003195969,0.9930558,0.00031068214],"about_ca_topic_score_codex":0.000008441171,"about_ca_topic_score_gemma":1.6511787e-7,"teacher_disagreement_score":0.9938185,"about_ca_system_score_codex":0.00013385946,"about_ca_system_score_gemma":0.000060338472,"threshold_uncertainty_score":0.999952},"labels":[],"label_agreement":null},{"id":"W2000708671","doi":"10.1517/14712598.6.11.1113","title":"Clinical applications of virosomes in cancer immunotherapy","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Immunotherapy; Cancer immunotherapy; Medicine; Cancer; Cancer vaccine; Antigen; Immunology; Melanoma; Immune system; Cancer research; Internal medicine","score_opus":0.1536356745790547,"score_gpt":0.4501499209983945,"score_spread":0.2965142464193398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000708671","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000110978996,0.99590486,0.000045586625,0.00006625202,0.0015437293,0.0017628738,0.00011249528,0.00014793222,0.0003052599],"genre_scores_gemma":[0.000064545005,0.9964128,0.00005369485,0.0003871276,0.00025390426,0.0018580992,0.00051807123,0.00009744167,0.00035427403],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943439,0.0021939455,0.002011695,0.00083177205,0.00007480185,0.0005439388],"domain_scores_gemma":[0.99665606,0.0015394507,0.00086018187,0.00086281175,0.000058603986,0.000022870017],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00074535585,0.0007417386,0.0029535315,0.00041080525,0.00011023099,0.000015494095,0.00094411685,0.001887569,0.00094471854],"category_scores_gemma":[0.00003796564,0.00046705987,0.0012694184,0.0005496605,0.0007354466,0.000046815865,0.000069027315,0.0010276033,0.00016620303],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007173614,0.0013534816,0.00008738094,0.000048499198,0.0003968067,7.80475e-7,0.000048913684,3.1875436e-7,0.0009369091,0.00040288462,0.0013082587,0.9946984],"study_design_scores_gemma":[0.0018805326,0.0010427183,0.00035352734,0.0016625739,0.0000015054881,0.000009732839,0.000014287331,5.9726396e-8,0.000335615,0.000063915,0.99411386,0.00052169396],"about_ca_topic_score_codex":0.00020115369,"about_ca_topic_score_gemma":0.0000020202112,"teacher_disagreement_score":0.9941767,"about_ca_system_score_codex":0.00010654946,"about_ca_system_score_gemma":0.00022024095,"threshold_uncertainty_score":0.9999685},"labels":[],"label_agreement":null},{"id":"W2003909801","doi":"10.1517/14712598.2011.556615","title":"Autologous cell therapy for cardiac repair","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cell therapy; Stem-cell therapy; Regenerative medicine; Stem cell; Intensive care medicine; Myocardial infarction; Expert opinion; Clinical trial; Bioinformatics; Transplantation; Surgery; Cardiology; Internal medicine; Biology","score_opus":0.3644719191005841,"score_gpt":0.4618652028833351,"score_spread":0.09739328378275103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003909801","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030958046,0.98424596,0.000027962393,0.00012431254,0.0016142648,0.0065061105,0.000053303866,0.00046228737,0.0069348696],"genre_scores_gemma":[0.000012547665,0.99202603,0.00087941234,0.0008737164,0.0018769274,0.002705885,0.00049609947,0.00013474176,0.0009946487],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954938,0.00091482094,0.0009041401,0.0013741768,0.0004041879,0.0009088553],"domain_scores_gemma":[0.9966799,0.0012007135,0.00032456274,0.0012025425,0.00016619648,0.00042607886],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010302063,0.00091168366,0.0033459677,0.0002499345,0.00028226926,0.000022437125,0.0005640238,0.0015810743,0.0013788069],"category_scores_gemma":[0.00017332876,0.00047924614,0.0028693157,0.00033390318,0.00024614256,0.000026770647,0.00012386385,0.00083514693,0.00038053066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010024764,0.0006623447,0.000013990861,0.00035897418,0.00033734593,0.0000111061145,0.00009072654,9.097293e-9,0.000044629778,0.00047241172,0.016603189,0.98040277],"study_design_scores_gemma":[0.0013077577,0.00805906,0.000032861386,0.0014777891,0.0000028775755,0.000019075522,0.000013958377,0.0000014845084,0.00014598976,0.00006276414,0.9883352,0.00054116355],"about_ca_topic_score_codex":0.000020740912,"about_ca_topic_score_gemma":4.8733057e-8,"teacher_disagreement_score":0.9798616,"about_ca_system_score_codex":0.00019886567,"about_ca_system_score_gemma":0.0003286746,"threshold_uncertainty_score":0.99976593},"labels":[],"label_agreement":null},{"id":"W2006861467","doi":"10.1517/14712598.2012.693469","title":"Exon skipping for nonsense mutations in Duchenne muscular dystrophy: too many mutations, too few patients?","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"","keywords":"Exon skipping; Nonsense mutation; Exon; Duchenne muscular dystrophy; Dystrophin; Genetics; Nonsense; Mutation; Biology; Muscular dystrophy; Bioinformatics; Medicine; Gene; Alternative splicing; Missense mutation","score_opus":0.11032140776613585,"score_gpt":0.3761372437882556,"score_spread":0.2658158360221197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006861467","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008689493,0.9878515,0.00044023365,0.00011112827,0.00080350484,0.0018177817,0.0001405284,0.000034372097,0.00011145684],"genre_scores_gemma":[0.0059538204,0.98301035,0.0005840244,0.0008407566,0.00060561986,0.0013418467,0.0075843786,0.000052340933,0.000026853388],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99742293,0.0004989435,0.0006295263,0.00081126567,0.000110862275,0.0005264452],"domain_scores_gemma":[0.9988205,0.00019739225,0.00028237185,0.00048630868,0.00008989913,0.00012356542],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025016235,0.0005573738,0.0008796844,0.00014128842,0.00018848882,0.00002447093,0.00032303832,0.0009172188,0.00007050715],"category_scores_gemma":[0.0001781913,0.0004047914,0.0006441598,0.00017515018,0.00017512597,0.000008882006,0.00006936659,0.0002660449,0.00003439792],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004782225,0.0010311625,0.000050264433,0.00015178554,0.00022477545,0.0000013277321,0.000088416906,0.000013915693,0.0010430956,0.0006888056,0.0011561044,0.9950721],"study_design_scores_gemma":[0.0012338446,0.0011515081,0.00038987593,0.00025584223,0.0000044045005,0.0000028407967,0.000043673295,0.0000035932005,0.00009818067,0.0001715162,0.99610835,0.0005363933],"about_ca_topic_score_codex":0.000012829725,"about_ca_topic_score_gemma":0.0000012532676,"teacher_disagreement_score":0.9949522,"about_ca_system_score_codex":0.000051825406,"about_ca_system_score_gemma":0.000085800166,"threshold_uncertainty_score":0.9998404},"labels":[],"label_agreement":null},{"id":"W2007006020","doi":"10.1517/14712598.2013.758706","title":"Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Probiotics and Fermented Foods","field":"Agricultural and Biological Sciences","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Micropharma (Canada); Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Probiotic; Bacteria; Medicine; Cholesterol; Bile acid; Pharmacology; Biology; Internal medicine","score_opus":0.19434818295732378,"score_gpt":0.4072012171945446,"score_spread":0.21285303423722082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007006020","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014410381,0.9893253,0.00014214769,0.0012782183,0.0006708908,0.0068314164,0.00019782408,0.00009989376,0.000013261597],"genre_scores_gemma":[0.0011294519,0.994406,0.00039104855,0.00039849072,0.0014336262,0.0018560677,0.00037037823,0.000006414948,0.000008558921],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99778986,0.00032855384,0.0006900965,0.00075293105,0.0001283433,0.00031018842],"domain_scores_gemma":[0.99854064,0.00047472882,0.0005755884,0.00014883486,0.00008884462,0.00017136015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041156894,0.00040566205,0.0011817657,0.000034706158,0.00025206245,0.00005812165,0.00023473256,0.000535098,0.00007404921],"category_scores_gemma":[0.000015624575,0.00013495833,0.00032784755,0.0002601822,0.00012813765,0.00009571865,0.0000466213,0.00030572293,0.0000068111426],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012832682,0.0003288726,0.0000049527266,0.00010681581,0.00006687419,2.951655e-8,0.000011826047,4.10396e-8,0.0012146075,0.00019022582,0.00011687539,0.99783057],"study_design_scores_gemma":[0.00022578733,0.007016152,0.000366047,0.0013952145,0.0000023292862,0.000009846869,0.00003353452,0.0000027259969,0.00020469837,0.000068933405,0.9904027,0.0002720304],"about_ca_topic_score_codex":0.00002423946,"about_ca_topic_score_gemma":0.0000038536905,"teacher_disagreement_score":0.99755853,"about_ca_system_score_codex":0.000060217895,"about_ca_system_score_gemma":0.00003791755,"threshold_uncertainty_score":0.5503441},"labels":[],"label_agreement":null},{"id":"W2009801310","doi":"10.1517/14712598.4.1.107","title":"18th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer","year":2004,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Government (linguistics); Library science; Gerontology; Medicine; Political science; Environmental ethics; Family medicine; Philosophy","score_opus":0.0865523282519976,"score_gpt":0.39436392432464834,"score_spread":0.30781159607265074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009801310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98128605,0.016123652,0.00008362478,0.0011239948,0.00058245315,0.0004419436,0.00023085182,0.000007969717,0.00011947165],"genre_scores_gemma":[0.90251654,0.09594142,0.00040224727,0.00057392655,0.0002723475,0.00014831043,0.000118293174,0.0000070756637,0.000019865382],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999072,0.00003940071,0.00018865897,0.00033376095,0.00017070652,0.00019545924],"domain_scores_gemma":[0.9994561,0.000033976463,0.00011148787,0.00021301993,0.00014404426,0.00004136494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021030346,0.00012654321,0.00014523252,0.000017469829,0.000119306555,0.000013374463,0.00038493995,0.00013947634,0.000038589493],"category_scores_gemma":[0.00005134686,0.000064098014,0.00035291185,0.00009260871,0.0003738881,0.0000032303158,0.00007741751,0.000059093047,5.7248604e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012789171,0.00047513426,0.0053624096,8.0252767e-7,0.00021434051,8.550812e-8,0.00016788761,0.00004648135,0.9598724,0.0003976652,0.0023380984,0.029845763],"study_design_scores_gemma":[0.0021207999,0.0012948182,0.0046829833,0.000020134565,8.8750305e-8,5.68748e-7,0.00008561063,0.0000038194585,0.6504495,0.00038674017,0.34087166,0.000083256644],"about_ca_topic_score_codex":0.000095539595,"about_ca_topic_score_gemma":0.000007846758,"teacher_disagreement_score":0.33853355,"about_ca_system_score_codex":0.000035100802,"about_ca_system_score_gemma":0.00010785618,"threshold_uncertainty_score":0.2613841},"labels":[],"label_agreement":null},{"id":"W2012383679","doi":"10.1517/14712598.3.7.1093","title":"Peptide action in stroke therapy","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Excitotoxicity; Glutamate receptor; Glutamatergic; Neuroscience; Neurotransmission; Receptor; Biology; Excitatory postsynaptic potential; Postsynaptic potential; Pharmacology; Cell biology; Inhibitory postsynaptic potential; Biochemistry","score_opus":0.5746120417242411,"score_gpt":0.5249621414531427,"score_spread":0.04964990027109839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012383679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001183922,0.99347776,0.0000022797617,0.00018921259,0.0024540436,0.0015500007,0.000023311173,0.00013185135,0.0009876016],"genre_scores_gemma":[0.00015677317,0.99253196,0.000006372135,0.00602984,0.00036334456,0.0005807604,0.0000061506516,0.000055148994,0.0002696706],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99328786,0.0031794535,0.0006231874,0.0015874507,0.00048782528,0.0008342377],"domain_scores_gemma":[0.9976508,0.0013713492,0.00024447084,0.00052551,0.000020368367,0.00018749679],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000498404,0.00065772346,0.001233448,0.00047839576,0.00024629134,0.00008802359,0.0010611127,0.00057831145,0.0007196803],"category_scores_gemma":[0.00026732925,0.00039419133,0.00050394895,0.00095930963,0.00043466568,0.0001285659,0.00008258954,0.0013910618,0.00046175544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018824033,0.0005738129,0.0000038194144,0.000014517447,0.000005283381,0.000054534645,0.000018302231,3.7739818e-7,0.03434026,0.00019444386,0.0010697773,0.9635366],"study_design_scores_gemma":[0.0007393508,0.001472342,0.000006449042,0.00023110051,1.255697e-7,0.00004983643,0.0000050167405,0.0000019315228,0.014414653,0.00004308907,0.98263985,0.00039622633],"about_ca_topic_score_codex":0.0000030522647,"about_ca_topic_score_gemma":1.2704992e-7,"teacher_disagreement_score":0.9815701,"about_ca_system_score_codex":0.00012311123,"about_ca_system_score_gemma":0.00014930444,"threshold_uncertainty_score":0.999851},"labels":[],"label_agreement":null},{"id":"W2013336468","doi":"10.1517/14712598.8.9.1381","title":"Development of targeted oncolytic virotherapeutics through translational research","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jennerex Biotherapeutics (Canada)","funders":"","keywords":"Oncolytic virus; Translational research; Clinical trial; New product development; Medicine; Computer science; Virology; Virus; Business","score_opus":0.41272849454925636,"score_gpt":0.5039105132071549,"score_spread":0.09118201865789849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013336468","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005271452,0.99702775,0.0001678374,0.000072425864,0.00023879204,0.0013925023,0.000051234056,0.000027965947,0.00049432873],"genre_scores_gemma":[0.0001121784,0.9945,0.0026081523,0.0002966505,0.00068674097,0.0004910851,0.0011561534,0.000091968075,0.000057118865],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953256,0.0013489556,0.00093070336,0.0009537228,0.0007851998,0.00065581204],"domain_scores_gemma":[0.9984092,0.0002640676,0.00023547278,0.00073870475,0.00021801819,0.00013452055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007886797,0.0005911959,0.0011383254,0.0002016526,0.0003017473,0.000019419158,0.00090112345,0.0010948231,0.00031699016],"category_scores_gemma":[0.00005919336,0.00040118402,0.0005926506,0.00048168446,0.00053730624,0.000004222363,0.00010405325,0.0006579087,0.000082249586],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013832689,0.0005550409,0.0000011578387,0.000054119442,0.00037884404,0.0000019671018,0.00022448965,0.0000018922127,0.011878664,0.00009748509,0.0010822167,0.98434085],"study_design_scores_gemma":[0.00074677326,0.0044147517,0.0000050438157,0.00048589054,4.307621e-7,0.000011419525,0.000020302941,0.0000013515705,0.017595375,0.00006246297,0.9762115,0.00044473025],"about_ca_topic_score_codex":0.0000023044083,"about_ca_topic_score_gemma":0.0000019641914,"teacher_disagreement_score":0.98389614,"about_ca_system_score_codex":0.00009326419,"about_ca_system_score_gemma":0.0010508547,"threshold_uncertainty_score":0.999844},"labels":[],"label_agreement":null},{"id":"W2014099400","doi":"10.1517/14712598.2014.880420","title":"The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Micropharma (Canada)","funders":"","keywords":"Dysbiosis; Microbiome; Biology; Metagenomics; Gut flora; Bile acid; Disease; Metaproteomics; Bioinformatics; Physiology; Immunology; Medicine; Genetics; Internal medicine; Endocrinology; Gene","score_opus":0.06233905028199166,"score_gpt":0.38908393972810057,"score_spread":0.3267448894461089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014099400","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014918767,0.99673146,0.000024331075,0.00025233108,0.00060662127,0.00074968353,0.0000915579,0.000026265885,0.000025893836],"genre_scores_gemma":[0.00095704285,0.99597645,0.0000515159,0.0008214946,0.0009146518,0.0001890676,0.0009850935,0.000042028198,0.000062659936],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997521,0.0006954252,0.00052102585,0.0008052153,0.000078505305,0.00037882966],"domain_scores_gemma":[0.9988846,0.000058544974,0.0002827126,0.00051476137,0.000039309092,0.00022002433],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004767937,0.00051834434,0.0008712797,0.000071129514,0.0004385957,0.00011152204,0.0003468437,0.0005129658,0.00002794241],"category_scores_gemma":[0.0000479089,0.00027151936,0.0004169843,0.0000888837,0.00035453826,0.000003670213,0.00020226315,0.00025098008,0.000012695908],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011679801,0.00015883199,0.00000828957,0.00017921084,0.00018922835,8.31356e-7,0.000016949967,8.81376e-9,0.026634973,0.0010515117,0.003995742,0.9676476],"study_design_scores_gemma":[0.0005342428,0.00043892683,0.00030491478,0.0004911402,0.0000052524383,0.000015382002,0.0000087436365,1.5434195e-7,0.00035505203,0.00006523252,0.99742,0.00036096806],"about_ca_topic_score_codex":0.000007718257,"about_ca_topic_score_gemma":0.000001245943,"teacher_disagreement_score":0.99342424,"about_ca_system_score_codex":0.000014739781,"about_ca_system_score_gemma":0.000037334383,"threshold_uncertainty_score":0.9999737},"labels":[],"label_agreement":null},{"id":"W2016420042","doi":"10.1517/14712598.8.5.583","title":"Immunological reconstitution after hematopoietic cell transplantation – its relation to the contents of the graft","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Immunology; Immunity; Immune system; Transplantation; Hematopoietic cell; Haematopoiesis; Acquired immune system; Medicine; Innate immune system; CD34; Hematopoietic stem cell transplantation; Biology; Stem cell; Internal medicine; Cell biology","score_opus":0.1296901490297976,"score_gpt":0.3541800439455187,"score_spread":0.2244898949157211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016420042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020925784,0.99120444,0.00035509162,0.00068013713,0.0011300052,0.0036377634,0.00006923878,0.00007007171,0.00076069735],"genre_scores_gemma":[0.016699437,0.9811617,0.00012418655,0.00080228894,0.00019799887,0.00067661214,0.00025514147,0.000030805313,0.000051811698],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969067,0.00077115034,0.0009993039,0.00057483156,0.0004451864,0.0003028465],"domain_scores_gemma":[0.9983063,0.000508437,0.00038987774,0.0005862957,0.000109291424,0.00009981394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026083825,0.00050231395,0.0011906591,0.00012504273,0.00017957654,0.000014480306,0.00036684974,0.00074343063,0.00022194764],"category_scores_gemma":[0.000070899456,0.00021321684,0.00078434346,0.00043975102,0.00023251594,0.000041203253,0.0000244886,0.0005495218,0.00020950164],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003739181,0.0016332917,0.00033746322,0.0021095783,0.00048901245,0.000055378183,0.0033534286,0.000013055608,0.0016035646,0.0017849831,0.0011038858,0.98377717],"study_design_scores_gemma":[0.0011418877,0.0008985984,0.0032491249,0.007878088,0.000016057556,0.0005464405,0.000042289183,0.0000017656326,0.0013147574,0.000021634212,0.98456603,0.00032334332],"about_ca_topic_score_codex":0.000005294527,"about_ca_topic_score_gemma":2.9477286e-7,"teacher_disagreement_score":0.98346215,"about_ca_system_score_codex":0.00011179825,"about_ca_system_score_gemma":0.000103828876,"threshold_uncertainty_score":0.86947304},"labels":[],"label_agreement":null},{"id":"W2024010256","doi":"10.1517/14712598.2013.770835","title":"Vedolizumab for Crohn's disease","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Vedolizumab; Medicine; Crohn's disease; Expert opinion; Adverse effect; Disease; Ustekinumab; Inflammatory bowel disease; Prednisone; Monoclonal antibody; Placebo; Intensive care medicine; Immunology; Internal medicine; Infliximab; Antibody; Alternative medicine; Pathology","score_opus":0.12473718159489504,"score_gpt":0.3899971346007448,"score_spread":0.26525995300584976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024010256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011608335,0.9955894,0.000114717885,0.000055688135,0.0009889804,0.002640535,0.00023351726,0.00006120229,0.0001998762],"genre_scores_gemma":[0.000026240157,0.98981816,0.00021956593,0.0011082448,0.0023965368,0.0034061617,0.0027741445,0.00009042865,0.00016050202],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976246,0.00033387743,0.0004801636,0.0009507733,0.00014166044,0.00046894344],"domain_scores_gemma":[0.9984286,0.00007769822,0.00023831816,0.000815853,0.000083854655,0.00035568676],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014922082,0.000667508,0.0007969751,0.000066282184,0.00014541889,0.00005654387,0.000589722,0.00072254037,0.00027556182],"category_scores_gemma":[0.0001706179,0.00042101907,0.001088768,0.000061026552,0.00015271205,0.000003314936,0.000104477724,0.00016856827,0.00021270117],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007350578,0.00021641473,0.0000029785128,0.00015589103,0.00014148685,0.000019384051,0.000004557788,4.5706398e-7,0.000049561673,0.00049366197,0.023885822,0.9742947],"study_design_scores_gemma":[0.0006541154,0.00042975167,0.00018366477,0.00050950464,0.0000018732826,0.0000028552208,0.0000030424007,0.0000016983973,0.000017245888,0.000112006135,0.99747664,0.0006076266],"about_ca_topic_score_codex":9.745715e-7,"about_ca_topic_score_gemma":7.009558e-8,"teacher_disagreement_score":0.9736871,"about_ca_system_score_codex":0.000042511576,"about_ca_system_score_gemma":0.00020258792,"threshold_uncertainty_score":0.99982417},"labels":[],"label_agreement":null},{"id":"W2027609803","doi":"10.1517/14712590903002039","title":"Reovirus-based therapy for cancer","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Immune system; Medicine; Toxicity; Cancer therapy; Antibody; Radiation therapy; Virus; Cancer; Cancer research; Immunology; Virology; Internal medicine","score_opus":0.211350578863113,"score_gpt":0.4692002501159638,"score_spread":0.25784967125285074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027609803","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014608451,0.99520487,0.00010744139,0.0004483736,0.0006674218,0.00295868,0.0002271724,0.00008444058,0.00015552202],"genre_scores_gemma":[0.000031976826,0.98560196,0.00022810214,0.006149697,0.0028125148,0.0030523587,0.0018640656,0.00014152702,0.00011778807],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99597603,0.0007471106,0.0006703053,0.0014529749,0.00032888624,0.000824665],"domain_scores_gemma":[0.9979798,0.00020778195,0.0003268713,0.0011022332,0.00015071804,0.0002325489],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006120861,0.0009653657,0.0014912337,0.00017918737,0.00023733932,0.00006265563,0.001086075,0.0013620909,0.00037782014],"category_scores_gemma":[0.000078284,0.00060983805,0.0013694157,0.0002763622,0.00021015339,0.00000337047,0.00005131838,0.00042174867,0.00004758303],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057029347,0.00041747277,0.000001082325,0.000037085014,0.00022910866,0.0000011620432,0.00000649632,0.0000048445704,0.004286303,0.000029769322,0.008289012,0.9809947],"study_design_scores_gemma":[0.0018557404,0.019961227,0.0000022309555,0.0006023977,0.0000010378699,0.0000023439425,0.0000025470297,0.0000035470796,0.0099026095,0.000055432665,0.9668134,0.00079751393],"about_ca_topic_score_codex":0.000007838955,"about_ca_topic_score_gemma":0.00000347152,"teacher_disagreement_score":0.9801972,"about_ca_system_score_codex":0.00010114813,"about_ca_system_score_gemma":0.00051321293,"threshold_uncertainty_score":0.9999344},"labels":[],"label_agreement":null},{"id":"W2031747016","doi":"10.1517/14712598.2014.922535","title":"Obinutuzumab for B-cell malignancies","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Obinutuzumab; Rituximab; Medicine; CD20; Chronic lymphocytic leukemia; Lymphoma; Oncology; Monoclonal antibody; Immunology; Internal medicine; Antibody; Leukemia","score_opus":0.25522970632836395,"score_gpt":0.4601535520919414,"score_spread":0.20492384576357747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031747016","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011743595,0.9933545,0.00016443316,0.00013573481,0.00087632105,0.0032779647,0.000036346162,0.00016902578,0.0019739273],"genre_scores_gemma":[0.000016427004,0.99242276,0.00062560407,0.0015388015,0.0022689472,0.0016861927,0.0006690048,0.000097945725,0.00067429506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99691623,0.00031329168,0.00072138663,0.00094576494,0.00039456255,0.0007087751],"domain_scores_gemma":[0.99714833,0.001352535,0.00024916485,0.0008656205,0.00011277974,0.00027157058],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005386618,0.0006742411,0.0025542073,0.00017447288,0.00012623271,0.000039194292,0.0004886766,0.0010602114,0.00046138413],"category_scores_gemma":[0.00026046805,0.00035826158,0.0013014568,0.00023126448,0.00022610177,0.000019649804,0.00008601989,0.00044552088,0.00044532248],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004998417,0.00025036163,1.04307894e-7,0.0010459764,0.00012481629,0.000009509633,0.000029593844,1.1848192e-7,0.000028754539,0.00086732587,0.024339804,0.9728038],"study_design_scores_gemma":[0.008241779,0.0040304167,2.5794688e-7,0.004312147,0.0000025365132,0.00008423521,0.000009696627,0.000032768276,0.00010920309,0.0000750757,0.9826802,0.00042166887],"about_ca_topic_score_codex":0.000015696409,"about_ca_topic_score_gemma":8.032697e-8,"teacher_disagreement_score":0.9723821,"about_ca_system_score_codex":0.0071174093,"about_ca_system_score_gemma":0.0036675704,"threshold_uncertainty_score":0.99988693},"labels":[],"label_agreement":null},{"id":"W2043054600","doi":"10.1517/14712598.8.7.941","title":"Regulation of collagen-derived antiangiogenic factors by p53","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Endostatin; Angiogenesis; Cancer research; Endogeny; Limiting; Biology; Suppressor; Cancer; Antiangiogenic therapy; Genetics; Endocrinology","score_opus":0.11182517663032905,"score_gpt":0.3674271000397027,"score_spread":0.25560192340937365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043054600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014583139,0.99713606,0.00011233979,0.000033835713,0.00046390307,0.0005179569,0.00014906746,0.00002078161,0.00010776815],"genre_scores_gemma":[0.0022278104,0.99413556,0.00008205356,0.00015882976,0.00055885373,0.00009023686,0.0026030638,0.0000496712,0.00009392952],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99822205,0.0002798288,0.0004226189,0.0006432398,0.00016624629,0.00026599193],"domain_scores_gemma":[0.99893576,0.000053199285,0.00039059037,0.0004690926,0.00006490365,0.00008646167],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000076404234,0.0004865249,0.0009703362,0.000064392276,0.000095309304,0.000012583885,0.00035428288,0.000922222,0.00014974999],"category_scores_gemma":[0.000032262877,0.00030331648,0.0010147393,0.00016692113,0.0001800211,0.0000024333838,0.00006043213,0.00006892801,0.0000084718395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015583744,0.0002671513,0.00004373998,0.000053100048,0.00051177514,7.169589e-7,0.00003374477,7.0684376e-7,0.12429155,0.000042151427,0.06795873,0.8066408],"study_design_scores_gemma":[0.00025861856,0.0008202532,0.00006394438,0.00025168547,0.0000011813048,0.0000064145743,0.000010790051,2.8504488e-7,0.020465892,0.0000031901927,0.9777489,0.00036886818],"about_ca_topic_score_codex":0.000005128255,"about_ca_topic_score_gemma":1.3979742e-7,"teacher_disagreement_score":0.90979016,"about_ca_system_score_codex":0.000031137133,"about_ca_system_score_gemma":0.0000859472,"threshold_uncertainty_score":0.9999419},"labels":[],"label_agreement":null},{"id":"W2044528239","doi":"10.1517/14712598.2013.764411","title":"Systemic lupus erythematosus: an update on current pharmacotherapy and future directions","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Pharmacotherapy; Current (fluid); Immunology; Intensive care medicine; Internal medicine","score_opus":0.16642661034340644,"score_gpt":0.44488979218688984,"score_spread":0.2784631818434834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044528239","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006767297,0.9873094,0.000010338137,0.00048792633,0.0056044543,0.0050710267,0.00006252058,0.00043023282,0.00034736877],"genre_scores_gemma":[0.00002298659,0.98997056,0.0000865255,0.00065227563,0.0061642495,0.0023848866,0.00043621752,0.00016910973,0.00011320641],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945348,0.0014090464,0.0010988306,0.0015010796,0.00068665954,0.0007696092],"domain_scores_gemma":[0.99710476,0.00046233193,0.0004570434,0.0011613728,0.00015740834,0.00065705786],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00060967717,0.0011659012,0.0030543203,0.00052765355,0.0002899365,0.00012278341,0.00051329343,0.00096728647,0.0010852368],"category_scores_gemma":[0.00003950146,0.0006126371,0.0007293938,0.00049894484,0.00024700267,0.00009575645,0.00007269836,0.0012845359,0.0006752446],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035190582,0.00075440976,0.00005036069,0.0012143548,0.00027706363,0.0000123129985,0.00028423496,2.4535106e-8,0.000058616886,0.0005992654,0.007319994,0.98907745],"study_design_scores_gemma":[0.00220306,0.0018679076,0.0000015681844,0.01433329,0.0000054468373,0.009787901,0.00017483949,0.0000066543766,0.0000144530495,0.000036055302,0.9709464,0.00062247156],"about_ca_topic_score_codex":0.000006129001,"about_ca_topic_score_gemma":1.0401886e-7,"teacher_disagreement_score":0.988455,"about_ca_system_score_codex":0.00035741003,"about_ca_system_score_gemma":0.000179444,"threshold_uncertainty_score":0.9998279},"labels":[],"label_agreement":null},{"id":"W2050062331","doi":"10.1517/14712598.2.6.665","title":"3rd World Congress on Vaccines and Immunisation","year":2002,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Virology; Medicine; Vaccination; Immunology","score_opus":0.14760584393702697,"score_gpt":0.3670298203704592,"score_spread":0.21942397643343226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050062331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85776025,0.030706609,0.000024013276,0.043138694,0.003271455,0.0007334528,0.0000051262837,0.00034865594,0.06401172],"genre_scores_gemma":[0.80103207,0.19353798,0.000038513368,0.003957854,0.0006455056,0.00002321861,0.0000048534584,0.000005795076,0.00075422734],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902785,0.00024354299,0.00014201019,0.0002389487,0.00014140521,0.00020624111],"domain_scores_gemma":[0.9994293,0.00026600444,0.000053451768,0.00014411908,0.000031467986,0.0000756702],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019000487,0.00012350916,0.0001524594,0.00006517416,0.00040750075,0.000060727187,0.00015338478,0.00010921786,0.0023690804],"category_scores_gemma":[0.00007245704,0.000081696686,0.00005251977,0.000152981,0.000033486715,0.000083520375,0.00001478874,0.000106648105,0.00009517921],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005931003,0.00073434424,0.021700982,9.882884e-7,0.000044994744,0.0000064689616,0.0075229825,0.0000029646135,0.0025464387,0.13310756,0.0978557,0.7358835],"study_design_scores_gemma":[0.0006202977,0.00049442047,0.024163077,0.000019165202,5.2359173e-8,3.4425028e-7,0.00032832994,0.000012338179,0.00047697243,0.0015046675,0.9722314,0.00014895509],"about_ca_topic_score_codex":0.0000508067,"about_ca_topic_score_gemma":0.000014655931,"teacher_disagreement_score":0.8743757,"about_ca_system_score_codex":0.00002966148,"about_ca_system_score_gemma":0.000005014357,"threshold_uncertainty_score":0.9985429},"labels":[],"label_agreement":null},{"id":"W2052659698","doi":"10.1517/14712598.2015.1001735","title":"Communicating in context: a priority for gene therapy researchers","year":2015,"lang":"en","type":"editorial","venue":"Expert Opinion on Biological Therapy","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; NeuroDevNet","funders":"University of British Columbia; Canada Research Chairs","keywords":"Context (archaeology); Public opinion; Ethical issues; Engineering ethics; Public involvement; Bioethics; Political science; Public relations; Medicine; Biology; Politics; Engineering","score_opus":0.13378243306530818,"score_gpt":0.45526483396988165,"score_spread":0.3214824009045735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052659698","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02979701,0.45467198,0.002012179,0.0012157502,0.50669503,0.004188384,0.0005167909,0.00015422136,0.0007486751],"genre_scores_gemma":[0.0218771,0.6466126,0.001701739,0.00058704044,0.3251114,0.00077189825,0.0031609694,0.00009827402,0.000078994744],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99778575,0.00032876118,0.00039705564,0.00069434574,0.00030962678,0.00048445744],"domain_scores_gemma":[0.9983403,0.0004018879,0.00011729918,0.0007681932,0.000226437,0.00014586505],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011652173,0.00040450515,0.00047652956,0.000077190685,0.000089301924,0.00004131664,0.00076099054,0.0013710409,0.000018047434],"category_scores_gemma":[0.0009266858,0.00030658868,0.00021578284,0.00010060063,0.00013584812,0.00000238479,0.00014433298,0.0006017814,0.0000049327764],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028669797,0.0003373025,0.000046570167,0.000004717505,0.0001030912,0.0000012723883,0.00037392866,0.000027593436,0.10360951,0.000023511282,0.76373976,0.12886578],"study_design_scores_gemma":[0.0028791835,0.002575938,0.000042038682,0.000042335327,9.470154e-8,6.2290525e-7,0.000105689076,0.000028334889,0.022954784,0.00008208559,0.97090036,0.0003885126],"about_ca_topic_score_codex":0.000078451194,"about_ca_topic_score_gemma":0.000016077713,"teacher_disagreement_score":0.20716064,"about_ca_system_score_codex":0.00007692068,"about_ca_system_score_gemma":0.00019428489,"threshold_uncertainty_score":0.9999386},"labels":[],"label_agreement":null},{"id":"W2053775344","doi":"10.1517/14712598.7.11.1731","title":"Review of hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine safety and efficacy","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Adjuvant; CpG Oligodeoxynucleotide; Hepatitis B virus; Vaccination; Immunology; Virology; Antigen; Immune system; Hepatitis B; Titer; Antibody titer; Antibody; Virus; Biology","score_opus":0.18240606643472634,"score_gpt":0.4394716266530102,"score_spread":0.25706556021828386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053775344","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000089381916,0.9953875,0.000046858546,0.00041471227,0.0005485176,0.0023894543,0.000080145524,0.00011997623,0.0009234728],"genre_scores_gemma":[0.000041053107,0.9939097,0.0006832132,0.0042805774,0.00052732794,0.00004701636,0.00041242596,0.00007044905,0.000028226092],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960376,0.000561726,0.0016408965,0.0008794701,0.0003504145,0.0005299033],"domain_scores_gemma":[0.9970869,0.0011761525,0.0006654919,0.00064580876,0.0001891389,0.00023651529],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011076988,0.00081281655,0.0049259276,0.00014279452,0.00014567965,0.000010451705,0.0002515865,0.00062572525,0.00059705804],"category_scores_gemma":[0.0006295128,0.00047870216,0.00069596904,0.0004420354,0.00018893433,0.000035411293,0.00013617128,0.0005920274,0.000055943874],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003893499,0.00024394934,0.0009353541,0.003953698,0.00036476177,0.000020291327,0.00007409313,1.816817e-8,0.000008597743,0.00009588831,0.0025656298,0.9913484],"study_design_scores_gemma":[0.0011749362,0.0025747004,0.0017749846,0.12252218,0.000008447632,0.000053171592,0.000005576899,5.7605905e-7,0.000014396291,0.0000039355687,0.87144876,0.0004183463],"about_ca_topic_score_codex":0.00022719117,"about_ca_topic_score_gemma":0.000005194465,"teacher_disagreement_score":0.99093,"about_ca_system_score_codex":0.00013143539,"about_ca_system_score_gemma":0.00011400525,"threshold_uncertainty_score":0.99976647},"labels":[],"label_agreement":null},{"id":"W2056009313","doi":"10.1517/14712598.2011.548800","title":"Intramuscular cell transplantation as a potential treatment of myopathies: clinical and preclinical relevant data","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Wilfrid Laurier University; Centre hospitalier de l'Université Laval","funders":"","keywords":"Skeletal muscle; Transplantation; Medicine; Pathology; Bioinformatics; Biology; Internal medicine","score_opus":0.2393148947207628,"score_gpt":0.4463102190954453,"score_spread":0.20699532437468252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056009313","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002930338,0.99531406,0.00013438989,0.000027272306,0.0005357256,0.0007333067,0.00015385961,0.000017406184,0.0001536456],"genre_scores_gemma":[0.0018973902,0.9932669,0.00027191045,0.00020531271,0.0005889156,0.00009712756,0.0036333234,0.000029063356,0.000010078712],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99677825,0.0009612336,0.0008490146,0.0010882958,0.00008413712,0.00023904667],"domain_scores_gemma":[0.9984192,0.00016462499,0.00033747248,0.00092317106,0.000031394102,0.00012409582],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036232648,0.0004518247,0.0011842585,0.000044995555,0.00006608777,0.000009024891,0.00047626335,0.0011977335,0.00008550145],"category_scores_gemma":[0.000076448436,0.00027211913,0.00051576673,0.000053544143,0.00048007624,0.0000043641885,0.00009546473,0.00019627386,0.000016900429],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016285087,0.0011941724,0.000021414542,0.00011061659,0.00025144982,0.0000038084654,0.000041229436,2.0009448e-7,0.00031885362,0.000093242874,0.00023355718,0.9961029],"study_design_scores_gemma":[0.0013921708,0.010004024,0.00012506777,0.00026513546,0.000011746001,0.00001644758,0.000016407414,0.0000021215285,0.00017289376,0.00012591199,0.9875445,0.00032361274],"about_ca_topic_score_codex":0.000016529779,"about_ca_topic_score_gemma":6.322345e-7,"teacher_disagreement_score":0.99577934,"about_ca_system_score_codex":0.00000567291,"about_ca_system_score_gemma":0.00011636369,"threshold_uncertainty_score":0.9999731},"labels":[],"label_agreement":null},{"id":"W2056126151","doi":"10.1517/14712598.4.4.507","title":"Hepatocyte growth factor gene therapy for islet transplantation","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institutes of Health; National Institute for Health and Care Research","keywords":"Islet; Transplantation; Hepatocyte growth factor; Biology; Beta cell; Immunology; Cancer research; Genetic enhancement; Context (archaeology); Pancreatic islets; Medicine; Endocrinology; Internal medicine; Diabetes mellitus; Gene","score_opus":0.20152012358907712,"score_gpt":0.4022186675813466,"score_spread":0.2006985439922695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056126151","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029660962,0.9940986,0.00060412346,0.00026765247,0.0010152104,0.002976409,0.0002270172,0.00021971321,0.000294674],"genre_scores_gemma":[0.000077582416,0.99108607,0.00086384837,0.0028829928,0.0012484762,0.0012390222,0.002481146,0.00006666051,0.00005420068],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978738,0.00019852845,0.0006055252,0.00069948606,0.00023494966,0.00038773054],"domain_scores_gemma":[0.9986126,0.0005346391,0.00023184471,0.0003393917,0.00008922345,0.00019231749],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016127387,0.0006350445,0.001774296,0.00017153569,0.00011985444,0.000028576385,0.0001794539,0.00075512164,0.0006124081],"category_scores_gemma":[0.00007311613,0.00034404863,0.0009986985,0.00020270144,0.000100045465,0.000036632468,0.000006857103,0.0002840313,0.00009515226],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014623671,0.00050695846,0.0000123887085,0.00046774102,0.00034202923,0.0000053686817,0.00009720638,8.431159e-8,0.00053182605,0.00063382165,0.0007327015,0.9952075],"study_design_scores_gemma":[0.0041003753,0.0038116083,0.00004627303,0.0028096624,0.0000046475902,0.00003093614,0.000005304563,0.0000014632082,0.0018826445,0.000192901,0.98670155,0.00041264883],"about_ca_topic_score_codex":0.0000076021183,"about_ca_topic_score_gemma":2.0077126e-8,"teacher_disagreement_score":0.99479485,"about_ca_system_score_codex":0.00015706864,"about_ca_system_score_gemma":0.0001813011,"threshold_uncertainty_score":0.9999012},"labels":[],"label_agreement":null},{"id":"W2056867349","doi":"10.1517/14712598.2.7.751","title":"HIV-1 drug resistance: can we overcome?","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Reverse transcriptase; Drug resistance; Drug; Nucleoside Reverse Transcriptase Inhibitor; Virology; Protease; Protease inhibitor (pharmacology); Biology; HIV drug resistance; Medicine; Human immunodeficiency virus (HIV); Immunology; Antiretroviral therapy; Viral load; Pharmacology; Genetics; Enzyme; RNA; Gene","score_opus":0.15405837618061594,"score_gpt":0.3821740819905895,"score_spread":0.22811570580997356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056867349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000033041254,0.9824016,0.0000032548583,0.010058779,0.0006826554,0.0014035526,0.000052822626,0.0002142055,0.0051797894],"genre_scores_gemma":[0.0000030346282,0.9573358,0.0005592253,0.0010380716,0.0008363316,0.00050413935,0.0010076578,0.00006680726,0.038648926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99715924,0.00033027894,0.0007129713,0.00089683983,0.00038678496,0.00051389966],"domain_scores_gemma":[0.9984788,0.00031301234,0.00024582903,0.00063867756,0.000043092492,0.00028062332],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00017994281,0.0008304553,0.002254195,0.00021435824,0.00015399078,0.000032151183,0.00029412785,0.0005847736,0.0024215349],"category_scores_gemma":[0.00003857373,0.00043806675,0.0008343321,0.00035927826,0.00012754988,0.000021756689,0.00004986967,0.00052490656,0.0010357121],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012264188,0.0005526861,0.000012931252,0.00015074578,0.00032111612,0.000054892233,0.00024058246,6.4983476e-9,8.377569e-7,0.00038679002,0.17103323,0.8271235],"study_design_scores_gemma":[0.0012996865,0.0001561474,0.000006255992,0.00700847,0.000004438394,0.000023038992,0.000026386018,2.1671013e-7,0.000007997826,0.000066844535,0.99089795,0.0005025862],"about_ca_topic_score_codex":0.0000015968379,"about_ca_topic_score_gemma":6.8372464e-7,"teacher_disagreement_score":0.82662094,"about_ca_system_score_codex":0.00038438253,"about_ca_system_score_gemma":0.00012991915,"threshold_uncertainty_score":0.9998071},"labels":[],"label_agreement":null},{"id":"W2057415537","doi":"10.1517/14712598.2012.693474","title":"<b>Probiotics as oral health biotherapeutics</b>","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Oral microbiology and periodontitis research","field":"Dentistry","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Gingivitis; Periodontitis; Medicine; Oral health; Immunology; Oral Microbiome; Intensive care medicine; Oral cavity; Dentistry","score_opus":0.45089260106818485,"score_gpt":0.5190177562518071,"score_spread":0.06812515518362228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057415537","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002392838,0.9927485,0.000021263077,0.00031798528,0.004340506,0.0013599236,0.00024225737,0.0002345255,0.0007110871],"genre_scores_gemma":[0.00004720816,0.99256134,0.0002679759,0.0036383045,0.0016227425,0.00013625101,0.0012053956,0.00008464981,0.0004361108],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945429,0.0021361432,0.0009348511,0.0009685373,0.0002462734,0.0011712871],"domain_scores_gemma":[0.9978818,0.0004209283,0.00043094755,0.0008398601,0.00006177209,0.00036467137],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008613329,0.00089085876,0.0024439362,0.00023224168,0.00036638443,0.000115529045,0.0009989367,0.0018683248,0.0067314506],"category_scores_gemma":[0.000046588117,0.0005354691,0.00095140876,0.00039972854,0.00044939393,0.000067424065,0.0001691147,0.0013542927,0.008199842],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014356598,0.00045472235,0.000024550134,0.0001350916,0.0002151963,0.000009680274,0.000042691056,2.3684093e-8,0.00002401332,0.0014039611,0.0069483966,0.9905981],"study_design_scores_gemma":[0.0004901343,0.0019137915,0.000031614672,0.0011285468,0.0000010765866,0.00017640885,0.000012434122,1.5811342e-7,0.000021993175,0.000075153446,0.9955201,0.0006285687],"about_ca_topic_score_codex":0.00006800202,"about_ca_topic_score_gemma":0.000005498072,"teacher_disagreement_score":0.98996955,"about_ca_system_score_codex":0.00024680508,"about_ca_system_score_gemma":0.00026295686,"threshold_uncertainty_score":0.99970967},"labels":[],"label_agreement":null},{"id":"W2059925584","doi":"10.1517/14712598.2013.743526","title":"Influence of lipoplex surface charge on siRNA delivery: application to the<i>in vitro</i>downregulation of CXCR4 HIV-1 co-receptor","year":2013,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Public Health Agency of Canada","funders":"Institut National de la Santé et de la Recherche Médicale; Public Health Agency of Canada","keywords":"Downregulation and upregulation; In vitro; Chemistry; Human immunodeficiency virus (HIV); Receptor; CXCR4; Cell biology; Surface charge; Pharmacology; Biophysics; Immunology; Biology; Biochemistry; Gene","score_opus":0.023968691748898152,"score_gpt":0.2919159093127898,"score_spread":0.26794721756389167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059925584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99740696,0.0008343925,0.0001723402,0.00079647166,0.00005671511,0.0005659363,0.000054264274,0.000008844849,0.0001041038],"genre_scores_gemma":[0.98864025,0.00918117,0.00014426657,0.0014476355,0.00012353397,0.000104612816,0.00032227742,0.00000895873,0.000027279884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895465,0.000118527576,0.0002953353,0.00033140328,0.00012903512,0.00017102298],"domain_scores_gemma":[0.99931186,0.000043232492,0.00012959512,0.0003543033,0.000112306334,0.00004868342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015114031,0.00015907429,0.00019137343,0.00003791115,0.000035188124,0.0000075308153,0.0002946855,0.0001737867,0.00008472229],"category_scores_gemma":[0.000031349395,0.00010011123,0.0000835422,0.00011440776,0.000075630946,0.000006547476,0.00003412226,0.00007091649,0.00023269474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070317066,0.00016389904,0.00073659886,9.3924615e-7,0.000013199938,2.6202997e-8,0.000086676446,0.0015877469,0.98026717,0.0000437023,0.0024562497,0.013940633],"study_design_scores_gemma":[0.00037815544,0.0012407923,0.024287071,0.000018719922,8.956454e-8,3.0858277e-7,0.00003914563,0.00015516738,0.9046354,0.000014026513,0.06910108,0.00012999606],"about_ca_topic_score_codex":0.000096817006,"about_ca_topic_score_gemma":9.4880335e-7,"teacher_disagreement_score":0.07563171,"about_ca_system_score_codex":0.000014275242,"about_ca_system_score_gemma":0.000014922643,"threshold_uncertainty_score":0.40824178},"labels":[],"label_agreement":null},{"id":"W2064487427","doi":"10.1517/14712598.2014.896335","title":"New developments in exon skipping and splice modulation therapies for neuromuscular diseases","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Exon skipping; Duchenne muscular dystrophy; Spinal muscular atrophy; Medicine; Dystrophin; Exon; Myopathy; Muscular dystrophy; SMA*; Bioinformatics; Alternative splicing; Biology; Genetics; Internal medicine; Disease; Gene","score_opus":0.19200563548559724,"score_gpt":0.43988141626171695,"score_spread":0.24787578077611971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064487427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004306361,0.9956507,0.0008695569,0.0002383715,0.00019377735,0.002512836,0.0000056913455,0.00004583307,0.00005261123],"genre_scores_gemma":[0.00027535405,0.9969159,0.00090894604,0.0007689425,0.00031997188,0.00047513927,0.00025827944,0.000048162605,0.000029336305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980489,0.0002981882,0.00041944807,0.0006775199,0.00022955355,0.00032638802],"domain_scores_gemma":[0.99906945,0.00030861245,0.0001110367,0.00029045952,0.00003472697,0.00018573678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019154129,0.00039148494,0.0011429652,0.00020086915,0.000078730816,0.000024196597,0.00015357186,0.00031266396,0.000042711687],"category_scores_gemma":[0.00012331326,0.00023924968,0.00033256906,0.00018787793,0.00005995371,0.000022619477,0.000046550853,0.00021769384,0.000008892811],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015673364,0.000119905264,0.00010787944,0.00024340836,0.00008116933,0.0000020777413,0.000053324842,3.1423463e-7,0.000038811944,0.00011947075,0.00019774243,0.99887913],"study_design_scores_gemma":[0.0014994221,0.00079216575,0.0029411742,0.0017635257,0.0000021356807,0.0000089480545,0.000013433878,0.000017057853,0.000005706528,0.00011194503,0.99259394,0.0002505581],"about_ca_topic_score_codex":0.000008799282,"about_ca_topic_score_gemma":2.905506e-7,"teacher_disagreement_score":0.9986286,"about_ca_system_score_codex":0.00004377447,"about_ca_system_score_gemma":0.00012307924,"threshold_uncertainty_score":0.9756319},"labels":[],"label_agreement":null},{"id":"W2067891932","doi":"10.1517/14712598.2013.849690","title":"Stem cells as a potential therapy for necrotizing enterocolitis","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Infant Nutrition and Health","field":"Nursing","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Necrotizing enterocolitis; Stem cell; Medicine; Disease; Stem-cell therapy; Enterocolitis; Mesenchymal stem cell; Intensive care medicine; Clinical trial; Cell therapy; Bioinformatics; Immunology; Internal medicine; Pathology; Biology","score_opus":0.21931025229118914,"score_gpt":0.432077471521882,"score_spread":0.21276721923069283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067891932","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004221582,0.98479885,0.0001135993,0.0009947493,0.005909861,0.0074484767,0.00013600606,0.00029434974,0.0002618702],"genre_scores_gemma":[0.000024336749,0.9831721,0.000476232,0.009430013,0.0029349742,0.003357845,0.00040815026,0.00011283202,0.00008350993],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99610144,0.0007978039,0.0009945893,0.0009885785,0.00027645176,0.0008411448],"domain_scores_gemma":[0.9981102,0.00046967246,0.0005267464,0.0005126678,0.00011453521,0.0002661879],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003548808,0.00081623835,0.0019992045,0.00022114268,0.00043145285,0.00017748543,0.00047331274,0.0011294356,0.0010789022],"category_scores_gemma":[0.000009579088,0.0005093659,0.0013440583,0.00017760819,0.000114037306,0.00008160199,0.000038442126,0.0005593794,0.0005394335],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070877833,0.0003827366,2.266111e-7,0.00019404152,0.00007089587,0.0000025653756,0.000108817694,6.739801e-8,0.00016528703,0.00057081104,0.019331394,0.97846437],"study_design_scores_gemma":[0.0020416619,0.004258608,0.0000012219134,0.0025328784,0.0000010268338,0.000038371232,0.00005337357,0.0000047007893,0.0004237285,0.0002569699,0.98976994,0.0006175182],"about_ca_topic_score_codex":0.000036134803,"about_ca_topic_score_gemma":1.3508416e-7,"teacher_disagreement_score":0.97784686,"about_ca_system_score_codex":0.00020808676,"about_ca_system_score_gemma":0.00006536363,"threshold_uncertainty_score":0.99983424},"labels":[],"label_agreement":null},{"id":"W2073735031","doi":"10.1517/14712598.7.11.1621","title":"Stem cell therapy for joint problems using the horse as a clinically relevant animal model","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Osteoarthritis; Stem cell; Articular cartilage; Joint disease; Cartilage; Medicine; Clinical trial; Stem-cell therapy; Animal model; Disease; Pathology; Bioinformatics; Biology; Internal medicine; Mesenchymal stem cell; Anatomy; Alternative medicine","score_opus":0.41343770787066864,"score_gpt":0.45639515892740135,"score_spread":0.04295745105673271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073735031","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008421258,0.9889506,0.0007879421,0.00028653635,0.0007227566,0.0078012114,0.00005207584,0.0001726664,0.00038410406],"genre_scores_gemma":[0.00017212391,0.99069625,0.0036512052,0.002615933,0.0011764932,0.001075798,0.00026981652,0.00013154247,0.00021082674],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961167,0.0003658554,0.0013530107,0.0010611996,0.00039200005,0.00071126287],"domain_scores_gemma":[0.99764776,0.00059187075,0.0006074945,0.00076391175,0.00013010969,0.00025884845],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001089882,0.00090370385,0.0023104476,0.0001420416,0.0002739449,0.00005641587,0.00035452688,0.0011746263,0.00009313732],"category_scores_gemma":[0.000028307602,0.00040571106,0.0016969609,0.00020994578,0.00017615734,0.00003867939,0.000059776492,0.000675457,0.00005538455],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001987783,0.0009866395,8.635388e-7,0.000107158456,0.0001376786,0.0000123133495,0.00015633187,0.0000016453713,0.0013449006,0.00057807507,0.000253284,0.99443334],"study_design_scores_gemma":[0.004270797,0.028605502,3.8212906e-7,0.003399828,0.000010125062,0.000076785815,0.00006657177,0.00015725421,0.0004110128,0.00031104693,0.9621859,0.0005047617],"about_ca_topic_score_codex":0.000003928004,"about_ca_topic_score_gemma":1.4152904e-7,"teacher_disagreement_score":0.99392855,"about_ca_system_score_codex":0.00016880574,"about_ca_system_score_gemma":0.0003258863,"threshold_uncertainty_score":0.9998395},"labels":[],"label_agreement":null},{"id":"W2079056967","doi":"10.1517/14712598.2013.825243","title":"Monoclonal versus polyclonal anti-D in the treatment of ITP","year":2013,"lang":"en","type":"editorial","venue":"Expert Opinion on Biological Therapy","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Polyclonal antibodies; Monoclonal antibody; Medicine; Platelet; Immunology; Monoclonal; Antibody; Immune thrombocytopenia; Antigen","score_opus":0.09213275429221066,"score_gpt":0.3777085335788159,"score_spread":0.28557577928660527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079056967","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3366233,0.059055556,0.0000017270364,0.0023361368,0.5975648,0.0021273093,0.00023139245,0.000066491935,0.0019932275],"genre_scores_gemma":[0.029070029,0.70941454,0.00012168399,0.00040111202,0.25812793,0.00042821944,0.002324923,0.00003480243,0.00007678762],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812484,0.0001743154,0.0003854208,0.00048598018,0.0004988761,0.00033058156],"domain_scores_gemma":[0.9982986,0.0010155749,0.00015639703,0.000391537,0.0000594474,0.00007846319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010250815,0.00044438717,0.00089482364,0.000107324115,0.00005647682,0.000017148572,0.00022182177,0.00083208387,0.00040885468],"category_scores_gemma":[0.00006451754,0.00020032648,0.00033779797,0.00013725556,0.00014691894,0.000022052074,0.000011942849,0.00029670182,0.00006538432],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011976048,0.01046288,0.0006723222,0.0000042467623,0.0007032206,0.00017889055,0.0007425192,0.0000011105542,0.00046029795,0.00016490615,0.87222165,0.10241189],"study_design_scores_gemma":[0.010779738,0.015779508,0.0024099187,0.000058031994,0.0000014123212,0.000004592138,0.00007977128,0.000004333189,0.00024722406,0.00006763108,0.9703806,0.00018725515],"about_ca_topic_score_codex":0.00025925657,"about_ca_topic_score_gemma":0.0000020476352,"teacher_disagreement_score":0.650359,"about_ca_system_score_codex":0.00013970464,"about_ca_system_score_gemma":0.000102467595,"threshold_uncertainty_score":0.8169077},"labels":[],"label_agreement":null},{"id":"W2080115034","doi":"10.1517/14712598.1.5.881","title":"Theratope® vaccine (STn-KLH)","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Keyhole limpet hemocyanin; Immunotherapy; Immunostimulant; Vaccination; Immunology; Oncology; Clinical trial; Cancer vaccine; Breast cancer; Cancer; Cyclophosphamide; Immune system; Antigen; Internal medicine; Cancer immunotherapy; Chemotherapy","score_opus":0.17855899932676764,"score_gpt":0.43677442727424215,"score_spread":0.25821542794747454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080115034","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004334031,0.995268,0.000108853936,0.00026136366,0.00048504234,0.0011102722,0.000030076968,0.000055585697,0.0026374583],"genre_scores_gemma":[0.00005525914,0.99445105,0.000109484616,0.0011830117,0.0017724414,0.00041663967,0.0013035518,0.00006863709,0.00063991785],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971948,0.0005873618,0.0005200278,0.0009354189,0.00026347587,0.00049887964],"domain_scores_gemma":[0.99866384,0.00006481968,0.00018605142,0.00080614554,0.00008771574,0.0001914525],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029742182,0.0006084248,0.00096480356,0.00012511357,0.00017605495,0.00006347832,0.0006677756,0.0010398589,0.0014404729],"category_scores_gemma":[0.00010233803,0.00035804164,0.0006289947,0.00031059756,0.000075360316,0.0000028902434,0.0001415828,0.0004265965,0.00040262123],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018864882,0.00021316546,0.0000045624774,0.000023585071,0.00011167977,0.000005122759,0.0000057001503,3.6683923e-7,0.0006877004,0.00018237042,0.011235269,0.9873418],"study_design_scores_gemma":[0.0006271151,0.0015673669,0.000007917962,0.0004053763,4.0262375e-7,0.000031063697,0.000005872904,8.516524e-7,0.0005021744,0.000032960557,0.9963448,0.0004740684],"about_ca_topic_score_codex":0.000007953147,"about_ca_topic_score_gemma":7.7119455e-7,"teacher_disagreement_score":0.9868678,"about_ca_system_score_codex":0.00003974146,"about_ca_system_score_gemma":0.000087629,"threshold_uncertainty_score":0.99988717},"labels":[],"label_agreement":null},{"id":"W2084040310","doi":"10.1517/14712598.1.2.205","title":"In utero stem cell transplantation: two steps forward but one step back?","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"In utero; Transplantation; Stem cell; Haematopoiesis; Genetic enhancement; Medicine; Immunology; Hematopoietic stem cell transplantation; Pathological; Immune system; Fetus; Bioinformatics; Biology; Internal medicine; Pregnancy; Gene; Genetics","score_opus":0.29569321843290425,"score_gpt":0.4462934717339949,"score_spread":0.15060025330109067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084040310","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013543047,0.9848974,0.0002029483,0.00039949414,0.0007107576,0.0033305488,0.000052804382,0.00008263372,0.01018798],"genre_scores_gemma":[0.00004434862,0.9937996,0.00049143087,0.0010469793,0.0012108836,0.00054524204,0.00067442533,0.000085600426,0.0021014356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948673,0.001151309,0.0011996903,0.0011719227,0.0007691641,0.0008405647],"domain_scores_gemma":[0.9976133,0.00083538704,0.0002785793,0.0007703232,0.0000838421,0.0004185738],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00074839697,0.0008051932,0.0026983146,0.0003937071,0.00008387229,0.000049601054,0.00055674475,0.00097148004,0.004370057],"category_scores_gemma":[0.00001585224,0.00049370993,0.00074331835,0.000705699,0.00014963877,0.0000691192,0.000057458466,0.0011522806,0.001180894],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008876236,0.0008461926,0.000021020136,0.0010270444,0.00010475344,0.00032811178,0.00008799884,2.6209912e-7,0.00006807168,0.00012123036,0.0016646159,0.99484307],"study_design_scores_gemma":[0.0032732298,0.0025492099,0.00002335461,0.005952016,0.0000031779489,0.0001809096,0.000042574655,0.0000045379697,0.00015502545,0.00001530717,0.98729074,0.00050991296],"about_ca_topic_score_codex":0.00005768689,"about_ca_topic_score_gemma":0.0000019781528,"teacher_disagreement_score":0.99433315,"about_ca_system_score_codex":0.00033659552,"about_ca_system_score_gemma":0.00018994261,"threshold_uncertainty_score":0.99975145},"labels":[],"label_agreement":null},{"id":"W2086624612","doi":"10.1517/14712598.8.2.191","title":"Antigen-specific therapy of rheumatoid arthritis","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Western University","funders":"Newcastle University","keywords":"Immunotherapy; Immunology; Medicine; Immune system; Antigen; Autoimmunity; Rheumatoid arthritis","score_opus":0.18537649515428006,"score_gpt":0.39376500467670594,"score_spread":0.20838850952242588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086624612","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042237988,0.9958028,0.00001705699,0.00017879944,0.0006815968,0.0018393012,0.000049619393,0.00018545632,0.00082299765],"genre_scores_gemma":[0.00014837064,0.9977756,0.0002665262,0.00037536985,0.00049893494,0.0003641178,0.00045582422,0.000108795895,0.0000064308438],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99580836,0.00064631994,0.001237938,0.00091897766,0.0006812652,0.0007071418],"domain_scores_gemma":[0.99762166,0.000497872,0.0004372589,0.00093695655,0.0001624979,0.00034373827],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028610896,0.00085647614,0.003417742,0.0003950814,0.00021287256,0.00003683545,0.00051056436,0.00081842137,0.0018495352],"category_scores_gemma":[0.00007207047,0.0005044244,0.0014930705,0.00049690803,0.0007331041,0.00006246219,0.00006272969,0.0007770579,0.00030575396],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005885787,0.0008174984,0.000020303132,0.000011912993,0.0003382117,0.000041542702,0.00013208992,2.2863302e-8,0.00012973793,0.000702955,0.0086425105,0.9885746],"study_design_scores_gemma":[0.002759875,0.0034091289,0.0000647682,0.008697046,6.5081367e-9,0.00048584962,0.00002514958,2.6506186e-7,0.00023217419,0.00008044984,0.9837541,0.00049121433],"about_ca_topic_score_codex":0.00001370698,"about_ca_topic_score_gemma":1.4637189e-7,"teacher_disagreement_score":0.9880834,"about_ca_system_score_codex":0.00007191226,"about_ca_system_score_gemma":0.00023997795,"threshold_uncertainty_score":0.9997407},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2087733415","doi":"10.1517/14712598.2011.592490","title":"Emepepimut-S for non-small cell lung cancer","year":2011,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Immunotherapy; Medicine; MUC1; Clinical trial; Lung cancer; Oncology; Cancer; Cancer vaccine; Immune system; Drug; Cancer immunotherapy; Internal medicine; Immunology; Pharmacology","score_opus":0.08542551647419659,"score_gpt":0.31445524941100444,"score_spread":0.22902973293680784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087733415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95306474,0.028619472,0.008425273,0.00035887305,0.0012395857,0.0014111492,0.000048470418,0.000052136533,0.0067803226],"genre_scores_gemma":[0.85318464,0.13650477,0.005064188,0.0033730713,0.0007622143,0.0006577873,0.00023406059,0.00003368731,0.00018560146],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991561,0.000026904767,0.00021857464,0.00028247785,0.00004834639,0.00026757928],"domain_scores_gemma":[0.9995078,0.000014412912,0.000086442065,0.00027713136,0.00005144847,0.000062790525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012166743,0.00020008713,0.00016825777,0.00002349936,0.000096863674,0.000014866052,0.00026484596,0.00022280747,0.00013111746],"category_scores_gemma":[0.000012604482,0.00012964784,0.00016097269,0.000042500473,0.00003190748,0.0000032530875,0.000050735813,0.00006669632,0.0000069063435],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002843992,0.0010213997,0.006774335,0.000019258398,0.00023321797,5.3189325e-7,0.0016673558,0.000016272292,0.8738215,0.00088700885,0.037137114,0.075578],"study_design_scores_gemma":[0.0016675275,0.0020253118,0.0027455974,0.000014293503,3.3590595e-7,0.0000013213254,0.00018051242,0.0003380792,0.45769286,0.00008107191,0.53492326,0.00032982108],"about_ca_topic_score_codex":0.000014950629,"about_ca_topic_score_gemma":5.841738e-7,"teacher_disagreement_score":0.49778613,"about_ca_system_score_codex":0.000009104231,"about_ca_system_score_gemma":0.00002412867,"threshold_uncertainty_score":0.52868855},"labels":[],"label_agreement":null},{"id":"W2088888314","doi":"10.1517/14712598.4.12.1871","title":"Myoblast transplantation for inherited myopathies: a clinical approach","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"","keywords":"Transplantation; Myocyte; Immunosuppression; Medicine; Cell; Immunology; Cancer research; Bioinformatics; Biology; Internal medicine; Genetics","score_opus":0.19767963522054371,"score_gpt":0.44143888833381967,"score_spread":0.24375925311327595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088888314","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013349076,0.9940594,0.0032110263,0.000037387716,0.00067211676,0.0014492292,0.00012034164,0.00004959703,0.00026744095],"genre_scores_gemma":[0.00020301936,0.9894385,0.00092277117,0.0010042267,0.001129273,0.0010343058,0.006203048,0.000051151477,0.000013730741],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99735314,0.0005285477,0.0006865,0.0009912099,0.000090091286,0.0003505038],"domain_scores_gemma":[0.99899095,0.00015825914,0.00026796752,0.00042457346,0.00004795975,0.000110310975],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00036391415,0.0005314105,0.0010689747,0.00006220296,0.000137233,0.000018695098,0.00039897577,0.0015399636,0.000030472673],"category_scores_gemma":[0.000095371746,0.00034524137,0.0010176979,0.00011460857,0.00025587948,0.0000028198594,0.00003255207,0.00030989794,0.000017660777],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015831728,0.00078279903,0.0000027903602,0.00038640655,0.00023681832,7.2369505e-7,0.00003906765,0.0000050344943,0.0002744527,0.0005199022,0.001337911,0.9948309],"study_design_scores_gemma":[0.0014698503,0.003496083,0.000029993314,0.0006511378,0.0000024659248,0.000009262473,0.000019446277,0.000002072906,0.000040709467,0.0001741803,0.99363756,0.00046721354],"about_ca_topic_score_codex":0.0000024812055,"about_ca_topic_score_gemma":2.0163205e-7,"teacher_disagreement_score":0.9943637,"about_ca_system_score_codex":0.000018620443,"about_ca_system_score_gemma":0.00014248934,"threshold_uncertainty_score":0.9999},"labels":[],"label_agreement":null},{"id":"W2090149045","doi":"10.1517/14728220802517935","title":"Trastuzumab cardiotoxicity: biological hypotheses and clinical open issues","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Trastuzumab; Cardiotoxicity; Medicine; Anthracycline; Oncology; Internal medicine; Breast cancer; Toxicity; Clinical trial; Adjuvant; Metastatic breast cancer; Cancer; Disease; Pharmacology","score_opus":0.35025699814929895,"score_gpt":0.44328700576051006,"score_spread":0.09303000761121111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090149045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812112,0.010011699,0.000114113456,0.0035000544,0.0004282813,0.0012163047,0.000012036717,0.00019835703,0.0033079688],"genre_scores_gemma":[0.6707205,0.32004473,0.00076272764,0.0073277247,0.0009456863,0.00006645349,0.00004098075,0.000018893867,0.00007231357],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976039,0.0004633355,0.00051336794,0.00079341704,0.00025956455,0.00036644985],"domain_scores_gemma":[0.9986624,0.00044329415,0.00010967637,0.0004229068,0.00007302893,0.0002886552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059069064,0.00034927155,0.0009457462,0.00006986997,0.00027922384,0.000046871704,0.0002869175,0.00059043826,0.00029753282],"category_scores_gemma":[0.00027096883,0.00021363865,0.00035953443,0.00017263695,0.00065025286,0.00009556849,0.000105357634,0.00042116773,0.00004443577],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009048125,0.0035393836,0.07503937,0.000005159214,0.0009095225,0.0001459331,0.001316581,0.0000012732619,0.3477275,0.0024555603,0.0148685295,0.54494303],"study_design_scores_gemma":[0.005664132,0.008134395,0.2117252,0.00008059034,0.000001009722,0.0003670769,0.00024434802,0.000015245461,0.08981308,0.0006382445,0.682844,0.0004726558],"about_ca_topic_score_codex":0.00004129274,"about_ca_topic_score_gemma":4.1222353e-7,"teacher_disagreement_score":0.6679755,"about_ca_system_score_codex":0.000063122585,"about_ca_system_score_gemma":0.00006825386,"threshold_uncertainty_score":0.8711931},"labels":[],"label_agreement":null},{"id":"W2096272151","doi":"10.1517/14712598.2012.679652","title":"Stem cells combined with bone graft substitutes in skeletal tissue engineering","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kensington Health","funders":"National Institute for Health and Care Research","keywords":"Mesenchymal stem cell; Stem cell; Induced pluripotent stem cell; Embryonic stem cell; Tissue engineering; Periosteum; Stem cell transplantation for articular cartilage repair; Clinical uses of mesenchymal stem cells; Bone marrow; Adipose tissue; Cell biology; Regenerative medicine; Umbilical cord; Adult stem cell; Biomedical engineering; Medicine; Chemistry; Immunology; Anatomy; Biology; Internal medicine; Biochemistry","score_opus":0.19062535733660024,"score_gpt":0.3929160616133326,"score_spread":0.20229070427673235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096272151","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004285443,0.9959834,0.00003756887,0.00009927082,0.0005610794,0.0024162852,0.000009832161,0.00013160805,0.00033239438],"genre_scores_gemma":[0.0009682255,0.99698937,0.00031116552,0.00010595981,0.000668362,0.0005005792,0.00017971078,0.000081042155,0.0001956094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99695146,0.00033515794,0.0006824802,0.00071737595,0.0005151745,0.00079836097],"domain_scores_gemma":[0.99825925,0.0005643104,0.00016793725,0.00057140324,0.000052078438,0.00038504085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056410045,0.0007155943,0.0023020888,0.00032720048,0.0000442425,0.00003094484,0.0003170146,0.00074303546,0.00060519093],"category_scores_gemma":[0.000017082262,0.00037507902,0.00030401567,0.00054518814,0.00013139816,0.00004834336,0.00007333069,0.0009602801,0.00032202378],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002955972,0.00055338896,0.000029167037,0.00056646584,0.0001139536,0.00010671326,0.0000534089,7.597742e-7,0.00047596436,0.00028121995,0.00013973964,0.9973836],"study_design_scores_gemma":[0.0012773923,0.0032028484,0.000034793815,0.004565244,0.0000022028166,0.00007310427,0.000010199044,0.000005958818,0.0006463963,0.0000014738507,0.9897267,0.0004536759],"about_ca_topic_score_codex":0.00001700087,"about_ca_topic_score_gemma":5.54546e-7,"teacher_disagreement_score":0.99692994,"about_ca_system_score_codex":0.00022241505,"about_ca_system_score_gemma":0.00010830589,"threshold_uncertainty_score":0.9998701},"labels":[],"label_agreement":null},{"id":"W2099780631","doi":"10.1517/14712598.6.7.685","title":"Pertussis immunisation in adolescents and adults –<i>Bordetella pertussis</i>epidemiology should guide vaccination recommendations","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bordetella pertussis; Whooping cough; Pediatrics; Vaccination; Booster dose; Pertussis vaccine; Diphtheria; Immunology; Immunization; Immune system","score_opus":0.17963763364229834,"score_gpt":0.4204783383208303,"score_spread":0.24084070467853197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099780631","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007153288,0.9940444,0.000043538465,0.0010155577,0.00257739,0.0011178285,0.00007327426,0.000135062,0.00027758317],"genre_scores_gemma":[0.0018599917,0.99362236,0.000087562614,0.00064034463,0.00034751234,0.00046265728,0.0028377636,0.000046004985,0.000095786934],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99456775,0.0024962863,0.0014296812,0.00094562286,0.000026831667,0.00053380476],"domain_scores_gemma":[0.99792665,0.00089547795,0.0005712866,0.00048069312,0.00007983333,0.000046064666],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00078618404,0.0007014782,0.0018078082,0.00045724396,0.00034295957,0.0000304775,0.0003296547,0.0017721751,0.0006928108],"category_scores_gemma":[0.00035557532,0.00045501516,0.00040722633,0.000338329,0.00011402924,0.000097995224,0.000109749024,0.0007764276,0.00011903003],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017776352,0.0004602954,0.00032811705,0.000067823,0.00008081066,2.976779e-7,0.000057175363,3.463551e-7,0.00016996282,0.0003672716,0.004853345,0.9934368],"study_design_scores_gemma":[0.0014023602,0.00063629664,0.0041861376,0.0025969113,0.0000030032895,0.00003392152,0.00003887437,0.0000029951113,0.000021668418,0.00008952927,0.9904789,0.00050940324],"about_ca_topic_score_codex":0.00054170884,"about_ca_topic_score_gemma":0.000027277327,"teacher_disagreement_score":0.9929274,"about_ca_system_score_codex":0.000190805,"about_ca_system_score_gemma":0.0000622733,"threshold_uncertainty_score":0.99979013},"labels":[],"label_agreement":null},{"id":"W2103654989","doi":"10.1517/14712598.2012.721765","title":"Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Spasticity; Multiple sclerosis; Medicine; Urinary system; Internal medicine; Physical therapy; Psychiatry","score_opus":0.262619153442457,"score_gpt":0.41079029027563396,"score_spread":0.14817113683317695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103654989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002714377,0.9926714,0.000010486668,0.0016951797,0.00015751606,0.0026296782,0.000034355868,0.000019659881,0.00006736608],"genre_scores_gemma":[0.003183664,0.9938583,0.000041503707,0.0008282482,0.00055538665,0.0013681372,0.00008876044,0.000026826565,0.00004920272],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99743706,0.0009415922,0.0004656591,0.00045562457,0.0002904477,0.00040963193],"domain_scores_gemma":[0.9988037,0.0004065448,0.00010378803,0.00044131145,0.00003953095,0.00020513662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079417747,0.00040416035,0.0014383668,0.00019401232,0.00006293015,0.00001967606,0.00021699599,0.0003678268,0.0001541869],"category_scores_gemma":[0.00010944654,0.00017420764,0.00039144894,0.00032765334,0.00016342751,0.000014463252,0.00004547577,0.0002316359,0.0000153739],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031395286,0.002166731,0.00023382518,0.000114539,0.0000671939,0.000011965267,0.00038241496,4.940727e-8,0.000030122786,0.000053158812,0.0012339093,0.99539214],"study_design_scores_gemma":[0.00095474283,0.014920299,0.004428254,0.0018291741,0.000002541869,0.000047210786,0.0000716201,0.0000016876385,0.000020771626,0.0000067762703,0.97752786,0.00018904891],"about_ca_topic_score_codex":0.000069165275,"about_ca_topic_score_gemma":9.422952e-7,"teacher_disagreement_score":0.9952031,"about_ca_system_score_codex":0.00015333253,"about_ca_system_score_gemma":0.00006383284,"threshold_uncertainty_score":0.7103982},"labels":[],"label_agreement":null},{"id":"W2103930742","doi":"10.1517/14712598.3.8.1295","title":"World Conference on Lung Cancer","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; International agency; Medicine; Cancer; Family medicine; Agency (philosophy); Gerontology; Library science; Oncology; Internal medicine; Sociology; Social science","score_opus":0.2072470305878788,"score_gpt":0.40351943176139266,"score_spread":0.19627240117351386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103930742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62207216,0.11725939,0.00028125587,0.05858927,0.0060316687,0.002824462,0.000035175366,0.0006943249,0.1922123],"genre_scores_gemma":[0.8070332,0.175288,0.00014746035,0.016643737,0.0003253084,0.00027770482,0.00001144155,0.000013220406,0.00025994185],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988877,0.00011564511,0.00017606546,0.0003790146,0.00018325279,0.00025830613],"domain_scores_gemma":[0.9994702,0.00006187217,0.00004879049,0.00023589966,0.000051317642,0.00013195234],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011650987,0.00019426066,0.00028513523,0.00006112607,0.00008029986,0.000017795557,0.000090407106,0.0001171881,0.006239379],"category_scores_gemma":[0.000028378308,0.00011082321,0.00012145122,0.00018137817,0.00007698562,0.000019061803,0.000007854995,0.00019750645,0.00004699479],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005851813,0.0033683924,0.0647498,0.000011180494,0.00038744,0.00001633932,0.00085539423,0.000014180625,0.056535054,0.20515925,0.12768482,0.53536636],"study_design_scores_gemma":[0.0016327816,0.0017399488,0.013894134,0.00015696285,3.025736e-7,0.0000021472126,0.000047752248,0.000040177154,0.030809032,0.00022965446,0.951239,0.0002080996],"about_ca_topic_score_codex":0.00001656561,"about_ca_topic_score_gemma":0.0000012548765,"teacher_disagreement_score":0.8235542,"about_ca_system_score_codex":0.000078206926,"about_ca_system_score_gemma":0.00004454276,"threshold_uncertainty_score":0.9946691},"labels":[],"label_agreement":null},{"id":"W2104334055","doi":"10.1517/14712598.6.1.23","title":"Pancreatic islet transplantation for treating diabetes","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transplantation; Islet; Immunosuppression; Medicine; Diabetes mellitus; Pancreas transplantation; Islet cell transplantation; Type 1 diabetes; Kidney transplantation; Internal medicine; Intensive care medicine; Endocrinology","score_opus":0.1532808932183194,"score_gpt":0.4049886632638141,"score_spread":0.2517077700454947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104334055","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002972682,0.9951614,0.000109183224,0.00024400561,0.0004808881,0.0019233958,0.00008456026,0.000206342,0.0014929458],"genre_scores_gemma":[0.000040188257,0.9907664,0.0013436753,0.0020239954,0.0020462363,0.0014400464,0.0021384181,0.00005623914,0.0001447973],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979764,0.00021481432,0.0006331189,0.0005942755,0.00017792133,0.0004034306],"domain_scores_gemma":[0.99783415,0.0014040855,0.00023942969,0.0003148567,0.000050138293,0.00015736783],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024659646,0.0005498691,0.001917181,0.00016484618,0.00012647825,0.000028326245,0.00012616903,0.0005739657,0.0005621591],"category_scores_gemma":[0.00017858115,0.0003078197,0.0008321585,0.00018439208,0.000078109304,0.000034917728,0.0000069947687,0.00023421021,0.00010090227],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002085394,0.00023107998,0.000020704245,0.00040657324,0.00022059497,0.0000010508669,0.000046877845,1.512011e-7,0.000115457886,0.00018622805,0.0015643955,0.99699837],"study_design_scores_gemma":[0.0016937224,0.0021226453,0.000029563218,0.0052482393,0.000017555201,0.0000102679805,0.000014288133,0.000019667814,0.00017085322,0.00003757494,0.99028754,0.00034806126],"about_ca_topic_score_codex":0.0000017631777,"about_ca_topic_score_gemma":2.5617128e-8,"teacher_disagreement_score":0.9966503,"about_ca_system_score_codex":0.00010363125,"about_ca_system_score_gemma":0.00006982312,"threshold_uncertainty_score":0.9999374},"labels":[],"label_agreement":null},{"id":"W2105558584","doi":"10.1517/14712598.5.10.1281","title":"Live bacterial cells as orally delivered therapeutics","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Infant Nutrition and Health","field":"Nursing","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Immune system; Medicine; Immunology; Biology; Probiotic; Intensive care medicine; Bacteria","score_opus":0.23554789703954135,"score_gpt":0.44540556594411856,"score_spread":0.20985766890457722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105558584","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003277245,0.9897313,0.0000049284067,0.0011748886,0.006153178,0.0015836417,0.000105476945,0.00046979907,0.0007440042],"genre_scores_gemma":[0.000013064286,0.9764902,0.00055165146,0.016580813,0.00530182,0.0001703741,0.0007370632,0.00012162579,0.00003339704],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961702,0.0010844219,0.00092298404,0.0008472541,0.00030830473,0.0006667988],"domain_scores_gemma":[0.9982108,0.00045339466,0.00046912773,0.00054970925,0.000096540985,0.00022045441],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00030905465,0.0008036414,0.0017898657,0.00016946405,0.00023681887,0.00010892019,0.0006015964,0.0014177118,0.0030801448],"category_scores_gemma":[0.000019546935,0.00050546776,0.00083939795,0.00020754481,0.00015555894,0.000062049796,0.00004789603,0.00078565086,0.001720758],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009593472,0.0004638405,2.0933884e-7,0.0000615252,0.00007600572,0.0000034872944,0.0002201272,7.191274e-8,0.000097655604,0.0002950117,0.008215298,0.9896074],"study_design_scores_gemma":[0.0011458268,0.0029898575,0.0000023433204,0.001891553,0.000002343297,0.000021372667,0.000029404619,0.0000018080119,0.000080683494,0.00009131969,0.9930678,0.00067566294],"about_ca_topic_score_codex":0.000023748062,"about_ca_topic_score_gemma":7.344107e-7,"teacher_disagreement_score":0.9889318,"about_ca_system_score_codex":0.00028523945,"about_ca_system_score_gemma":0.000107624975,"threshold_uncertainty_score":0.99987864},"labels":[],"label_agreement":null},{"id":"W2106522681","doi":"10.1517/14712598.2013.812629","title":"Quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine (MenACWY-TT): a review","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reactogenicity; Toxoid; Tetanus; Conjugate vaccine; Medicine; Immunogenicity; Neisseria meningitidis; Vaccination; Meningococcal disease; Meningococcal vaccine; Immunology; Pediatrics; Immunization; Virology; Antigen; Biology","score_opus":0.13174182670930829,"score_gpt":0.3786822260094649,"score_spread":0.2469403993001566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106522681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025097316,0.99365026,0.000006696245,0.000640944,0.0025695842,0.0023928976,0.000060792285,0.00021754029,0.00021030694],"genre_scores_gemma":[0.00003077444,0.9958138,0.00004423387,0.0012264432,0.00050454726,0.0012490195,0.0008855858,0.000054944292,0.00019068722],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961706,0.0011587399,0.001062208,0.0009853011,0.000035197612,0.0005879707],"domain_scores_gemma":[0.9983109,0.00039446558,0.00049288414,0.0006253349,0.000079292135,0.00009708127],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00041426788,0.00092749123,0.0027606515,0.00014153517,0.0002890871,0.00005751923,0.00041526422,0.0011542292,0.0052825767],"category_scores_gemma":[0.00007614605,0.00050677086,0.00062031683,0.00023036439,0.0001397663,0.000077837605,0.00017475183,0.0007395642,0.0011144207],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081189115,0.00026671504,0.0000047860635,0.0004020529,0.0004098046,0.000001075129,0.000019272014,8.011065e-9,0.0012949244,0.00041556108,0.020242209,0.97686243],"study_design_scores_gemma":[0.0010060271,0.0016206313,0.00002475401,0.008012319,0.000008997352,0.00020151227,0.0000069187913,8.60785e-8,0.00010283375,0.000031253214,0.98835,0.0006347152],"about_ca_topic_score_codex":0.000047781537,"about_ca_topic_score_gemma":7.3872695e-7,"teacher_disagreement_score":0.9762277,"about_ca_system_score_codex":0.00006768837,"about_ca_system_score_gemma":0.000048665974,"threshold_uncertainty_score":0.9997384},"labels":[],"label_agreement":null},{"id":"W2110077613","doi":"10.1517/14712598.2011.536530","title":"Immune monitoring of pancreatic islet graft: towards a better understanding, detection and treatment of harmful events","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Islet; Transplantation; Immune system; Autoimmunity; Immunology; Medicine; Transplant rejection; Intensive care medicine; Diabetes mellitus; Internal medicine; Endocrinology","score_opus":0.2188828599284303,"score_gpt":0.39258257992319356,"score_spread":0.17369971999476327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110077613","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019640861,0.97829074,0.00006344757,0.000075084776,0.0008165259,0.00087082403,0.000017141516,0.00004143779,0.00018392492],"genre_scores_gemma":[0.010027324,0.9889382,0.00024642405,0.000045071076,0.00045563187,0.00017513425,0.000060580252,0.000025929834,0.000025677466],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984663,0.0001785379,0.00060216547,0.00036367626,0.00018932359,0.00019998383],"domain_scores_gemma":[0.99891657,0.00026256306,0.00035844324,0.00032078012,0.00003998537,0.00010167233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014838966,0.0003963315,0.0018287686,0.0001790521,0.00005349859,0.000006519202,0.00007168326,0.0005006221,0.00014253767],"category_scores_gemma":[0.000067425884,0.00021475261,0.00047890533,0.00015593109,0.00013316679,0.000021385342,0.000016646045,0.00019274374,0.000005208288],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030739923,0.00042129116,0.00051905285,0.00017942704,0.00037569404,0.0000011984314,0.00010032564,1.10447615e-8,0.0035265728,0.000030465257,0.000008447725,0.99453014],"study_design_scores_gemma":[0.0024069396,0.006756112,0.0014745557,0.0043808604,0.000028998938,0.000021278502,0.00008809026,0.0000021912388,0.0074982396,0.00012245704,0.9769582,0.0002620848],"about_ca_topic_score_codex":0.000029329376,"about_ca_topic_score_gemma":5.3777256e-8,"teacher_disagreement_score":0.994268,"about_ca_system_score_codex":0.00016870719,"about_ca_system_score_gemma":0.000045760273,"threshold_uncertainty_score":0.8757357},"labels":[],"label_agreement":null},{"id":"W2110517597","doi":"10.1517/14712598.2010.528387","title":"Nanoscaffold based stem cell regeneration therapy: recent advancement and future potential","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Electrospun Nanofibers in Biomedical Applications","field":"Materials Science","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Stem cell; Regeneration (biology); Stem-cell therapy; Medicine; Biology; Cell biology","score_opus":0.06386919091040937,"score_gpt":0.34084808727388083,"score_spread":0.27697889636347145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110517597","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005476593,0.9915304,0.0011917995,0.0022217082,0.002853579,0.0017707205,0.00007241071,0.00019213115,0.00011244196],"genre_scores_gemma":[0.000006411881,0.98832524,0.0052981637,0.001894623,0.0026627565,0.0011661974,0.00054821617,0.000054993943,0.000043381307],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99653465,0.0005591975,0.0007434936,0.001191075,0.00045981878,0.0005117742],"domain_scores_gemma":[0.99826664,0.00018890823,0.0004846277,0.0007422283,0.000087832,0.00022974494],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00050595566,0.00068533415,0.0010850123,0.000117903735,0.00035291264,0.00012206918,0.0006346703,0.0011434105,0.001109873],"category_scores_gemma":[0.000003988336,0.00039548244,0.0002807022,0.00033602404,0.00026650477,0.00005830613,0.000070697286,0.0004526636,0.00010882428],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084798194,0.00034345884,1.2006981e-7,0.00002951182,0.000010229644,9.739833e-7,0.000014514487,1.3256974e-7,0.068053685,0.00064336014,0.0013983991,0.9294208],"study_design_scores_gemma":[0.00064154627,0.0009783979,0.0000010616529,0.00022872255,0.0000011640416,0.000005957437,0.0000058546166,0.000004450484,0.029261936,0.00009149952,0.9682888,0.00049064215],"about_ca_topic_score_codex":0.0000019549807,"about_ca_topic_score_gemma":1.9285864e-7,"teacher_disagreement_score":0.9668904,"about_ca_system_score_codex":0.00012791337,"about_ca_system_score_gemma":0.00014947551,"threshold_uncertainty_score":0.9998497},"labels":[],"label_agreement":null},{"id":"W2111021925","doi":"10.1517/14712598.5.1.97","title":"Progress in prion vaccines and immunotherapies","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Prion Diseases and Protein Misfolding","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto","funders":"","keywords":"Epitope; Gene isoform; Virology; Antibody; Prion protein; Immunotherapy; Biology; Immunology; Computational biology; Immune system; Medicine; Disease; Genetics","score_opus":0.08530481527831522,"score_gpt":0.39987048508160705,"score_spread":0.3145656698032918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111021925","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00057937345,0.9983052,0.000006051187,0.00013765047,0.00018936615,0.00072216144,0.000012940268,0.00002449499,0.000022737648],"genre_scores_gemma":[0.00027089717,0.9977088,0.00020096709,0.0004048773,0.0007707793,0.00036348088,0.00023645737,0.00003496859,0.000008764779],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984075,0.0002735056,0.00036802585,0.00060045277,0.00008509973,0.0002654478],"domain_scores_gemma":[0.9993968,0.000037958882,0.00015373256,0.00032122788,0.000018460181,0.00007183068],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018674613,0.00040832855,0.00065621076,0.00008448466,0.00006494495,0.00004173652,0.00027011707,0.00055524864,0.00008430104],"category_scores_gemma":[0.000024005927,0.00025434804,0.00025580905,0.00009973383,0.000083055726,0.000003230353,0.00009393818,0.00017359931,0.000008731897],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001490407,0.00011150701,0.000059113278,0.00003395946,0.000050005172,0.0000010704049,0.000015913383,8.7701586e-8,0.00009519188,0.00005220737,0.00017134016,0.99926054],"study_design_scores_gemma":[0.0004972109,0.0006178199,0.00015699826,0.0009336605,3.9296634e-7,0.000008824649,0.000008421446,6.3051255e-7,0.000059736063,0.000025460617,0.99733937,0.00035145206],"about_ca_topic_score_codex":0.0000022641962,"about_ca_topic_score_gemma":3.9918103e-7,"teacher_disagreement_score":0.9989091,"about_ca_system_score_codex":0.000020506941,"about_ca_system_score_gemma":0.000041825093,"threshold_uncertainty_score":0.9999909},"labels":[],"label_agreement":null},{"id":"W2111772750","doi":"10.1517/14712598.7.9.1415","title":"Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Oncolytic virus; Myxoma virus; Virotherapy; Vaccinia; Tropism; Virus; Virology; Tissue tropism; Cancer; Biology; Cancer research; Immunology; Gene","score_opus":0.20941624472468517,"score_gpt":0.4613797584558881,"score_spread":0.2519635137312029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111772750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005472365,0.99134946,0.000018625411,0.00046209493,0.00037042273,0.001983735,0.000053548767,0.000038364295,0.0002513924],"genre_scores_gemma":[0.00024215235,0.9904546,0.00004702978,0.006345837,0.001735085,0.00065655913,0.00035819397,0.000082212035,0.0000783242],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955541,0.0013639986,0.0007052212,0.0012463542,0.00033146283,0.0007988856],"domain_scores_gemma":[0.998302,0.00031486148,0.00025855753,0.00088035694,0.000039568564,0.00020466922],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011736986,0.0008610051,0.0012271567,0.00023033576,0.00017090843,0.000056203175,0.001104129,0.0013090216,0.00017146193],"category_scores_gemma":[0.00007600052,0.00044983035,0.00050433096,0.0004747921,0.00034627103,0.000004972775,0.00013139327,0.00075611525,0.000042164353],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017478163,0.00026462515,0.000012923231,0.000029231938,0.00014096338,0.000010917993,0.00009079872,0.0000013941002,0.008628182,0.000021299671,0.0026083065,0.9864435],"study_design_scores_gemma":[0.0011628167,0.007089406,0.00003740943,0.00059670815,0.0000010918089,0.00001581809,0.000036913603,0.0000019294027,0.001450336,0.000048676604,0.98894286,0.0006160545],"about_ca_topic_score_codex":0.00008219957,"about_ca_topic_score_gemma":0.00006213264,"teacher_disagreement_score":0.98633456,"about_ca_system_score_codex":0.00011724017,"about_ca_system_score_gemma":0.00032725118,"threshold_uncertainty_score":0.9999875},"labels":[],"label_agreement":null},{"id":"W2116144836","doi":"10.1517/14712598.2011.538677","title":"Immunotherapy for metastatic prostate cancer: where are we at with sipuleucel-T?","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Prostate cancer; Immunotherapy; Cancer; Clinical trial; Oncology; Clinical endpoint; Internal medicine; Cancer vaccine; Immune system; Cancer immunotherapy; Malignancy; Population; Immunology","score_opus":0.11307659179833304,"score_gpt":0.37802113644184104,"score_spread":0.26494454464350803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116144836","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015909807,0.99060935,0.000039122737,0.0011207348,0.0028670796,0.004251109,0.0006071986,0.00027482517,0.00007148429],"genre_scores_gemma":[0.000010678258,0.98912895,0.00024183946,0.000879408,0.0002575807,0.005517864,0.001035324,0.00022179732,0.0027065405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99507105,0.0013194315,0.0010901387,0.0013153132,0.00011624108,0.0010878105],"domain_scores_gemma":[0.99606967,0.0014459303,0.0011627865,0.0011118031,0.00014741778,0.00006241102],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0005124411,0.0014786433,0.0033092303,0.00027004076,0.0007609841,0.000074253076,0.00103362,0.0015605047,0.0032684552],"category_scores_gemma":[0.000032816828,0.0007918656,0.0012305888,0.0003203518,0.0007260615,0.000092916795,0.000090313646,0.0012790079,0.00033116256],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0087220725,0.00056141894,0.00000649059,0.00021216841,0.0016626909,0.000004589308,0.00025955433,4.318184e-7,0.00692399,0.00012972245,0.009688526,0.97182834],"study_design_scores_gemma":[0.0046278196,0.0037151324,0.000010837287,0.004811959,0.000009268216,0.00012516876,0.00008119607,1.6939867e-7,0.0019027924,0.000040129526,0.98348653,0.0011890118],"about_ca_topic_score_codex":0.000028362352,"about_ca_topic_score_gemma":0.0000048157804,"teacher_disagreement_score":0.973798,"about_ca_system_score_codex":0.00022005383,"about_ca_system_score_gemma":0.00027544328,"threshold_uncertainty_score":0.9997963},"labels":[],"label_agreement":null},{"id":"W2116315024","doi":"10.1517/14712598.2013.833601","title":"Improvement of gastrointestinal health status in subjects consuming<i>Lactobacillus reuteri</i>NCIMB 30242 capsules: a<i>post-hoc</i>analysis of a randomized controlled trial","year":2013,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Probiotics and Fermented Foods","field":"Agricultural and Biological Sciences","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre; McGill University; Micropharma (Canada); Université du Québec à Montréal","funders":"","keywords":"Lactobacillus reuteri; Medicine; Diarrhea; Placebo; Internal medicine; Clinical trial; Post-hoc analysis; Randomized controlled trial; Clinical endpoint; Gastroenterology; Double blind; Probiotic; Pathology; Alternative medicine","score_opus":0.03721049144491918,"score_gpt":0.2873916802764125,"score_spread":0.2501811888314933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116315024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908815,0.0031323598,0.000020287689,0.0014713311,0.00023739088,0.004005653,0.00008379019,0.00003406763,0.0001336323],"genre_scores_gemma":[0.97472495,0.0230717,0.00024922803,0.0012113121,0.00009564056,0.00044406427,0.00019299859,0.0000019063405,0.000008172263],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965742,0.00072314974,0.0013981531,0.00047007372,0.00030718188,0.00052724563],"domain_scores_gemma":[0.9975239,0.0011578121,0.0008064546,0.00014120078,0.00019407061,0.00017658468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012642627,0.00031551046,0.0023119268,0.000105361745,0.000072900235,0.000031909985,0.0002870639,0.00014144201,0.0006384252],"category_scores_gemma":[0.00030671214,0.00010528356,0.00084653037,0.00056819426,0.000283175,0.000047952257,0.00005900909,0.00017061329,0.000004463732],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6487865,0.0014047875,0.00042023635,0.0000024938402,0.0004669331,6.9209347e-7,0.00023605333,0.0000075913213,0.3178633,0.0004288462,0.00006220891,0.030320369],"study_design_scores_gemma":[0.9413759,0.037687577,0.011395931,0.00016341929,0.000010162044,0.0000017416105,0.00088310626,0.0005380722,0.004780342,0.000341064,0.0023259541,0.00049670425],"about_ca_topic_score_codex":0.0013081046,"about_ca_topic_score_gemma":0.000053489937,"teacher_disagreement_score":0.31308293,"about_ca_system_score_codex":0.00006815435,"about_ca_system_score_gemma":0.00004181522,"threshold_uncertainty_score":0.6990308},"labels":[],"label_agreement":null},{"id":"W2117989459","doi":"10.1517/14712598.2012.745507","title":"Oncolytic reovirus type 3 (Dearing) as a novel therapy in head and neck cancer","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Oncolytics Biotech; Cancer Research UK","keywords":"Oncolytic virus; Head and neck cancer; Medicine; Radiation therapy; Combination therapy; Chemotherapy; Cancer; Cancer research; Oncology; Internal medicine","score_opus":0.26031126105683533,"score_gpt":0.4696592634367377,"score_spread":0.20934800237990236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117989459","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022350913,0.9752299,0.0000021992641,0.0001274279,0.0005750541,0.00128038,0.000031683183,0.00003260438,0.00036984464],"genre_scores_gemma":[0.0012216085,0.99466556,0.00006968761,0.0016572454,0.0013108489,0.0005881911,0.0002501945,0.00009900546,0.0001376289],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99696267,0.000486466,0.0005343662,0.0010233431,0.00026360608,0.0007295665],"domain_scores_gemma":[0.9986855,0.00010536648,0.00019762204,0.00069761195,0.00007012243,0.00024382536],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005188002,0.00070369046,0.0011520927,0.00017288703,0.00010755065,0.000051229614,0.000518715,0.0010837485,0.00037999108],"category_scores_gemma":[0.00005901906,0.00045952474,0.00031650366,0.00035293348,0.00020987343,0.000006259564,0.00015775174,0.0005815969,0.00008440394],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033124685,0.00048402464,0.00006695495,0.000038335416,0.00017035095,0.0000027671,0.00004426154,8.829774e-7,0.009994391,0.00003977499,0.00024755506,0.9855982],"study_design_scores_gemma":[0.001621209,0.010054336,0.0000981777,0.0006867039,8.854915e-7,0.000018485458,0.0000072772227,0.0000011841294,0.0014368795,0.000020033223,0.98546416,0.00059066154],"about_ca_topic_score_codex":0.00013573217,"about_ca_topic_score_gemma":0.000025750845,"teacher_disagreement_score":0.9852166,"about_ca_system_score_codex":0.00011871748,"about_ca_system_score_gemma":0.00033450278,"threshold_uncertainty_score":0.99978566},"labels":[],"label_agreement":null},{"id":"W2118336485","doi":"10.1517/14712598.5.11.1415","title":"Current status of animal-to-human transplantation","year":2005,"lang":"en","type":"editorial","venue":"Expert Opinion on Biological Therapy","topic":"Xenotransplantation and immune response","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Xenotransplantation; Transplantation; Organ transplantation; Medicine; Graft rejection; Immunology; Intensive care medicine; Biology; Internal medicine","score_opus":0.08197580101850363,"score_gpt":0.41958958718160244,"score_spread":0.3376137861630988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118336485","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0629025,0.083782874,0.00038402365,0.0013124751,0.8458135,0.0028267226,0.0012326336,0.00038053875,0.0013646903],"genre_scores_gemma":[0.010569279,0.7096393,0.0002115563,0.0004105029,0.275294,0.000087747474,0.00371212,0.00004059832,0.000034880322],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99750733,0.00027227597,0.00064046006,0.00053192925,0.000620343,0.00042767744],"domain_scores_gemma":[0.99852955,0.00048971287,0.00019924206,0.0003288522,0.00018331238,0.0002693085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023444586,0.00040955257,0.00074157136,0.00026424578,0.000076114105,0.000015354082,0.00018526045,0.00070347404,0.000606185],"category_scores_gemma":[0.00014007179,0.00027657964,0.00029032028,0.00018917369,0.0000975966,0.000032950808,0.000009990564,0.00062245684,0.000083394756],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042268638,0.0015503218,0.00009061465,0.00006409621,0.00014857599,0.000011078225,0.001436135,0.0000022312925,0.14839128,0.00018111485,0.6799866,0.12586932],"study_design_scores_gemma":[0.0035340786,0.007879843,0.0049627647,0.00051174854,0.0000017254421,0.0000033529338,0.000023252336,0.0000016833825,0.008840614,0.000007969846,0.9739343,0.0002986588],"about_ca_topic_score_codex":0.000031441006,"about_ca_topic_score_gemma":6.948155e-7,"teacher_disagreement_score":0.62585646,"about_ca_system_score_codex":0.00012169698,"about_ca_system_score_gemma":0.00019044048,"threshold_uncertainty_score":0.99996865},"labels":[],"label_agreement":null},{"id":"W2120169125","doi":"10.1517/14712598.3.2.215","title":"Adult stem cell therapy for heart failure","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Stem cell; Medicine; Vasculogenesis; Progenitor cell; Stem-cell therapy; Cell therapy; Induced pluripotent stem cell; Bone marrow; Heart failure; Adult stem cell; Endothelial stem cell; Cancer research; Pathology; Immunology; Cardiology; Cell biology; Biology; Mesenchymal stem cell; Embryonic stem cell; In vitro","score_opus":0.25877000713205034,"score_gpt":0.44854271323490535,"score_spread":0.18977270610285502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120169125","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002682163,0.9897368,0.00005562259,0.0009786478,0.0008291439,0.006373953,0.000050365314,0.00015442928,0.0017942083],"genre_scores_gemma":[0.000010853053,0.9902634,0.0011172632,0.0036066577,0.0012592765,0.0021790392,0.000421236,0.00013643384,0.00100583],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99537027,0.0009089703,0.000909127,0.0012929619,0.0006109447,0.0009077274],"domain_scores_gemma":[0.9969571,0.0010763977,0.0002762586,0.00096736156,0.00025818867,0.0004646606],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007125331,0.0009369378,0.002862108,0.00023104761,0.00019565284,0.000062148945,0.0004955625,0.0014553383,0.0014289122],"category_scores_gemma":[0.000063569605,0.00049344695,0.0015913955,0.0004302174,0.0001684912,0.000032151132,0.000045282763,0.0009029879,0.00045424906],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058823766,0.00068211573,0.000007787666,0.0004241747,0.00014404692,0.000005346534,0.000032311596,3.3986947e-8,0.00016225896,0.0003831578,0.05463704,0.9429335],"study_design_scores_gemma":[0.0024282034,0.006228178,0.0000031659947,0.002348022,0.0000013837583,0.00004111903,0.000039449395,0.0000012244795,0.0003933532,0.000032610824,0.98793864,0.0005446549],"about_ca_topic_score_codex":0.0000055261303,"about_ca_topic_score_gemma":1.1600012e-7,"teacher_disagreement_score":0.94238883,"about_ca_system_score_codex":0.00020840131,"about_ca_system_score_gemma":0.0003064891,"threshold_uncertainty_score":0.999841},"labels":[],"label_agreement":null},{"id":"W2121661128","doi":"10.1517/14712598.8.9.1337","title":"Gene therapy of arthritis and orthopaedic disorders: current experimental approaches in China and in Canada","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Genetic enhancement; Medicine; China; Intensive care medicine; Bioinformatics; Gene; Political science; Biology; Genetics","score_opus":0.12175382309577786,"score_gpt":0.365207489598627,"score_spread":0.2434536665028491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121661128","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16929662,0.8296964,0.0000011900943,0.00003409377,0.00012747034,0.00078587286,0.000034583925,0.0000043873306,0.00001933656],"genre_scores_gemma":[0.04388714,0.95518416,0.000027243383,0.000075622396,0.00015368345,0.0003464164,0.0002889538,0.000035722962,0.0000010602789],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99748397,0.0005875331,0.00053457735,0.0007682876,0.00020388664,0.00042174943],"domain_scores_gemma":[0.9993199,0.000057920028,0.00015222543,0.0003303947,0.000011042286,0.00012853586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021933771,0.00047670875,0.000970675,0.00014046313,0.000049627855,0.000010340919,0.00026536582,0.000320229,0.000030607705],"category_scores_gemma":[0.000021285083,0.00033269776,0.0001646286,0.00018403066,0.00025347347,0.000003857669,0.00010038453,0.00032583522,4.4724365e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090765726,0.0003227819,0.0004150756,0.000023282731,0.00004026535,0.0000032324742,0.00006139481,0.0000012416411,0.000919028,0.00000343015,0.00006475314,0.99723786],"study_design_scores_gemma":[0.0025242723,0.004449704,0.0008949063,0.0008565042,1.3567328e-7,0.000027674858,0.00006815945,0.0000052085247,0.00524199,0.000014592271,0.98533994,0.00057693094],"about_ca_topic_score_codex":0.008539071,"about_ca_topic_score_gemma":0.014466887,"teacher_disagreement_score":0.99666095,"about_ca_system_score_codex":0.000096598,"about_ca_system_score_gemma":0.00049035315,"threshold_uncertainty_score":0.9999125},"labels":[],"label_agreement":null},{"id":"W2122440892","doi":"10.1517/14712598.2013.814637","title":"Genomic instability in multiple myeloma: mechanisms and therapeutic implications","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heritage Medical Research Clinic; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Genome instability; Biology; Chromosome instability; Epigenetics; Comparative genomic hybridization; Multiple myeloma; Somatic evolution in cancer; Genetics; Homologous recombination; Computational biology; Genome; Gene; Cancer research; DNA damage; DNA; Chromosome; Immunology","score_opus":0.26650271805668735,"score_gpt":0.4271962167632671,"score_spread":0.16069349870657973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122440892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014738839,0.9937815,0.000041681385,0.00038501844,0.00012896625,0.0038661328,0.000049096023,0.000083008264,0.00019068627],"genre_scores_gemma":[0.0051093423,0.99081457,0.0008038253,0.0004448072,0.00013324193,0.002251575,0.00038218335,0.000043406515,0.000017039767],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974666,0.00046944333,0.000567283,0.00084451446,0.00017385738,0.00047828286],"domain_scores_gemma":[0.99827284,0.00062725524,0.00014185539,0.0006344784,0.0000465904,0.00027699617],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002524785,0.0005249408,0.0014623159,0.0002170316,0.00012862975,0.000034628654,0.000225129,0.00056047534,0.00037822122],"category_scores_gemma":[0.00010585509,0.00028562412,0.00032671788,0.00024154049,0.00019266672,0.000027510092,0.00008719144,0.00048721136,0.00016911575],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015052341,0.0006337622,0.0006657556,0.0000842828,0.00013663585,0.00000416542,0.000034696506,2.6410081e-8,0.00025708,0.00067790353,0.000032807104,0.9973224],"study_design_scores_gemma":[0.0021423076,0.0012375608,0.021856936,0.00072051055,0.0000017095002,0.000035390884,0.000018374416,0.00001244728,0.000019633455,0.0008057536,0.97285277,0.0002966044],"about_ca_topic_score_codex":0.00005836402,"about_ca_topic_score_gemma":0.0000020974849,"teacher_disagreement_score":0.9970257,"about_ca_system_score_codex":0.000276776,"about_ca_system_score_gemma":0.000124977,"threshold_uncertainty_score":0.9999596},"labels":[],"label_agreement":null},{"id":"W2128183109","doi":"10.1517/14712598.1.6.923","title":"Developments in liposomal drug delivery systems","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":339,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Liposome; Drug delivery; Medicine; Drug; Pharmacology; Clinical trial; Drug carrier; Targeted drug delivery; Biology; Chemistry; Internal medicine","score_opus":0.1247826064773836,"score_gpt":0.3687485482794017,"score_spread":0.24396594180201808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128183109","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025427863,0.9944303,0.000007708262,0.000015250812,0.0013509125,0.0006425151,0.000022675786,0.000025942898,0.000961907],"genre_scores_gemma":[0.0008078385,0.9962791,0.000043763725,0.00046229028,0.0009310121,0.00034682502,0.00089589285,0.00003980458,0.00019345304],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974771,0.00041605145,0.0006333643,0.00084499596,0.00015719382,0.00047130766],"domain_scores_gemma":[0.99915504,0.0000503464,0.00020103881,0.00043360313,0.000048656402,0.000111293375],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023323638,0.00056412956,0.0009708008,0.00014200961,0.00006445796,0.00004443937,0.0005911136,0.0007905955,0.0000474777],"category_scores_gemma":[0.000023917515,0.00036852466,0.00037707834,0.00019439387,0.00007075476,0.0000036936085,0.00012796583,0.00028486754,0.00016623028],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001491824,0.00020972628,0.00006241384,0.000041239848,0.00012016101,0.000014084664,0.000021891237,0.0000015865083,0.0003489702,0.000031582083,0.0040715993,0.9949276],"study_design_scores_gemma":[0.00036656694,0.000551776,0.000033134063,0.0016494984,4.1953703e-7,0.000027712562,0.000025633904,7.7431605e-7,0.00016133288,0.000003847431,0.9966802,0.00049910473],"about_ca_topic_score_codex":0.000044925066,"about_ca_topic_score_gemma":0.0000026241605,"teacher_disagreement_score":0.99442846,"about_ca_system_score_codex":0.000070537884,"about_ca_system_score_gemma":0.00013681907,"threshold_uncertainty_score":0.9998767},"labels":[],"label_agreement":null},{"id":"W2133192063","doi":"10.1517/14712598.8.4.463","title":"Oncolytic virotherapy for multiple myeloma","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital; Toronto General Hospital; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Oncolytic virus; Virotherapy; Multiple myeloma; Medicine; Cancer research; Virology; Immunology; Tumor cells","score_opus":0.19491580122188426,"score_gpt":0.43800906222506286,"score_spread":0.2430932610031786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133192063","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024103285,0.99514157,0.00022366794,0.000106359665,0.0006601377,0.003209009,0.00015405628,0.0000790967,0.00018507996],"genre_scores_gemma":[0.00004049931,0.9905028,0.0004048761,0.0016127236,0.0027513322,0.0026741496,0.0016498095,0.00017814375,0.00018569878],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962316,0.0006502644,0.0006888381,0.0013526003,0.0003041779,0.00077251316],"domain_scores_gemma":[0.9979454,0.00036930182,0.00028363336,0.0010586154,0.00010513852,0.00023790615],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0003270855,0.00090196304,0.0014761129,0.00016313297,0.0002871906,0.000043090477,0.0009928286,0.0013266817,0.0001765751],"category_scores_gemma":[0.00015314964,0.00059422106,0.0013851083,0.0002259387,0.000292748,0.0000035199764,0.00009526586,0.00038561763,0.00011755586],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034972108,0.0003810424,0.000001857709,0.000037987542,0.00030271598,0.0000026904554,0.000017325277,0.0000012990932,0.004811303,0.000023772574,0.009152943,0.98176986],"study_design_scores_gemma":[0.0018533487,0.016428921,0.0000024423448,0.00038593818,6.115634e-7,0.000029859935,0.0000059115378,0.000005184677,0.004289704,0.00002624672,0.9762111,0.00076077384],"about_ca_topic_score_codex":0.0000033636588,"about_ca_topic_score_gemma":0.0000020872978,"teacher_disagreement_score":0.98100907,"about_ca_system_score_codex":0.00010338709,"about_ca_system_score_gemma":0.00030894703,"threshold_uncertainty_score":0.9999698},"labels":[],"label_agreement":null},{"id":"W2135293060","doi":"10.1517/14712590903110709","title":"Nimotuzumab: a novel anti-EGFR monoclonal antibody that retains anti-EGFR activity while minimizing skin toxicity","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University","funders":"","keywords":"Nimotuzumab; Medicine; Monoclonal antibody; Clinical trial; Pharmacology; Epidermal growth factor receptor; Drug; Toxicity; EGFR inhibitors; Oncology; Cancer research; Cancer; Antibody; Immunology; Internal medicine","score_opus":0.2533466771946822,"score_gpt":0.4340411261167223,"score_spread":0.18069444892204012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135293060","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011336167,0.9819087,0.00007059213,0.00098341,0.0010532268,0.0022058403,0.00017884794,0.0002566845,0.0020065648],"genre_scores_gemma":[0.014655346,0.9811503,0.0004213032,0.001365402,0.0014254536,0.00026252418,0.0005722719,0.00007511872,0.00007224512],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99597174,0.0003608028,0.00073538575,0.0015614901,0.00050373655,0.0008668569],"domain_scores_gemma":[0.997849,0.0004627547,0.00053525163,0.00075072295,0.00010282664,0.00029944675],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00034488222,0.0012983766,0.0041672527,0.00025897563,0.00041729194,0.00007935866,0.00041012777,0.001020518,0.00033002978],"category_scores_gemma":[0.00008583569,0.00074339675,0.0015713937,0.00050125347,0.000290175,0.0000981961,0.00015247912,0.00088296,0.000047241836],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074501376,0.002583176,0.00030184406,0.00015557893,0.00084923586,0.000050993058,0.0001557824,3.0278318e-7,0.00060981256,0.000114288276,0.0014331074,0.99300086],"study_design_scores_gemma":[0.0022167312,0.0043929527,0.007154064,0.0038547225,0.000018033406,0.000100146,0.000049043618,0.0000088266015,0.00039003888,0.000016393878,0.98098326,0.00081576634],"about_ca_topic_score_codex":0.000070242895,"about_ca_topic_score_gemma":0.0000021185233,"teacher_disagreement_score":0.9921851,"about_ca_system_score_codex":0.0006989323,"about_ca_system_score_gemma":0.00024794327,"threshold_uncertainty_score":0.9999768},"labels":[],"label_agreement":null},{"id":"W2136385642","doi":"10.1517/14712598.2012.657622","title":"Obinutuzumab for the treatment of lymphoproliferative disorders","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Obinutuzumab; Rituximab; Medicine; Antibody-dependent cell-mediated cytotoxicity; CD20; Clinical trial; Lymphoma; Oncology; Monoclonal antibody; Immunology; Monoclonal antibody therapy; Internal medicine; Antibody","score_opus":0.28090023864748026,"score_gpt":0.44167147150498937,"score_spread":0.1607712328575091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136385642","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027329826,0.99407923,0.000016623999,0.00039240226,0.0007326926,0.004383258,0.00009602461,0.00003850581,0.00023396013],"genre_scores_gemma":[0.00029476863,0.9922414,0.00012476198,0.0003265515,0.0009098382,0.0055914433,0.00042869025,0.00003493287,0.000047634352],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99848497,0.0001544764,0.0004708662,0.00041947112,0.00015354271,0.00031664464],"domain_scores_gemma":[0.99783945,0.0012661774,0.00025686048,0.00048630213,0.000040224095,0.000111002664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097148724,0.00054340804,0.0016913858,0.000061881045,0.00012491576,0.000011032526,0.00014371135,0.00037557626,0.00019583397],"category_scores_gemma":[0.000018241617,0.00019437136,0.0013593143,0.000118971555,0.00015290151,0.000014652208,0.000011965986,0.00005396312,0.00003208983],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044033412,0.0023526691,0.000035867117,0.000057592362,0.0009977716,5.784509e-7,0.00020549976,1.09586324e-7,8.3199694e-7,0.0008714508,0.00044890837,0.9945884],"study_design_scores_gemma":[0.0032069387,0.010031813,0.000101408725,0.0007286714,0.000025741752,0.000010549215,0.000032604956,0.0000016896671,0.000055091852,0.00003730388,0.98556733,0.00020082868],"about_ca_topic_score_codex":0.000027703549,"about_ca_topic_score_gemma":4.954013e-7,"teacher_disagreement_score":0.99438757,"about_ca_system_score_codex":0.000700042,"about_ca_system_score_gemma":0.00018117219,"threshold_uncertainty_score":0.7926234},"labels":[],"label_agreement":null},{"id":"W2136686197","doi":"10.1517/14712598.2.8.793","title":"Islet transplantation for diabetes: current status and future prospects","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Islet; Transplantation; Immunosuppression; Xenotransplantation; Context (archaeology); Medicine; Immunology; Islet cell transplantation; Diabetes mellitus; Biology; Internal medicine; Endocrinology","score_opus":0.13386832083026895,"score_gpt":0.3889620883406808,"score_spread":0.25509376751041185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136686197","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015965015,0.995465,0.000018718853,0.00032515544,0.0013850088,0.002102148,0.00011525974,0.00011429304,0.00031480807],"genre_scores_gemma":[0.000010669426,0.9938538,0.00020695482,0.001030428,0.002606094,0.00090383785,0.0013289825,0.000032970194,0.000026233869],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984355,0.00012381497,0.00039055856,0.00053933123,0.0001495795,0.00036119766],"domain_scores_gemma":[0.9990637,0.0003333628,0.00015362485,0.00021409249,0.000043018816,0.0001922267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001156544,0.00043505736,0.0012804045,0.00011477817,0.00008860806,0.000025922018,0.00006563743,0.00041790184,0.0003286106],"category_scores_gemma":[0.000043133965,0.00023445289,0.00036620838,0.00014098856,0.000075552794,0.000026798469,0.00000674503,0.0002644542,0.000027871474],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013607599,0.00023164584,0.00003272324,0.0007881328,0.00009072937,5.9414225e-7,0.00007126992,6.959165e-9,0.000012759008,0.00035866202,0.0028529689,0.99542445],"study_design_scores_gemma":[0.0016743658,0.0020699867,0.0000937798,0.0028982384,0.000008085855,0.000004644121,0.0000106113785,0.000004709203,0.000024736055,0.000053155036,0.99287766,0.00027999817],"about_ca_topic_score_codex":3.592066e-7,"about_ca_topic_score_gemma":1.0236405e-8,"teacher_disagreement_score":0.9951444,"about_ca_system_score_codex":0.00006174874,"about_ca_system_score_gemma":0.000037987396,"threshold_uncertainty_score":0.95607114},"labels":[],"label_agreement":null},{"id":"W2138376454","doi":"10.1517/14712598.4.6.927","title":"Antisense approaches in prostate cancer","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Prostate cancer; Clusterin; Cancer research; Cancer; Gene; Biology; Oligonucleotide; Antisense therapy; Prostate; Apoptosis; Genetics","score_opus":0.4175150990230393,"score_gpt":0.4700249454075821,"score_spread":0.05250984638454281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138376454","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002538151,0.9955687,0.0000025745608,0.00054083084,0.00079888233,0.002242244,0.00005843974,0.00011583752,0.00041868037],"genre_scores_gemma":[0.00012119547,0.9962368,0.00019980331,0.0009277632,0.0005665028,0.0014565163,0.00038548722,0.00006169223,0.000044233344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99747753,0.00039335078,0.0006307339,0.00087262917,0.00017906362,0.00044667278],"domain_scores_gemma":[0.9989218,0.00016543746,0.0002042166,0.00051492074,0.000022682196,0.00017094662],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020856189,0.0005745625,0.0019581916,0.00022499677,0.000040779138,0.00001468295,0.00021108455,0.0006163608,0.00042674897],"category_scores_gemma":[0.000073875875,0.00032907564,0.00050574203,0.00031870732,0.00022921014,0.00001847842,0.0000768061,0.0005772715,0.00010507095],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044511916,0.0006025621,0.000076070435,0.0005157743,0.00007375094,0.00016591085,0.000116306765,0.0000013136296,0.000008650039,0.00013945012,0.00025706354,0.99759805],"study_design_scores_gemma":[0.0015292703,0.00080263964,0.00028212875,0.011338065,0.000001714333,0.00013962269,0.00001792744,0.0000015077621,0.000007855459,0.00007646252,0.98543215,0.00037065867],"about_ca_topic_score_codex":0.000021527703,"about_ca_topic_score_gemma":5.456637e-7,"teacher_disagreement_score":0.9972274,"about_ca_system_score_codex":0.00033813703,"about_ca_system_score_gemma":0.00026729135,"threshold_uncertainty_score":0.99991614},"labels":[],"label_agreement":null},{"id":"W2140207145","doi":"10.1517/14712598.2011.557657","title":"The role of bevacizumab in colorectal cancer: understanding its benefits and limitations","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Bevacizumab; Colorectal cancer; Medicine; Oncology; Clinical trial; Angiogenesis; Cancer; Expert opinion; Adjuvant; Internal medicine; Bioinformatics; Intensive care medicine; Chemotherapy; Biology","score_opus":0.35379127628350016,"score_gpt":0.40764959911489307,"score_spread":0.05385832283139291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140207145","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007105992,0.9959786,2.8015805e-7,0.00017201512,0.00024203537,0.0009486857,0.00003225401,0.000019760075,0.0018957593],"genre_scores_gemma":[0.011199121,0.98799014,0.0000113337055,0.000051641236,0.000107073036,0.00058889505,0.000029571023,0.000015925107,0.0000063201524],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99892306,0.00011788888,0.00035227305,0.00031166838,0.00008810814,0.00020699938],"domain_scores_gemma":[0.9989264,0.0007100367,0.00016184736,0.0001091498,0.000035705154,0.00005684736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010806048,0.00027736693,0.00093504577,0.00008224118,0.00015201957,0.000010356697,0.00009544512,0.00021758678,0.000030770614],"category_scores_gemma":[0.00006823093,0.00012772248,0.0001707351,0.00018672981,0.00014970204,0.000016038497,0.000041773677,0.00019089598,0.000002331139],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046940707,0.00014035843,0.000087195134,0.000027344253,0.00020556412,8.575396e-7,0.0003601586,5.076581e-8,0.000006655829,0.008555718,0.000028776522,0.9901179],"study_design_scores_gemma":[0.00070128375,0.002365163,0.00061511743,0.002157076,0.000004190323,0.0000068146696,0.00033971158,0.000001337289,0.00003126854,0.00033107336,0.993303,0.00014395303],"about_ca_topic_score_codex":0.000040309875,"about_ca_topic_score_gemma":0.000045859426,"teacher_disagreement_score":0.9932742,"about_ca_system_score_codex":0.0002573265,"about_ca_system_score_gemma":0.00008038773,"threshold_uncertainty_score":0.5208371},"labels":[],"label_agreement":null},{"id":"W2144847294","doi":"10.1517/14712590903439702","title":"Trastuzumab for gastric cancer","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Alberta Cancer Foundation","funders":"","keywords":"Medicine; Trastuzumab; Cancer; Oncology; Chemotherapy; Internal medicine; Targeted therapy; Breast cancer","score_opus":0.4923854008211455,"score_gpt":0.5606512124964915,"score_spread":0.06826581167534601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144847294","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000023368605,0.992976,0.00010119243,0.0011370778,0.0009546525,0.0037121256,0.00011373189,0.00014979717,0.00085304875],"genre_scores_gemma":[0.000003644708,0.989655,0.0005545637,0.0024611903,0.0034786216,0.0031167108,0.0004334987,0.00007711248,0.00021963767],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969794,0.0002997121,0.0006512192,0.0009284998,0.00042473536,0.0007163912],"domain_scores_gemma":[0.9982831,0.00052548683,0.00019536972,0.00057514745,0.000111904126,0.00030901065],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004123911,0.0006268144,0.0022246107,0.00024593776,0.00011607007,0.000033691358,0.00043469176,0.00085928483,0.0014195753],"category_scores_gemma":[0.00015159808,0.00034287755,0.0010317706,0.0004617801,0.0001325405,0.00001902191,0.000031158183,0.0007300481,0.00010807658],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037760223,0.00033021547,0.0000022588865,0.00023452927,0.00013412692,0.0000057856587,0.000019859184,8.809516e-8,0.000011627649,0.00013452616,0.031585723,0.9671637],"study_design_scores_gemma":[0.0012231063,0.0057916623,0.000020069578,0.005934399,0.000002593671,0.00003693195,0.000006753194,0.000002222381,0.000014818866,0.00006243358,0.9865436,0.00036140982],"about_ca_topic_score_codex":0.00001635981,"about_ca_topic_score_gemma":2.557041e-7,"teacher_disagreement_score":0.96680224,"about_ca_system_score_codex":0.0006381519,"about_ca_system_score_gemma":0.0005859279,"threshold_uncertainty_score":0.9999023},"labels":[],"label_agreement":null},{"id":"W2145525874","doi":"10.1517/14712598.2014.866648","title":"Adult adherent stromal cells in the management of graft-versus-host disease","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical trial; Graft-versus-host disease; Mesenchymal stem cell; Clinical endpoint; Transplantation; Disease; Stem cell; Intensive care medicine; Refractory (planetary science); Immunology; Oncology; Internal medicine; Pathology; Biology","score_opus":0.248931904013494,"score_gpt":0.45673517761548627,"score_spread":0.20780327360199227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145525874","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022200866,0.99242973,0.000010226887,0.00035367665,0.0006429953,0.0031972313,0.000030439192,0.000032212538,0.0030814935],"genre_scores_gemma":[0.00068944535,0.9972897,0.00011556612,0.00037900748,0.0004429277,0.00072301517,0.00023369204,0.00003512459,0.000091516056],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99614924,0.0010575302,0.00079554546,0.0007100184,0.00079140003,0.0004962414],"domain_scores_gemma":[0.9978481,0.00065878866,0.00025563774,0.0009169643,0.00006703683,0.00025345676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007254053,0.0005202411,0.0015264895,0.00016077013,0.000056060573,0.0000221504,0.00073065684,0.0003485539,0.0007766888],"category_scores_gemma":[0.00005098105,0.00023379647,0.0007272688,0.0003832769,0.00019242494,0.000015595437,0.00012159345,0.00060307793,0.00019061679],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022002782,0.0011315916,0.000016637785,0.0016059089,0.00027788416,0.00007458455,0.000052573178,1.8686414e-7,0.000019400062,0.0029147312,0.0018960838,0.98981017],"study_design_scores_gemma":[0.001966714,0.002695472,0.00027628354,0.0070369313,0.0000053531867,0.000002425655,0.0000799055,0.0000035302803,0.000014445368,0.00001822895,0.9876613,0.00023939],"about_ca_topic_score_codex":0.00001553849,"about_ca_topic_score_gemma":3.4648488e-7,"teacher_disagreement_score":0.98957074,"about_ca_system_score_codex":0.00012552837,"about_ca_system_score_gemma":0.000068949674,"threshold_uncertainty_score":0.9533943},"labels":[],"label_agreement":null},{"id":"W2145931873","doi":"10.1517/14712598.1.4.583","title":"Block copolymeric biotransport carriers as versatile vehicles for drug delivery","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Advanced Polymer Synthesis and Characterization","field":"Chemistry","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Supratek Pharma (Canada)","funders":"","keywords":"Copolymer; Amphiphile; Flexibility (engineering); Drug delivery; Block (permutation group theory); Drug; Drug carrier; Combinatorial chemistry; Nanotechnology; Computer science; Chemistry; Materials science; Biochemical engineering; Mathematics; Pharmacology; Polymer; Organic chemistry; Engineering; Biology","score_opus":0.08563207482724042,"score_gpt":0.35223633752692635,"score_spread":0.26660426269968596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145931873","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00053255283,0.99700814,0.000034979614,0.00007472164,0.00068786164,0.00046301977,0.000325168,0.00020497559,0.0006685628],"genre_scores_gemma":[0.00023608071,0.9950244,0.00008393006,0.00051536015,0.0012164004,0.00059269945,0.0019994825,0.00009381888,0.0002378273],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99770343,0.00008669258,0.000658546,0.0008288678,0.00020771562,0.0005147684],"domain_scores_gemma":[0.99842376,0.00043763703,0.00042285028,0.0004863497,0.000041451716,0.00018798582],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009189917,0.00070935785,0.0013745353,0.00008379659,0.00021416339,0.000038700106,0.00047999565,0.00072050805,0.0014690444],"category_scores_gemma":[0.000025992342,0.0004821072,0.0008382264,0.00021800776,0.00015083028,0.00005859128,0.000024934296,0.00028571568,0.00005646207],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019143833,0.00015105316,0.000004200823,0.0001320279,0.00014967324,0.0000033048345,0.00007771026,2.2178061e-7,0.0019048154,0.000064593034,0.00060829165,0.9967127],"study_design_scores_gemma":[0.00042920932,0.00016506412,8.2554067e-7,0.001470558,0.0000041166577,0.000009177075,0.00007545612,0.0000022252552,0.009385017,0.000028005357,0.9878098,0.0006205495],"about_ca_topic_score_codex":0.000020942003,"about_ca_topic_score_gemma":1.9715539e-7,"teacher_disagreement_score":0.99609214,"about_ca_system_score_codex":0.00011798134,"about_ca_system_score_gemma":0.000108533066,"threshold_uncertainty_score":0.9997631},"labels":[],"label_agreement":null},{"id":"W2147070032","doi":"10.1517/14712598.5.3.313","title":"Involvement of ICAM-1 in bone metabolism: a potential target in the treatment of bone diseases?","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Osteoclast; Medicine; Osteoporosis; Rheumatoid arthritis; Intercellular Adhesion Molecule-1; Bone remodeling; Bone disease; Inflammation; Cell adhesion molecule; Immunology; Receptor; Internal medicine","score_opus":0.15203345513730984,"score_gpt":0.4260539516775159,"score_spread":0.2740204965402061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147070032","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015820377,0.99484813,0.0000068032373,0.0005076626,0.00013552366,0.0027466784,0.00006732396,0.000014297385,0.000091560745],"genre_scores_gemma":[0.0011340714,0.9965484,0.0002743856,0.00033329727,0.0003929819,0.0007365189,0.0005238293,0.000030438901,0.000026083577],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960896,0.0010616662,0.0012187584,0.00058832613,0.0006387064,0.00040294993],"domain_scores_gemma":[0.99843776,0.00033795318,0.00034825204,0.00068892207,0.00005432801,0.00013279007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044117717,0.00048649256,0.0026503208,0.00048402403,0.000025278816,0.000008772715,0.0002978566,0.00039826886,0.0006777648],"category_scores_gemma":[0.00007028036,0.00022246952,0.00094704604,0.00060571556,0.00021977734,0.000017391774,0.00004974832,0.00032599713,0.000017611268],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001031426,0.008068608,0.000041318282,0.00016632999,0.00012342287,0.000077986995,0.000237446,0.0000014836401,0.0005165401,0.00015861157,0.00028504938,0.9892918],"study_design_scores_gemma":[0.0030200735,0.0036165072,0.00087251834,0.0013317011,0.000005471762,0.000012172706,0.00007852857,0.0000063068746,0.00015681355,0.000039955805,0.9906667,0.0001932611],"about_ca_topic_score_codex":0.00005581332,"about_ca_topic_score_gemma":0.0000014609465,"teacher_disagreement_score":0.99038166,"about_ca_system_score_codex":0.00021316194,"about_ca_system_score_gemma":0.00017020003,"threshold_uncertainty_score":0.9072044},"labels":[],"label_agreement":null},{"id":"W2147109841","doi":"10.1517/14712598.2015.971749","title":"Erythropoiesis-stimulating agents in allogeneic and autologous hematopoietic stem cell transplantation","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Stem cell; Expert opinion; Intensive care medicine; Haematopoiesis; Hematopoietic stem cell transplantation; Erythropoiesis; Transplantation; Aplastic anemia; Clinical trial; Anemia; Oncology; Immunology; Internal medicine; Bone marrow","score_opus":0.15419707096536678,"score_gpt":0.4010795418792463,"score_spread":0.24688247091387955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147109841","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025071583,0.9949374,0.000032666012,0.0003178567,0.00034265182,0.0012767873,0.000013202126,0.00011491203,0.000457374],"genre_scores_gemma":[0.0053210836,0.99264723,0.00043558027,0.0006649747,0.00023161335,0.00021549716,0.00038060034,0.000053053656,0.00005034128],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99735546,0.00047411368,0.00076470437,0.0007967947,0.00021286948,0.00039605162],"domain_scores_gemma":[0.998777,0.0004530194,0.00025101466,0.00033380635,0.000021356582,0.00016381795],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025082275,0.00063342,0.0019658087,0.00017511327,0.00010367752,0.000023737128,0.00013383238,0.00074644486,0.00017503659],"category_scores_gemma":[0.000010647273,0.0003721267,0.00038251455,0.00017748089,0.00015991424,0.000019958685,0.000026731392,0.00039743268,0.000065302556],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001460535,0.00048871955,0.00021199498,0.0011329398,0.00007705533,0.000082559534,0.00035373893,0.0000013617597,0.000027893693,0.000091071066,0.00022042,0.9971662],"study_design_scores_gemma":[0.0024256425,0.0023949682,0.00036603937,0.0077039776,0.000009400317,0.00025040944,0.000084361,0.0000144589585,0.00006170024,0.00002819607,0.9861814,0.0004794585],"about_ca_topic_score_codex":0.0000113371325,"about_ca_topic_score_gemma":4.2113658e-7,"teacher_disagreement_score":0.99668676,"about_ca_system_score_codex":0.0001400152,"about_ca_system_score_gemma":0.000055566437,"threshold_uncertainty_score":0.99987304},"labels":[],"label_agreement":null},{"id":"W2147154643","doi":"10.1517/14712598.7.11.1723","title":"L-BLP25: a MUC1-targeted peptide vaccine therapy in prostate cancer","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Alberta","funders":"","keywords":"Prostate cancer; Medicine; MUC1; Cancer vaccine; Antigen; Cancer; Peptide vaccine; Oncology; Prostate-specific antigen; Immunotherapy; Cancer research; Immunology; Internal medicine; Epitope","score_opus":0.12476821738793602,"score_gpt":0.39932030448054656,"score_spread":0.27455208709261053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147154643","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011931347,0.9923032,0.0000040959535,0.00026160703,0.0031239847,0.002503464,0.000100948,0.00025254287,0.0002570022],"genre_scores_gemma":[0.00016914346,0.9940962,0.00003177455,0.0020491555,0.00031162784,0.0012945548,0.0010086062,0.00013173003,0.00090716605],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936082,0.0021849643,0.0015775684,0.0012570495,0.0001128145,0.0012594009],"domain_scores_gemma":[0.99724793,0.0010760592,0.0006454399,0.0008817114,0.00008983005,0.000059011432],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0010344217,0.0013297801,0.0030686227,0.0006985855,0.0002785785,0.000045749024,0.0009997374,0.0018118821,0.0043918802],"category_scores_gemma":[0.00009521957,0.00079045177,0.0010072305,0.00081946835,0.00028665582,0.000096474425,0.00009873851,0.001650013,0.0006828725],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005192416,0.00079512177,0.00003576288,0.000041841122,0.00060938863,0.0000164045,0.0003785562,3.7958725e-7,0.0034779245,0.00010273033,0.0033086652,0.98604083],"study_design_scores_gemma":[0.0043720184,0.0026777412,0.00028279691,0.0027192542,0.000001320063,0.000061330575,0.00006335142,1.2082329e-7,0.0017315057,0.00003368065,0.9870396,0.0010172557],"about_ca_topic_score_codex":0.00022873457,"about_ca_topic_score_gemma":0.0000048066763,"teacher_disagreement_score":0.98502356,"about_ca_system_score_codex":0.00026256262,"about_ca_system_score_gemma":0.00027978767,"threshold_uncertainty_score":0.99994534},"labels":[],"label_agreement":null},{"id":"W2149106614","doi":"10.1517/14712598.6.1.73","title":"The emerging role of recombinant activated Factor VII (rFVIIa) in the treatment of blunt traumatic haemorrhage","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Novo Nordisk","keywords":"Coagulopathy; Medicine; Recombinant factor VIIa; Haemophilia; Coagulation; Factor VII; Transfusion therapy; Factor IX; Intensive care medicine; Surgery; Blood transfusion; Internal medicine","score_opus":0.2772478901078796,"score_gpt":0.4655169931661655,"score_spread":0.18826910305828592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149106614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009897832,0.9861443,4.0223412e-7,0.0008515855,0.0002245986,0.002527385,0.000013961512,0.000020649311,0.00031925825],"genre_scores_gemma":[0.0052610794,0.99374545,0.000034757424,0.00004655685,0.00021555393,0.0004693028,0.00012112263,0.00002621161,0.000079941405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997274,0.0008162091,0.00079790177,0.00037285444,0.00036106742,0.00037796688],"domain_scores_gemma":[0.99774355,0.0012297827,0.0003066898,0.00060477236,0.000040563835,0.00007465686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003523469,0.0004451368,0.0016319762,0.00015586171,0.00011661121,0.000012706095,0.00035712434,0.0003692825,0.00023917522],"category_scores_gemma":[0.000054645134,0.00014377532,0.0007419365,0.00036729907,0.0001968647,0.000017534572,0.000017847657,0.0003022206,0.000016296888],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003119728,0.002314768,0.000024877289,0.00006905491,0.00023948809,0.000007205862,0.0011063141,1.0012399e-7,0.00021783178,0.00006332317,0.000049882437,0.99559516],"study_design_scores_gemma":[0.0014158874,0.0055753132,0.00025521254,0.0018698141,0.0000043730925,0.000013467279,0.00042636582,0.000008400399,0.00064252975,0.000031974563,0.9896106,0.00014604456],"about_ca_topic_score_codex":0.00003663737,"about_ca_topic_score_gemma":0.0000013493686,"teacher_disagreement_score":0.9954491,"about_ca_system_score_codex":0.00021617748,"about_ca_system_score_gemma":0.000100505036,"threshold_uncertainty_score":0.5862987},"labels":[],"label_agreement":null},{"id":"W2150081030","doi":"10.1517/14712598.2015.983897","title":"The capsular group B meningococcal vaccine, 4CMenB: clinical experience and potential efficacy","year":2014,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council; Sparks; Action Medical Research","keywords":"Reactogenicity; Medicine; Meningococcal disease; Immunogenicity; Context (archaeology); Group B; Meningococcal vaccine; Clinical trial; European union; Meningitis; Group A; Pediatrics; Neisseria meningitidis; Intensive care medicine; Immunology; Immunization; Internal medicine; Antigen","score_opus":0.052579186302081936,"score_gpt":0.34492859288552663,"score_spread":0.2923494065834447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150081030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98643345,0.0061869184,0.0005023118,0.0013050481,0.0049697617,0.00029741338,0.0000030458752,0.0001334554,0.00016859942],"genre_scores_gemma":[0.9404271,0.057867263,0.000054967546,0.0008009809,0.0006785694,0.00007448258,0.00003816884,0.000012156401,0.000046258116],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977961,0.0009258466,0.000427939,0.00047281993,0.00002354651,0.0003537541],"domain_scores_gemma":[0.9987964,0.00066327164,0.00011341642,0.0003356386,0.000038533035,0.000052729894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070579775,0.00023514836,0.00031697936,0.00003125094,0.0006873063,0.00005974477,0.0002634572,0.00038837155,0.00035490238],"category_scores_gemma":[0.00021589074,0.00011956965,0.00014820088,0.000080724676,0.00026904637,0.000050581337,0.00008814679,0.00031132193,0.00010260371],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021929622,0.0006607568,0.0047893752,4.0284945e-7,0.00013864377,5.4328086e-7,0.0002785395,0.0000010880754,0.54607683,0.011713296,0.005695103,0.42845243],"study_design_scores_gemma":[0.0024994025,0.0019003096,0.079930596,0.0000079967285,3.0591815e-7,0.000025063751,0.00006876763,0.00001214885,0.004658677,0.00018265306,0.9105218,0.00019229627],"about_ca_topic_score_codex":0.000027569644,"about_ca_topic_score_gemma":7.581422e-7,"teacher_disagreement_score":0.9048267,"about_ca_system_score_codex":0.000009936858,"about_ca_system_score_gemma":0.0000066017096,"threshold_uncertainty_score":0.52862734},"labels":[],"label_agreement":null},{"id":"W2152228047","doi":"10.1517/14712598.4.5.631","title":"Stem cell bioengineering for regenerative medicine","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Stem cell; Regenerative medicine; Embryonic stem cell; Biology; Stem cell biology; Computational biology; Transplantation; Cellular differentiation; Biotechnology; Cell biology; Medicine; Genetics; Embryo; Gene; Embryogenesis","score_opus":0.16387817595006207,"score_gpt":0.40478039732466314,"score_spread":0.24090222137460107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152228047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018055194,0.99549633,0.0016263693,0.00015653757,0.000747334,0.0015854569,0.00007109533,0.000041034767,0.00025777452],"genre_scores_gemma":[0.0000517011,0.99502116,0.00039967473,0.00023045475,0.0017120112,0.0007762687,0.0014204043,0.000075250486,0.0003130822],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976444,0.0002427529,0.00049863383,0.00093029917,0.00020216992,0.00048174892],"domain_scores_gemma":[0.99889755,0.0001263593,0.00018784923,0.000544469,0.00007882192,0.00016495804],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032069942,0.0006025299,0.0010668875,0.00011829404,0.00011369477,0.000019996629,0.0005703946,0.00083235605,0.00005318155],"category_scores_gemma":[0.000026315833,0.00035156254,0.00051728147,0.00015593531,0.00015574321,0.0000019797046,0.00009915346,0.00025880896,0.000031788106],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016414636,0.00016374179,2.341162e-7,0.00039521078,0.00016352399,0.0000028350964,0.000031632746,0.000014164988,0.015149724,0.0002467326,0.004299777,0.97936827],"study_design_scores_gemma":[0.0008398603,0.0037091367,2.4809174e-7,0.0015687329,8.753147e-7,0.00000840136,0.000013800883,0.000003108353,0.0085140625,0.000016399295,0.9848985,0.0004268609],"about_ca_topic_score_codex":0.0000030198107,"about_ca_topic_score_gemma":1.0194972e-7,"teacher_disagreement_score":0.98059875,"about_ca_system_score_codex":0.000089070745,"about_ca_system_score_gemma":0.00012579735,"threshold_uncertainty_score":0.99989367},"labels":[],"label_agreement":null},{"id":"W2155747763","doi":"10.1517/14712598.2013.784266","title":"From the Zeno's paradoxes to novel immunotherapeutic agents for kidney cancer: moving from an era of wrong premises and conclusions to a better comprehension of immunology","year":2013,"lang":"en","type":"letter","venue":"Expert Opinion on Biological Therapy","topic":"Empathy and Medical Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Zeno's paradoxes; Tortoise; Comprehension; Perception; Medicine; Aesthetics; Philosophy; Epistemology; Biology; Zoology","score_opus":0.11253763910774385,"score_gpt":0.3887531931756504,"score_spread":0.27621555406790654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155747763","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56275064,0.010739131,0.00039151756,0.4227229,0.0011806525,0.001696806,0.00048364254,0.000028741266,0.000005956968],"genre_scores_gemma":[0.073217675,0.035635464,0.0030484896,0.881815,0.0036525067,0.0006967386,0.001859312,0.000050741644,0.000024043307],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980784,0.00021634012,0.0005514753,0.0005915296,0.00025123468,0.00031101398],"domain_scores_gemma":[0.9976804,0.0011521011,0.0002563531,0.00057370437,0.0001496818,0.00018772656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013222647,0.00035317108,0.0008645637,0.0000651219,0.00012413814,0.000014935752,0.00034953514,0.00074998103,0.00077216123],"category_scores_gemma":[0.00020787657,0.00019480889,0.00016503473,0.000096923104,0.00024128203,0.000036512163,0.00009877749,0.0006501285,0.000005491958],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031474333,0.0010140666,0.0009786969,0.000023857392,0.0007613218,0.0000017096241,0.027972095,0.0000022511244,0.4539107,0.000023253768,0.27618134,0.23598325],"study_design_scores_gemma":[0.0028403257,0.0031155113,0.027007038,0.0013722845,0.000008763925,0.000002120305,0.0010829786,0.000041417286,0.008788344,0.00030518472,0.95514303,0.00029302554],"about_ca_topic_score_codex":0.00279536,"about_ca_topic_score_gemma":0.0000018663152,"teacher_disagreement_score":0.67896163,"about_ca_system_score_codex":0.000056148045,"about_ca_system_score_gemma":0.000117809395,"threshold_uncertainty_score":0.8454624},"labels":[],"label_agreement":null},{"id":"W2159512922","doi":"10.1517/14712590902942284","title":"Costimulatory blockade with belatacept in clinical and experimental transplantation – a review","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Belatacept; Abatacept; Immunosuppression; Transplantation; Medicine; Organ transplantation; Clinical trial; Immunology; CD80; Pharmacology; Oncology; Kidney transplantation; Internal medicine; Biology; Rituximab; Antibody; In vitro; Cytotoxic T cell","score_opus":0.1881148553626472,"score_gpt":0.47522044437996946,"score_spread":0.2871055890173223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159512922","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025921414,0.9970063,0.0000087896915,0.00020389195,0.00012340063,0.002061215,0.000025665946,0.000052269374,0.00025923122],"genre_scores_gemma":[0.00026842838,0.99559605,0.00033778336,0.0026251338,0.00015364998,0.00021349126,0.00076085894,0.000029226718,0.00001536612],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976273,0.0003915956,0.00086553296,0.00065550883,0.00022524905,0.0002347811],"domain_scores_gemma":[0.9990591,0.00028485578,0.00020073241,0.00025341817,0.000018968944,0.00018297069],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002327676,0.00050906476,0.0020012737,0.00011773315,0.0000478117,0.000012623753,0.00009537628,0.00042307426,0.0001374159],"category_scores_gemma":[0.00001044544,0.00025819702,0.00038712492,0.0001872506,0.0001338441,0.0000377105,0.0000057478096,0.0004332507,0.000025558496],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010518708,0.00091978034,0.0003766906,0.0011981727,0.00019411446,0.00016713853,0.00004973486,1.9594503e-7,0.000002153312,0.0000599387,0.000060505296,0.9959197],"study_design_scores_gemma":[0.0050752917,0.004542063,0.0015778281,0.07677433,0.000016944512,0.00034719147,0.000005647031,8.8374145e-7,0.000012581512,0.0000045802185,0.9113104,0.00033230122],"about_ca_topic_score_codex":0.0000039600836,"about_ca_topic_score_gemma":2.4493224e-7,"teacher_disagreement_score":0.9955874,"about_ca_system_score_codex":0.00005492713,"about_ca_system_score_gemma":0.00006729815,"threshold_uncertainty_score":0.999987},"labels":[],"label_agreement":null},{"id":"W2160274449","doi":"10.1517/14712598.2015.977249","title":"The effect of parathyroid hormone and teriparatide on fracture healing","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Bone health and treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Teriparatide; Parathyroid hormone; Bone healing; Medicine; Internal medicine; Osteoporosis; Endocrinology; Bioinformatics; Biology; Surgery; Calcium","score_opus":0.09238361252833933,"score_gpt":0.43412428351101423,"score_spread":0.3417406709826749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160274449","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005817889,0.9967567,0.0000051788156,0.00060181826,0.00019996267,0.0016135831,0.000009720322,0.00003777362,0.00019351182],"genre_scores_gemma":[0.0013483303,0.99610287,0.000029476942,0.0016569974,0.00032593095,0.00032953167,0.00015847788,0.000025971216,0.000022438458],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979445,0.0006542401,0.00050841965,0.00042186846,0.00017717,0.00029385267],"domain_scores_gemma":[0.9975629,0.0015243137,0.0002975707,0.00041568564,0.000016789503,0.00018274279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004120972,0.00045690592,0.0017933288,0.0000517151,0.00017230348,0.000014546069,0.00010964847,0.00051525485,0.000012645451],"category_scores_gemma":[0.00009658464,0.00016537507,0.00033225334,0.00008711359,0.00012981366,0.000008630899,0.00001697838,0.00043881216,0.00003148979],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001437811,0.00009832042,0.000013482385,0.00012492668,0.00013118127,0.000003114062,0.000017861363,5.3320566e-8,0.0000149494745,0.00005416207,0.0025583894,0.99554574],"study_design_scores_gemma":[0.0016306917,0.018024415,0.00028647756,0.0017617285,0.0000033554422,0.000021668458,0.0000016167155,0.0000010810526,0.000050799765,0.000014612716,0.97806513,0.00013842095],"about_ca_topic_score_codex":0.000014493289,"about_ca_topic_score_gemma":1.1954509e-7,"teacher_disagreement_score":0.99540734,"about_ca_system_score_codex":0.000045443787,"about_ca_system_score_gemma":0.000037041147,"threshold_uncertainty_score":0.67437994},"labels":[],"label_agreement":null},{"id":"W2162039329","doi":"10.1517/14712598.2012.685713","title":"Oncolytic virotherapy for renal cell carcinoma: a novel treatment paradigm?","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Oncolytic virus; Virotherapy; Medicine; Immunotherapy; Disease; Immune system; Renal cell carcinoma; Malignancy; Cancer research; Immunology; Oncology; Internal medicine","score_opus":0.2400492890182544,"score_gpt":0.4259792513334449,"score_spread":0.1859299623151905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162039329","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00059674203,0.99430764,0.0003919386,0.000103100545,0.0005749158,0.0034937393,0.00025846253,0.000044935543,0.00022850758],"genre_scores_gemma":[0.0005491439,0.989367,0.00039270552,0.00069628836,0.0033190022,0.0035426733,0.0017108878,0.00016389343,0.00025842685],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964513,0.00046949048,0.00065965275,0.0012154157,0.00025515413,0.00094894844],"domain_scores_gemma":[0.99802244,0.00022702024,0.0003076346,0.0010551465,0.00005535696,0.00033238385],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042458574,0.0010193961,0.0014870439,0.00014443915,0.00021377654,0.000051709605,0.000715476,0.0011535279,0.00020833679],"category_scores_gemma":[0.000019084117,0.00062354055,0.0013319011,0.00017425435,0.00019566642,0.0000043638784,0.000065316985,0.00026602874,0.00008361889],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003735381,0.0016436306,0.0000019614881,0.000061667335,0.00028790976,0.0000012974001,0.000037987054,0.0000013415267,0.020787794,0.00007234471,0.0008230207,0.9725457],"study_design_scores_gemma":[0.0031268548,0.030784149,0.0000027536403,0.00015411736,0.000004571862,0.000013942223,0.0000059289446,0.0000026285868,0.014137145,0.000019166417,0.9510092,0.00073952967],"about_ca_topic_score_codex":0.0000091453385,"about_ca_topic_score_gemma":0.000001992571,"teacher_disagreement_score":0.9718061,"about_ca_system_score_codex":0.0002466563,"about_ca_system_score_gemma":0.00035200204,"threshold_uncertainty_score":0.99962157},"labels":[],"label_agreement":null},{"id":"W2163096595","doi":"10.1517/14712598.2013.779249","title":"New developments in lentiviral vector design, production and purification","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; PROTEO","funders":"","keywords":"Genetic enhancement; Lentivirus; Viral vector; Vector (molecular biology); Retrovirus; Bioproduction; Vectors in gene therapy; Computational biology; Recombinant DNA; Gene delivery; Biology; Virology; Biotechnology; Gene; Human immunodeficiency virus (HIV); Virus; Genetics; Viral disease","score_opus":0.21384630436002708,"score_gpt":0.4105336812077076,"score_spread":0.19668737684768053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163096595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068072096,0.9967459,0.00019071014,0.00013924956,0.00041639645,0.0017521635,0.000003913643,0.000023672705,0.00004726929],"genre_scores_gemma":[0.00022046929,0.9965799,0.0011674026,0.00014518277,0.00069350796,0.0006228812,0.00033569706,0.00004396765,0.00019100432],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974288,0.00073599565,0.0004148473,0.0008987814,0.00017414594,0.00034745949],"domain_scores_gemma":[0.9992389,0.000041208626,0.00015591481,0.00040580484,0.0000430684,0.000115089584],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042983377,0.00042600196,0.00058937375,0.00014558481,0.00007356858,0.0000473462,0.00032302414,0.0006007422,0.00008542793],"category_scores_gemma":[0.000104455605,0.0002864448,0.00013643483,0.00020290275,0.00008094087,0.000006596299,0.00007082525,0.00025877997,0.00007684505],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051498564,0.00010315797,0.000007724213,0.000022083772,0.0000583666,4.479206e-7,0.00002221198,5.324074e-7,0.012532755,0.000014224083,0.0022864132,0.9844371],"study_design_scores_gemma":[0.0003500657,0.0024704176,0.00006118821,0.00042750192,3.2565148e-7,0.0000058998876,0.0000054389275,5.6051704e-7,0.010894313,0.000028915736,0.98539656,0.00035882194],"about_ca_topic_score_codex":0.000009433617,"about_ca_topic_score_gemma":0.0000020598902,"teacher_disagreement_score":0.9840783,"about_ca_system_score_codex":0.0000656383,"about_ca_system_score_gemma":0.00021114908,"threshold_uncertainty_score":0.99995875},"labels":[],"label_agreement":null},{"id":"W2166481231","doi":"10.1517/14712598.5.6.809","title":"Refining an Alzheimer’s vaccine to avoid an inflammatory response","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto","funders":"","keywords":"Immune system; Meningoencephalitis; Immunotherapy; Immunology; Disease; Medicine; Epitope; Peptide vaccine; Alzheimer's disease; Clinical trial; Antibody; Internal medicine","score_opus":0.32650752973233327,"score_gpt":0.49549101078151686,"score_spread":0.1689834810491836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166481231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011437213,0.99580324,0.0000023966033,0.00055210496,0.0002807377,0.0016295196,0.00007252868,0.00031526908,0.00020045617],"genre_scores_gemma":[0.00030967535,0.9928065,0.00059797027,0.0022653232,0.0016815882,0.0008498885,0.0013456603,0.000119834775,0.000023582206],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99466306,0.001929195,0.00079007924,0.0012702569,0.00055138493,0.0007960344],"domain_scores_gemma":[0.9963529,0.00046215867,0.00021605616,0.0012753838,0.00011702764,0.0015764835],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008761597,0.0008842703,0.0019541008,0.00042578462,0.00023492993,0.00006198935,0.00049317256,0.0007628476,0.0009891904],"category_scores_gemma":[0.00018098041,0.0005105726,0.000607646,0.00036861416,0.00008208961,0.00013004255,0.00009770679,0.0006817006,0.0009571039],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00890316,0.0014240934,0.000050767132,0.00002959598,0.0030974206,0.0001287843,0.00007770896,2.0847294e-7,0.000020931955,0.000050619798,0.0011928998,0.9850238],"study_design_scores_gemma":[0.0017606074,0.010892389,0.0006846031,0.0022379209,0.000017493558,0.00006534555,0.000025926234,0.0000015799803,0.000019255494,0.000007993313,0.98374015,0.0005467205],"about_ca_topic_score_codex":0.000014542237,"about_ca_topic_score_gemma":0.0000010268284,"teacher_disagreement_score":0.9844771,"about_ca_system_score_codex":0.00023081494,"about_ca_system_score_gemma":0.00046267532,"threshold_uncertainty_score":0.99992406},"labels":[],"label_agreement":null},{"id":"W2166847481","doi":"10.1517/14712598.2012.631909","title":"International seminar on the red blood cells as vehicles for drugs","year":2011,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Society for Cellular Therapy","funders":"","keywords":"Medicine; Red blood cell; Pharmacology; Immunology","score_opus":0.12817692438234457,"score_gpt":0.3355154922616316,"score_spread":0.207338567879287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166847481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9246571,0.001413716,0.000105085295,0.023144715,0.004528126,0.0014025548,0.00002587346,0.00025585102,0.044466987],"genre_scores_gemma":[0.88978845,0.057019964,0.0010251976,0.049254216,0.0017549059,0.00030231054,0.00011393698,0.000025415813,0.0007156045],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.999145,0.000100522804,0.00017143352,0.000296912,0.000116956464,0.0001691895],"domain_scores_gemma":[0.99925876,0.00031773452,0.00006540743,0.00023117874,0.000059564616,0.00006733298],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016484162,0.0001527323,0.0001869036,0.000041498915,0.00010150199,0.000006690088,0.00015890149,0.00017466756,0.0022163766],"category_scores_gemma":[0.000071411785,0.00007442382,0.00016167414,0.00005461319,0.00010723475,0.000015442482,0.000018293968,0.0001533148,0.00015774356],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01603202,0.002210836,0.00026546154,0.0000020587702,0.0002550759,0.000008035856,0.002099378,7.5002527e-7,0.8185745,0.022404585,0.06662702,0.071520306],"study_design_scores_gemma":[0.0018105427,0.006033566,0.0014146143,0.000028399985,4.1843964e-7,0.000008173215,0.00026648253,0.000015916934,0.19766735,0.0012758811,0.79137325,0.00010540806],"about_ca_topic_score_codex":0.0000053089625,"about_ca_topic_score_gemma":2.8509211e-8,"teacher_disagreement_score":0.7247462,"about_ca_system_score_codex":0.000016578708,"about_ca_system_score_gemma":0.000013641477,"threshold_uncertainty_score":0.99869573},"labels":[],"label_agreement":null},{"id":"W2167573919","doi":"10.1517/14712598.2014.959924","title":"Update on belimumab for the management of systemic lupus erythematosus","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Belimumab; Medicine; Clinical trial; Placebo; Intensive care medicine; Immunology; Internal medicine; B-cell activating factor; Alternative medicine; Antibody; B cell; Pathology","score_opus":0.16357567254011562,"score_gpt":0.4257702727252415,"score_spread":0.26219460018512586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167573919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048172526,0.9881438,0.00038141693,0.00039912996,0.0021029334,0.007976378,0.000048492024,0.000121731326,0.0007779467],"genre_scores_gemma":[0.00018840545,0.9941333,0.00023736412,0.00047923444,0.0009237161,0.0033001283,0.00021031832,0.00011471871,0.00041282258],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99582833,0.00057517824,0.0013134745,0.0009333647,0.0007291668,0.0006204865],"domain_scores_gemma":[0.99542695,0.001955542,0.00065992173,0.0016441665,0.00014313686,0.00017025929],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014103259,0.00076875364,0.0031068698,0.00023885335,0.0001653286,0.000030081092,0.00091879914,0.0006950272,0.00016065793],"category_scores_gemma":[0.00007904389,0.00032805436,0.0013906019,0.000341252,0.0002195922,0.000014916527,0.00012952137,0.00048186196,0.00027369085],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001247444,0.00038473203,0.000009845963,0.008947213,0.0015908234,0.000010797987,0.00010558467,6.4795046e-7,0.0000070572655,0.0125078885,0.008172949,0.967015],"study_design_scores_gemma":[0.0027142402,0.0021448391,7.216418e-7,0.05349442,0.000014003893,0.0024340174,0.00018812671,0.000009328214,0.000012549519,0.00008581069,0.93858814,0.00031378536],"about_ca_topic_score_codex":0.0000023783098,"about_ca_topic_score_gemma":3.5862705e-8,"teacher_disagreement_score":0.9667012,"about_ca_system_score_codex":0.00025608088,"about_ca_system_score_gemma":0.00008701791,"threshold_uncertainty_score":0.99991715},"labels":[],"label_agreement":null},{"id":"W2167992220","doi":"10.1517/14712598.2014.924496","title":"Efficacy and safety of subcutaneous interferon-β-1a in patients with a first demyelinating event and early multiple sclerosis","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"EMD Serono; Teva Pharmaceutical Industries","keywords":"Multiple sclerosis; Medicine; Demyelinating disease; Event (particle physics); Immunology; Interferon; Physics","score_opus":0.1471201261681221,"score_gpt":0.3693502222295723,"score_spread":0.22223009606145022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167992220","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07375544,0.9233785,0.000017548275,0.000116916206,0.00007605933,0.0025707278,0.000027261472,0.000034061373,0.000023460943],"genre_scores_gemma":[0.13403364,0.8652478,0.00027534933,0.00005817168,0.00009726171,0.00019110272,0.00005921724,0.0000353447,0.0000021194894],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973586,0.00039432046,0.00080351235,0.0007109373,0.00034536226,0.00038727117],"domain_scores_gemma":[0.9969924,0.0020950946,0.00031942275,0.00032221805,0.00009936368,0.00017149572],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003991159,0.00050917553,0.0021099239,0.00021304518,0.00011286418,0.000019612948,0.00016804789,0.00034929707,0.000026710333],"category_scores_gemma":[0.0006343876,0.00026944335,0.00017234123,0.00021053117,0.0003504424,0.000026953217,0.00017662485,0.00046379725,0.0000032265332],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062008323,0.00059688446,0.010562371,0.0005260759,0.00019298523,0.000001938386,0.00028770752,4.3602233e-7,0.0000095493715,0.000006811936,0.000030233155,0.9815842],"study_design_scores_gemma":[0.013478417,0.028684774,0.24749514,0.045855977,0.0000055801784,0.000009033577,0.00003912591,0.000021657283,0.000008069569,0.0000024283474,0.6637886,0.0006111945],"about_ca_topic_score_codex":0.000047121317,"about_ca_topic_score_gemma":0.0000054319516,"teacher_disagreement_score":0.980973,"about_ca_system_score_codex":0.000113999755,"about_ca_system_score_gemma":0.000033051627,"threshold_uncertainty_score":0.9999758},"labels":[],"label_agreement":null},{"id":"W2168921856","doi":"10.1517/14712598.1.1.121","title":"O-raffinose-polymerised haemoglobin. A biochemical and pharmacological profile of an oxygen carrier","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Hemoglobin structure and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Raffinose; Nitric oxide; Oxygen; Chemistry; Hemodynamics; Medicine; Perioperative; Blood volume; Biochemistry; Pharmacology; Surgery; Internal medicine","score_opus":0.07237689146987646,"score_gpt":0.3724817281050197,"score_spread":0.30010483663514326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168921856","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00988437,0.98809755,0.00003345926,0.000033748474,0.00048356067,0.00090399914,0.00016205035,0.000048435733,0.00035280766],"genre_scores_gemma":[0.0014541083,0.9942621,0.0003110178,0.0005744493,0.0013382019,0.00022542839,0.0017537689,0.00004457799,0.00003634392],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99741936,0.00043270146,0.0005763721,0.0010017856,0.0001769033,0.0003928585],"domain_scores_gemma":[0.99892247,0.000056338286,0.00027950955,0.00044462836,0.000058410522,0.00023863405],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00018122743,0.00061645824,0.0011560952,0.00007877617,0.00009286643,0.000023465444,0.00038688842,0.0013737127,0.00031953183],"category_scores_gemma":[0.000059358474,0.0003797782,0.00041688196,0.00020734781,0.00032436106,0.000005060139,0.00009484792,0.00031559722,0.000007902644],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049246545,0.0002445475,0.0000050858916,0.000049329803,0.00018853562,0.0000046205882,0.000016648286,1.4982847e-7,0.07514144,0.000026904769,0.0037742907,0.920056],"study_design_scores_gemma":[0.00074741535,0.0024588348,0.000020545243,0.00023999525,0.000004365694,0.000073024254,0.000016204393,0.0000020441837,0.021870527,0.000015366628,0.97407633,0.00047533974],"about_ca_topic_score_codex":0.0000062200975,"about_ca_topic_score_gemma":1.0113905e-7,"teacher_disagreement_score":0.97030205,"about_ca_system_score_codex":0.000026059613,"about_ca_system_score_gemma":0.00009378034,"threshold_uncertainty_score":0.9999227},"labels":[],"label_agreement":null},{"id":"W2198610527","doi":"10.1517/14712598.2015.1083552","title":"Biosimilar monoclonal antibodies: the scientific basis for extrapolation","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Infliximab; Medicine; Pharmacology; Disease; Internal medicine","score_opus":0.38047339994214074,"score_gpt":0.4642009020635223,"score_spread":0.08372750212138158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2198610527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004732711,0.9913839,0.000314013,0.001090107,0.004740006,0.0016687475,0.00039440615,0.00010545839,0.00029862276],"genre_scores_gemma":[0.00001025442,0.9957363,0.000984482,0.0012071069,0.00055823196,0.00040221727,0.000746049,0.00003817083,0.0003171729],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961921,0.001344939,0.0007476025,0.0010065492,0.00010524963,0.0006035911],"domain_scores_gemma":[0.99673396,0.001965756,0.00036259918,0.00069825916,0.00017036314,0.00006903111],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0020477504,0.0006602573,0.00157235,0.0001759363,0.0006638306,0.00011305295,0.00086791354,0.0015218303,0.0007911781],"category_scores_gemma":[0.00039036822,0.00029006758,0.0010855331,0.00040928114,0.0010540873,0.0000427884,0.00010261812,0.0005917656,0.00015755963],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023046558,0.0002024001,0.0000019072586,0.000035471625,0.0002872174,3.3794393e-7,0.000049171802,4.9681685e-8,0.00022964155,0.0015280901,0.053983293,0.94345194],"study_design_scores_gemma":[0.00047410818,0.0008645308,0.0000064103197,0.0006598818,0.000007014437,0.00001414719,0.000035462344,0.0000027533613,0.0002839856,0.00054302893,0.99666584,0.0004428625],"about_ca_topic_score_codex":0.0000027107885,"about_ca_topic_score_gemma":2.606316e-7,"teacher_disagreement_score":0.9430091,"about_ca_system_score_codex":0.00009628548,"about_ca_system_score_gemma":0.0001646403,"threshold_uncertainty_score":0.9999551},"labels":[],"label_agreement":null},{"id":"W2202409929","doi":"10.1517/14712598.2016.1118045","title":"Novel approaches to biological therapy for psoriatic arthritis","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Psoriatic arthritis; Medicine; Etanercept; Psoriasis; Computational biology; Dermatology; Biology; Immunology; Rheumatoid arthritis","score_opus":0.611622334140147,"score_gpt":0.4386725925280474,"score_spread":0.17294974161209958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2202409929","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007032003,0.9903541,0.0001796755,0.0008912802,0.0014406507,0.0061592394,0.00026509413,0.00019556795,0.00044405734],"genre_scores_gemma":[0.00005563888,0.9856008,0.0032345846,0.0021987522,0.0021599072,0.005343028,0.0012836807,0.00008573998,0.000037867656],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99665695,0.00021303023,0.0008215104,0.0012729677,0.0003184548,0.0007170851],"domain_scores_gemma":[0.9981245,0.00046782076,0.00025435403,0.0006224386,0.00010135142,0.00042954527],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004319992,0.0009796205,0.0033263615,0.00017377765,0.00021004688,0.00004429289,0.00032944613,0.0009482295,0.00020438623],"category_scores_gemma":[0.0001860762,0.00050609553,0.0011562039,0.00034278104,0.00017249028,0.000026179014,0.00008755687,0.00034491176,0.0001778137],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010827829,0.0015417625,0.000006744383,0.000030820684,0.0005435661,0.000008491046,0.000091304515,7.5942104e-8,0.0000071438108,0.00084665517,0.004368851,0.9914718],"study_design_scores_gemma":[0.0064011654,0.013598739,0.00004358616,0.0022559946,0.000002163163,0.00008187138,0.00005151676,7.709511e-7,0.000009108423,0.0001764267,0.97679764,0.00058104447],"about_ca_topic_score_codex":0.000009373303,"about_ca_topic_score_gemma":4.9573134e-7,"teacher_disagreement_score":0.99089074,"about_ca_system_score_codex":0.00020545685,"about_ca_system_score_gemma":0.0001303217,"threshold_uncertainty_score":0.99973905},"labels":[],"label_agreement":null},{"id":"W2221971298","doi":"10.1517/14712598.2016.1121231","title":"Vedolizumab for the treatment of ulcerative colitis","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Vedolizumab; Ulcerative colitis; Medicine; Colitis; Intensive care medicine; Internal medicine; Disease","score_opus":0.16582781536460267,"score_gpt":0.4142006915334602,"score_spread":0.2483728761688575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2221971298","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006971333,0.99646014,0.000057880803,0.000046916477,0.0006102799,0.00219847,0.00034483845,0.000014879376,0.00019687679],"genre_scores_gemma":[0.00005089406,0.99550354,0.00007615625,0.00017947785,0.001247024,0.0018469304,0.0009853047,0.000035039142,0.00007561492],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984432,0.00036807446,0.00038054754,0.00045990644,0.00010987012,0.0002384023],"domain_scores_gemma":[0.9988616,0.00015039441,0.00023908414,0.00053722,0.00011604914,0.00009563512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016970737,0.0004136132,0.00075242645,0.000029428977,0.000091841255,0.000014580979,0.00031985954,0.00046063308,0.000049691225],"category_scores_gemma":[0.000050753548,0.00019400958,0.00073277054,0.000049704962,0.00018786028,0.0000011713013,0.00002603053,0.000057992675,0.00001362082],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013876338,0.00032120035,8.84359e-7,0.000032412383,0.0003154176,0.0000020769774,0.00005745481,8.234864e-7,0.00001615029,0.00042828295,0.004966269,0.9924714],"study_design_scores_gemma":[0.0010594433,0.0039078076,0.00004302396,0.00017213119,0.0000031139946,0.0000037144034,0.000022491042,0.0000015228347,0.00011383412,0.000049605675,0.9943809,0.0002424418],"about_ca_topic_score_codex":0.0000029326416,"about_ca_topic_score_gemma":9.293027e-7,"teacher_disagreement_score":0.9922289,"about_ca_system_score_codex":0.00007415299,"about_ca_system_score_gemma":0.00020888951,"threshold_uncertainty_score":0.7911481},"labels":[],"label_agreement":null},{"id":"W2298021796","doi":"10.1517/14712598.2016.1167868","title":"Vascular endothelial growth factor inhibitor use and treatment approach for choroidal neovascularization secondary to pathologic myopia","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Aflibercept; Ranibizumab; Medicine; Macular degeneration; Choroidal neovascularization; Ophthalmology; Vascular endothelial growth factor; Bevacizumab; Surgery; VEGF receptors; Internal medicine; Chemotherapy","score_opus":0.1476687661530578,"score_gpt":0.36970562108051064,"score_spread":0.22203685492745284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2298021796","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011680115,0.9904036,0.0010769977,0.00008256209,0.00041215264,0.0055320403,0.001191341,0.00009379195,0.00003948573],"genre_scores_gemma":[0.00021259746,0.9918785,0.0013260985,0.00043136053,0.0011256182,0.002351177,0.0025355064,0.00006882818,0.00007031755],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975586,0.00030683543,0.0004751897,0.0010436758,0.00021673348,0.0003989498],"domain_scores_gemma":[0.99863803,0.00031754616,0.00016629383,0.0004305826,0.00008757858,0.00035996133],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000091696376,0.00074264314,0.0016654229,0.00015317247,0.00013681478,0.00008368866,0.00012144572,0.00058250263,0.000089878944],"category_scores_gemma":[0.0001485118,0.0003370089,0.0010569164,0.0001142284,0.000086609,0.00006294368,0.000042319174,0.00013381614,0.000021164513],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077713275,0.0009632648,0.00015378052,0.0001509663,0.00066563475,0.000012818122,0.000034121862,1.15178125e-7,0.00004966066,0.00020440112,0.0001635805,0.9968245],"study_design_scores_gemma":[0.0036588917,0.0080522,0.0010534844,0.001073341,0.000019287898,0.000029164155,0.000007643312,0.0000025220588,0.00002487006,0.000021510083,0.98564804,0.00040906505],"about_ca_topic_score_codex":0.000012398978,"about_ca_topic_score_gemma":3.5979895e-8,"teacher_disagreement_score":0.99641544,"about_ca_system_score_codex":0.00022572525,"about_ca_system_score_gemma":0.00009838776,"threshold_uncertainty_score":0.9999082},"labels":[],"label_agreement":null},{"id":"W2302397867","doi":"10.1517/14712598.2016.1134483","title":"<i>Mycobacterium phlei</i>cell wall-nucleic acid complex in the treatment of nonmuscle invasive bladder cancer unresponsive to bacillus Calmette-Guerin","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Telesta Therapeutics (Canada); Queen's University","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Regimen; Clinical trial; BCG vaccine; Refractory (planetary science); Oncology; Internal medicine; Intensive care medicine; Surgery; Cancer; Immunology; Vaccination; Biology","score_opus":0.26248453615048944,"score_gpt":0.4282477445639823,"score_spread":0.16576320841349285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2302397867","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033726122,0.98932797,0.0000023768805,0.0010903535,0.00064918306,0.0042721475,0.0004515358,0.000048347487,0.0007854565],"genre_scores_gemma":[0.0013945715,0.98962086,0.00011680844,0.0052663865,0.00070807076,0.002208129,0.000524036,0.00007166261,0.00008948211],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99641514,0.00087759626,0.00081477314,0.00088323967,0.00045463987,0.0005545998],"domain_scores_gemma":[0.9979919,0.00044347916,0.00030114816,0.00083008583,0.00014492503,0.00028843744],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024136817,0.000888903,0.002559759,0.00023455235,0.00007613383,0.000025819527,0.00044786226,0.0005294793,0.0009149758],"category_scores_gemma":[0.000037100403,0.00042241334,0.00072909886,0.00055134017,0.000165616,0.000031866268,0.000048390506,0.00029542085,0.00015454655],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021595813,0.0028169444,0.000057703044,0.00013256197,0.00051483716,0.00006372769,0.0025938926,0.0000010362471,0.0009885905,0.0000141195,0.005445884,0.98521113],"study_design_scores_gemma":[0.0037589772,0.013854519,0.00040889508,0.0011896185,0.000020494448,0.000024624786,0.00020836259,4.9948903e-7,0.00051245943,0.000011024535,0.9795835,0.00042700852],"about_ca_topic_score_codex":0.00039001243,"about_ca_topic_score_gemma":0.000023044246,"teacher_disagreement_score":0.9847841,"about_ca_system_score_codex":0.00074222666,"about_ca_system_score_gemma":0.0005110255,"threshold_uncertainty_score":0.99999833},"labels":[],"label_agreement":null},{"id":"W2320245919","doi":"10.1517/14712598.2010.532483","title":"siRNA therapy for cancer and non-lethal diseases such as arthritis and osteoporosis","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Genetic enhancement; Rheumatoid arthritis; Gene silencing; Osteoporosis; Osteoarthritis; Arthritis; Bioinformatics; Cancer; Disease; Immunology; Pathology; Internal medicine; Gene; Alternative medicine; Biology","score_opus":0.0684498500099538,"score_gpt":0.38252299792797106,"score_spread":0.31407314791801727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320245919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021733182,0.97604555,0.000013198234,0.00016335734,0.00071844534,0.00097482296,0.00028709965,0.000017343025,0.000046982805],"genre_scores_gemma":[0.0016710766,0.99380773,0.000072665214,0.0012570518,0.0013122938,0.0010392596,0.0007371143,0.000042120835,0.000060695453],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983274,0.000102006175,0.00033044425,0.00083819823,0.00009156106,0.0003103976],"domain_scores_gemma":[0.99917835,0.00010207537,0.00016527367,0.0003291912,0.00006474963,0.00016033942],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000108050495,0.00050406286,0.00084944576,0.000051893414,0.00014068189,0.00006436431,0.0002476541,0.0008328403,0.000083325205],"category_scores_gemma":[0.000041898435,0.00031474055,0.0003518071,0.00004971985,0.00022299132,0.000004747682,0.000073680516,0.00020977034,0.0000057802927],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002598192,0.00009793868,0.000034383134,0.000028193506,0.000105281964,0.000001219636,0.00002590354,2.8699919e-8,0.0035758456,0.000017885079,0.0014633733,0.99439013],"study_design_scores_gemma":[0.00086664606,0.0030932308,0.00010065634,0.00069028727,0.0000016413732,0.00001652242,0.000020656224,5.5887773e-7,0.0019083557,0.00006764116,0.9927757,0.00045811286],"about_ca_topic_score_codex":0.00002894566,"about_ca_topic_score_gemma":0.0000031136058,"teacher_disagreement_score":0.993932,"about_ca_system_score_codex":0.0000093901635,"about_ca_system_score_gemma":0.00008567077,"threshold_uncertainty_score":0.99993044},"labels":[],"label_agreement":null},{"id":"W2335443846","doi":"10.1517/14712598.2016.1169268","title":"Prospect of ultrasound-mediated gene delivery in cardiovascular applications","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Institute of Circulatory and Respiratory Health; Canadian Institutes of Health Research","keywords":"Gene delivery; Medicine; Genetic enhancement; Computational biology; Gene; Biology; Bioinformatics; Genetics","score_opus":0.059132822661843124,"score_gpt":0.30462247758819266,"score_spread":0.24548965492634955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335443846","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040295992,0.9966151,0.0006863827,0.000009792273,0.0001658827,0.0014784965,0.00017826074,0.00023633947,0.00058943115],"genre_scores_gemma":[0.000420122,0.99569356,0.00021632858,0.000039326933,0.00041072798,0.0027364825,0.0004148743,0.000063441155,0.0000051338707],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983173,0.0001310362,0.0006086163,0.00047193246,0.00017344115,0.00029767118],"domain_scores_gemma":[0.9984942,0.0006056842,0.00009462088,0.00069008884,0.00003525121,0.00008015254],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018547362,0.0004392231,0.0013847877,0.00017179271,0.000047068963,0.000013981734,0.00044558814,0.0005300192,0.00015237338],"category_scores_gemma":[0.000020084135,0.00026304042,0.0007499829,0.00042762392,0.00011189643,0.000030450223,0.000017455695,0.0002642718,0.00018882687],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000073929637,0.00013055591,0.0000058247147,0.00008298801,0.00032530894,5.665972e-7,0.000029516925,0.000012987536,0.0010559772,0.0004170326,0.00017486874,0.99775696],"study_design_scores_gemma":[0.0002968375,0.000077397664,0.000026687008,0.00070287165,0.0000015770851,0.000009085113,0.0000048867846,0.0000016122235,0.00010553932,0.000095518444,0.9983298,0.00034817687],"about_ca_topic_score_codex":0.000005853116,"about_ca_topic_score_gemma":2.6105275e-7,"teacher_disagreement_score":0.99815494,"about_ca_system_score_codex":0.00012373518,"about_ca_system_score_gemma":0.00003888364,"threshold_uncertainty_score":0.9999822},"labels":[],"label_agreement":null},{"id":"W2412338323","doi":"10.1080/14712598.2016.1193594","title":"HIV-1 Immunogen: an overview of almost 30 years of clinical testing of a candidate therapeutic vaccine","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Clinical trial; HIV vaccine; Immunogen; AIDS Vaccines; Intensive care medicine; Immunology; Human immunodeficiency virus (HIV); Vaccine trial; Virology; Internal medicine","score_opus":0.4007525412356802,"score_gpt":0.4963771413272392,"score_spread":0.09562460009155899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412338323","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018607831,0.99601156,0.000005662317,0.000030301002,0.00044139847,0.0008304387,0.0006648467,0.000029985711,0.0001250224],"genre_scores_gemma":[0.0024723676,0.9963057,0.00008929153,0.00006616375,0.0001090824,0.000099704004,0.00079500966,0.000033085074,0.000029607141],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950837,0.0021340572,0.0016686571,0.00059131166,0.00009772304,0.00042455102],"domain_scores_gemma":[0.9959147,0.0020380307,0.001045643,0.00079984183,0.00013584507,0.000065914996],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00091788545,0.00044329982,0.0028762426,0.0001495413,0.000053615444,0.000004021645,0.00068033393,0.00085647876,0.0021874234],"category_scores_gemma":[0.00025454356,0.00023084176,0.00078743254,0.00024373752,0.00040207335,0.000031103158,0.00011711152,0.00040560996,0.0003358195],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053727435,0.001049833,0.000298559,0.00013241854,0.0010502385,0.0000034130087,0.000044825214,2.5281173e-8,0.002401583,0.0002050004,0.00023545463,0.9940414],"study_design_scores_gemma":[0.002346965,0.0059316177,0.0013305743,0.00396801,0.000005904842,0.000017987373,0.0000147238425,8.990027e-8,0.00067261874,0.000043827135,0.9854292,0.0002384592],"about_ca_topic_score_codex":0.000059555477,"about_ca_topic_score_gemma":3.8002227e-7,"teacher_disagreement_score":0.9938029,"about_ca_system_score_codex":0.00003528592,"about_ca_system_score_gemma":0.00024535853,"threshold_uncertainty_score":0.9987247},"labels":[],"label_agreement":null},{"id":"W2463180023","doi":"10.1080/14712598.2016.1205582","title":"Ustekinumab: a novel therapeutic option in Crohn’s disease","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Ustekinumab; Medicine; Crohn's disease; Disease; Expert opinion; Vedolizumab; Monoclonal; Tumor necrosis factor alpha; Intensive care medicine; Monoclonal antibody; Immunology; Internal medicine; Infliximab; Antibody","score_opus":0.11186438393638137,"score_gpt":0.38005003603072296,"score_spread":0.2681856520943416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463180023","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047571736,0.99684316,0.00024665456,0.00007230592,0.00072686886,0.0012809598,0.0001311332,0.00005010613,0.00017309196],"genre_scores_gemma":[0.00072271976,0.99537206,0.000050046452,0.0010438665,0.0011714644,0.00085840543,0.00062682695,0.000078568504,0.000076023854],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99715877,0.0005059825,0.0006043247,0.0010390906,0.00020013878,0.0004916972],"domain_scores_gemma":[0.9985631,0.000070001886,0.00025683397,0.000810507,0.0000467073,0.00025282713],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002705817,0.0006908179,0.00078750664,0.00014448691,0.000080617734,0.00003958318,0.00056533347,0.00078336714,0.00019586629],"category_scores_gemma":[0.00008506075,0.0004028984,0.0006975695,0.00012137508,0.00016981474,0.0000056313093,0.000113553666,0.0002428502,0.00017651802],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010660553,0.00046769143,0.000045713048,0.000080642574,0.00010215002,0.000055495835,0.0000104585,0.0000010833829,0.0004352696,0.0010215213,0.00036864707,0.9963453],"study_design_scores_gemma":[0.0010555899,0.000221823,0.00314151,0.001732136,0.0000011211201,0.0000055993887,0.0000042242687,0.0000019608992,0.000012536597,0.0000997449,0.9930994,0.00062435406],"about_ca_topic_score_codex":0.0000016740199,"about_ca_topic_score_gemma":4.819153e-7,"teacher_disagreement_score":0.9957209,"about_ca_system_score_codex":0.00010854189,"about_ca_system_score_gemma":0.00022561588,"threshold_uncertainty_score":0.9998423},"labels":[],"label_agreement":null},{"id":"W2508017949","doi":"10.1080/14712598.2016.1235149","title":"Biomaterial strategies to improve the efficacy of bone marrow cell therapy for myocardial infarction","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Ontario Ministry of Research and Innovation; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Research, Innovation and Science","keywords":"Medicine; Cell therapy; Biomaterial; Myocardial infarction; Clinical trial; Intensive care medicine; Stem-cell therapy; Transplantation; Stem cell; Pathology; Internal medicine; Biomedical engineering; Biology","score_opus":0.08882421842129841,"score_gpt":0.38483580552993746,"score_spread":0.29601158710863906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508017949","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048635565,0.98942727,0.00085467944,0.0010976846,0.0045210184,0.0033623304,0.00008651739,0.00010129815,0.00006284743],"genre_scores_gemma":[0.00081222935,0.9912646,0.0002736906,0.00022289988,0.006180968,0.0008220611,0.00020322604,0.000060293045,0.00016006366],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99801683,0.00023547416,0.00064725644,0.00053480186,0.00022875384,0.00033687605],"domain_scores_gemma":[0.9984918,0.0005331588,0.00025367827,0.00049337186,0.0000915442,0.00013640514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003955762,0.0005417066,0.001697251,0.0001614875,0.0000938291,0.00002337477,0.000205796,0.00048859953,0.00012415566],"category_scores_gemma":[0.000089730835,0.00020372009,0.0006849606,0.00018842127,0.0001851386,0.000021913354,0.000027368289,0.0001932978,0.000025444177],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013348256,0.00023285439,4.3265612e-7,0.00013927503,0.00024888432,0.0000011077434,0.00013445604,8.4363495e-7,0.049030926,0.0004600205,0.0025538746,0.9458625],"study_design_scores_gemma":[0.0030715936,0.0071036518,0.0000337841,0.0019335552,0.0000039385072,0.000011173685,0.00002960984,7.415193e-7,0.0032594942,0.0000159449,0.9842683,0.00026819887],"about_ca_topic_score_codex":0.0000070168835,"about_ca_topic_score_gemma":3.1673515e-8,"teacher_disagreement_score":0.9817144,"about_ca_system_score_codex":0.000068984125,"about_ca_system_score_gemma":0.00012964463,"threshold_uncertainty_score":0.8307464},"labels":[],"label_agreement":null},{"id":"W2727069163","doi":"10.1080/14712598.2017.1346080","title":"Cellular mechanisms underlying cardiac engraftment of stem cells","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Institute of Circulatory and Respiratory Health; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Stem cell; Ex vivo; Regeneration (biology); Cell therapy; Transplantation; Cell; Limiting; Cancer research; Cell biology; Biology; Neuroscience; Medicine; Immunology; In vivo; Internal medicine; Biotechnology","score_opus":0.42307159238040176,"score_gpt":0.44437146097184466,"score_spread":0.021299868591442894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2727069163","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016435513,0.9934984,0.0017362925,0.0000956166,0.0031657415,0.001240806,0.000027074915,0.00009571042,0.0001239318],"genre_scores_gemma":[0.00022627678,0.99741,0.000594551,0.00004674403,0.00073515734,0.00017484855,0.00015452891,0.00005832243,0.000599585],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979302,0.00028448194,0.0005903047,0.0005633602,0.00031773854,0.00031388318],"domain_scores_gemma":[0.9984471,0.0001888254,0.00035906423,0.00076196034,0.000052793654,0.00019021079],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037946017,0.0005797245,0.0027159522,0.00015209585,0.00011611794,0.000013880382,0.0002744205,0.00060198206,0.00011328182],"category_scores_gemma":[0.000014998396,0.00029916927,0.00083912717,0.000094043535,0.00013888913,0.000013374871,0.000043472468,0.00045597123,0.000042115204],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037284168,0.00016815793,1.4739133e-7,0.00028299965,0.00039233748,0.000014771953,0.00006815595,0.0000012145119,0.00699695,0.0021286304,0.0004778592,0.9894315],"study_design_scores_gemma":[0.0005691759,0.0022446376,0.000001321606,0.007235478,0.0000076197184,0.000007051338,0.000033974502,0.000003121432,0.0062976293,0.000015731744,0.98328876,0.00029547274],"about_ca_topic_score_codex":0.0000053163258,"about_ca_topic_score_gemma":1.0892008e-8,"teacher_disagreement_score":0.98913604,"about_ca_system_score_codex":0.000107010615,"about_ca_system_score_gemma":0.00008142481,"threshold_uncertainty_score":0.99994606},"labels":[],"label_agreement":null},{"id":"W2749145761","doi":"10.1080/14712598.2017.1363886","title":"Bezlotoxumab for the prevention of<i>Clostridium difficile</i>recurrence","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Sanofi Pasteur; U.S. Food and Drug Administration; Pfizer","keywords":"Medicine; Intensive care medicine","score_opus":0.439279009154149,"score_gpt":0.5042040518800215,"score_spread":0.06492504272587246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749145761","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000056037738,0.99185103,0.000098760494,0.0006622605,0.0012890298,0.005209448,0.00020705324,0.000069020156,0.0005573287],"genre_scores_gemma":[0.000268946,0.9951745,0.00009209473,0.00012359014,0.001888365,0.0015761267,0.0005591207,0.00006734619,0.0002498787],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966461,0.00031096497,0.0009900505,0.0008769385,0.0005704859,0.0006054798],"domain_scores_gemma":[0.9955566,0.0017825317,0.00074553094,0.001491798,0.0002334995,0.00019006357],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074251747,0.00069696223,0.0023370318,0.0001773949,0.00042349924,0.00006820959,0.0009996423,0.00077987654,0.0003130792],"category_scores_gemma":[0.00076914154,0.000339816,0.001966219,0.0002451078,0.0004693163,0.00003552295,0.00015158758,0.00078269106,0.00006247955],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000781641,0.00075595017,7.630522e-7,0.0004069988,0.0003346214,0.0000026970747,0.000021818556,1.5559881e-7,0.00017295197,0.00029697723,0.0057492056,0.99147624],"study_design_scores_gemma":[0.0014597233,0.0041686157,0.0000048080346,0.0055508995,0.000014008462,0.00002901813,0.00001879952,0.000009033592,0.0027460218,0.000046161786,0.98559314,0.00035975128],"about_ca_topic_score_codex":0.000012519847,"about_ca_topic_score_gemma":3.0071743e-7,"teacher_disagreement_score":0.99111646,"about_ca_system_score_codex":0.0001655808,"about_ca_system_score_gemma":0.00051102805,"threshold_uncertainty_score":0.9999054},"labels":[],"label_agreement":null},{"id":"W2912092093","doi":"10.1080/14712598.2019.1575359","title":"Disease modeling of cardiac arrhythmias using human induced pluripotent stem cells","year":2019,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Institute of Circulatory and Respiratory Health","keywords":"Induced pluripotent stem cell; Disease; Neuroscience; Medicine; Bioinformatics; Stem cell; Genome editing; Biology; Phenotype; Ex vivo; Computational biology; Pathology; Embryonic stem cell; In vivo; CRISPR; Cell biology; Genetics; Gene","score_opus":0.2512743457737118,"score_gpt":0.40365702252840946,"score_spread":0.15238267675469763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912092093","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014967342,0.9813169,0.000024300933,0.000040031882,0.0015479275,0.001869738,0.000059201702,0.000085057975,0.00008947446],"genre_scores_gemma":[0.006024671,0.99116445,0.000062751475,0.0003005635,0.0019766162,0.00011936945,0.00024707013,0.00007879751,0.000025707579],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966677,0.0006747787,0.00089773204,0.0009401577,0.0003119033,0.0005077186],"domain_scores_gemma":[0.9981267,0.00019525595,0.00042124558,0.0008876718,0.000097740805,0.00027142814],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023347221,0.0007404391,0.0034831194,0.00021411474,0.00013256392,0.000012857609,0.00020295066,0.00086458476,0.00007831468],"category_scores_gemma":[0.000016607699,0.00045393102,0.0022559348,0.00024520728,0.00011534308,0.000032680946,0.00008703635,0.00079114374,0.0000593967],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009256007,0.00035839967,0.0000037611157,0.00081275374,0.0009911177,0.00005986347,0.000063388405,0.00022062204,0.010417578,0.00037959716,0.00012222161,0.9856451],"study_design_scores_gemma":[0.00089431356,0.0021970123,0.0000072425455,0.008384858,0.00003969696,0.0000400549,0.00003297579,0.0003719162,0.00056443684,0.00005863622,0.98657435,0.000834485],"about_ca_topic_score_codex":0.000011127003,"about_ca_topic_score_gemma":1.2161499e-8,"teacher_disagreement_score":0.98645216,"about_ca_system_score_codex":0.00018966086,"about_ca_system_score_gemma":0.0002785805,"threshold_uncertainty_score":0.99979126},"labels":[],"label_agreement":null},{"id":"W2939487002","doi":"10.1080/14712598.2019.1608179","title":"Facing the future: challenges and opportunities in adoptive T cell therapy in cancer","year":2019,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Immunotherapy; Tumor microenvironment; Chimeric antigen receptor; T cell; Cancer immunotherapy; Context (archaeology); Medicine; Adoptive cell transfer; Cell therapy; Cancer; Cancer research; Immune system; Immunology; Cell; Biology; Internal medicine","score_opus":0.5050365452917507,"score_gpt":0.4602758091893972,"score_spread":0.04476073610235348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939487002","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004813971,0.990005,3.666456e-7,0.003879794,0.0006738211,0.0028466587,0.000019859826,0.00004312105,0.0020499506],"genre_scores_gemma":[0.00012332914,0.9950368,0.000012038927,0.002180108,0.0011642943,0.000975449,0.00008906631,0.00006982402,0.0003491333],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99649537,0.0011013434,0.0006078427,0.0008456102,0.0003745619,0.0005752785],"domain_scores_gemma":[0.9982822,0.00072071777,0.00019853386,0.0005989368,0.000066259076,0.00013335816],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00083915837,0.000673645,0.0019925463,0.00035568886,0.000064686974,0.000035245113,0.0003889443,0.0008045979,0.0013845998],"category_scores_gemma":[0.000016980934,0.00032024694,0.0003727879,0.00024239218,0.00025763284,0.00004692079,0.000087346176,0.001306445,0.000020170211],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006179204,0.00029367468,0.000015989157,0.00018037911,0.000087781555,0.000020063817,0.0013117451,2.1628557e-7,0.00006969391,0.0002553955,0.00022244648,0.9969247],"study_design_scores_gemma":[0.0019092647,0.0019897467,0.00020736546,0.0027096332,9.062545e-7,0.000017044898,0.0012900867,0.000002641045,0.00003101696,0.000039825325,0.99142617,0.00037629332],"about_ca_topic_score_codex":0.000059313214,"about_ca_topic_score_gemma":0.000009077406,"teacher_disagreement_score":0.9965484,"about_ca_system_score_codex":0.00026393106,"about_ca_system_score_gemma":0.00025329358,"threshold_uncertainty_score":0.99992496},"labels":[],"label_agreement":null},{"id":"W2982452225","doi":"10.1080/14712598.2020.1685976","title":"Blockade of the CD47-SIRPα axis: a promising approach for cancer immunotherapy","year":2019,"lang":"en","type":"editorial","venue":"Expert Opinion on Biological Therapy","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"Cancer immunotherapy; Blockade; CD47; Immunotherapy; Medicine; Cancer; Immunology; Cancer research; Immune system; Internal medicine; Receptor","score_opus":0.05707326455684902,"score_gpt":0.3338030003295742,"score_spread":0.2767297357727252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982452225","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005120518,0.21509805,0.00032714102,0.000498051,0.77481663,0.0032931787,0.00042051004,0.0001638107,0.00026213026],"genre_scores_gemma":[0.042502593,0.54400826,0.00053162914,0.0009940852,0.4025339,0.002806892,0.0042964956,0.00033750606,0.0019886899],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99733806,0.0005590023,0.0006906003,0.00076413224,0.0001531164,0.0004951092],"domain_scores_gemma":[0.9973944,0.00083244726,0.00072893646,0.00081214006,0.00021365992,0.000018433593],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00048387097,0.0005647537,0.0010307261,0.00009274704,0.0002354403,0.00002822206,0.00095028884,0.002236096,0.00016701403],"category_scores_gemma":[0.00017812526,0.00030084772,0.00071883324,0.00016047743,0.00035439522,0.000049493352,0.00009311337,0.0007592961,0.000010728626],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029470942,0.0005657442,0.0000369702,0.000014933732,0.0006080878,2.9669629e-8,0.00036465944,0.000018837804,0.4576247,0.00014717666,0.49334008,0.044331666],"study_design_scores_gemma":[0.0034062853,0.0011096431,0.00025434903,0.00018418906,0.0000014118787,0.0000011018784,0.00004720271,0.000011862038,0.08401219,0.00007480459,0.91051996,0.00037702144],"about_ca_topic_score_codex":0.000078608035,"about_ca_topic_score_gemma":4.1170878e-7,"teacher_disagreement_score":0.41717985,"about_ca_system_score_codex":0.00014661546,"about_ca_system_score_gemma":0.00023324396,"threshold_uncertainty_score":0.9999444},"labels":[],"label_agreement":null},{"id":"W3001974054","doi":"10.1080/14712598.2020.1718097","title":"Epidemiological data and utilization patterns of anti-TNF alpha therapy in the Hungarian ulcerative colitis population between 2012-2016","year":2020,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Infliximab; Medicine; Adalimumab; Ulcerative colitis; Reimbursement; Epidemiology; Internal medicine; Population; Retrospective cohort study; Maintenance therapy; Pediatrics; Tumor necrosis factor alpha; Disease; Chemotherapy; Health care; Environmental health","score_opus":0.1693804087647284,"score_gpt":0.37346683809806874,"score_spread":0.20408642933334034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001974054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934477,0.002256043,0.0011309964,0.002177354,0.00008415063,0.00061182043,0.00022847335,0.00001720318,0.000046228175],"genre_scores_gemma":[0.93845713,0.054519914,0.00008961743,0.004171921,0.00048813227,0.0000367472,0.0022240554,0.000011019216,0.0000014584513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976426,0.0011051729,0.00037572632,0.0005452527,0.00012631329,0.00020493077],"domain_scores_gemma":[0.9991653,0.00014278227,0.00014996267,0.00041802847,0.00003766357,0.00008625969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005646432,0.0002098852,0.00027798273,0.000024694853,0.000079125064,0.000018651122,0.0004376205,0.0002629941,0.0000676865],"category_scores_gemma":[0.00023725521,0.00012001275,0.00006443354,0.000074528165,0.000111202055,0.000015388698,0.00010692579,0.00012382581,0.0000028667534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033623888,0.000372047,0.81843424,0.000006685731,0.00011618802,0.000010892313,0.0009614984,0.000021033722,0.022148618,0.0015148378,0.002902851,0.15014875],"study_design_scores_gemma":[0.001070416,0.0010154021,0.9509429,0.000014981951,3.0016574e-7,0.0000010643535,0.00012611621,0.00010092522,0.0014159166,0.00021741327,0.044928763,0.00016583125],"about_ca_topic_score_codex":0.00002640363,"about_ca_topic_score_gemma":0.0000045397796,"teacher_disagreement_score":0.14998291,"about_ca_system_score_codex":0.00000723343,"about_ca_system_score_gemma":0.000020364672,"threshold_uncertainty_score":0.4893978},"labels":[],"label_agreement":null},{"id":"W4213140979","doi":"10.1517/eobt.3.6.1001.21267","title":"Drug discovery for inflammatory diseases","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Immunology; Drug discovery; Innate immune system; Immune system; Chemokine; Autoimmunity; Bioinformatics; Biology","score_opus":0.0927975923568113,"score_gpt":0.3822565203587953,"score_spread":0.28945892800198403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213140979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9389602,0.04468366,0.0002868096,0.008184677,0.0010332325,0.0014429402,0.00008151381,0.00015533736,0.0051716473],"genre_scores_gemma":[0.8209013,0.16517115,0.0006849315,0.009202301,0.0012311942,0.0003879886,0.00021661066,0.000029675388,0.0021748722],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988936,0.000114143186,0.00018436632,0.00030853465,0.00019812549,0.00030118992],"domain_scores_gemma":[0.99919343,0.00035696843,0.00003397191,0.00019006373,0.000047906713,0.00017764929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014329192,0.00017065306,0.00025548006,0.000049083355,0.0001298967,0.00002429158,0.00009837638,0.00008632394,0.00040050675],"category_scores_gemma":[0.00015013356,0.00009257062,0.00023014126,0.00007095636,0.00014336787,0.000049659266,0.00001609896,0.00012091782,0.000049414713],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030719554,0.004897732,0.14508438,0.000057081008,0.00058687833,0.000068630405,0.0007149529,0.000006815487,0.1151507,0.31107235,0.17352177,0.21811916],"study_design_scores_gemma":[0.0014305231,0.0011112222,0.019729137,0.000032620912,1.5973359e-7,0.0000073726555,0.000060128048,0.000007471511,0.011848019,0.0016865543,0.96394056,0.00014623215],"about_ca_topic_score_codex":0.000004706744,"about_ca_topic_score_gemma":1.4946741e-7,"teacher_disagreement_score":0.7904188,"about_ca_system_score_codex":0.000027330569,"about_ca_system_score_gemma":0.00005109757,"threshold_uncertainty_score":0.4385268},"labels":[],"label_agreement":null},{"id":"W4214611031","doi":"10.1517/eobt.3.7.1093.21269","title":"Peptide action in stroke therapy","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Excitotoxicity; Glutamate receptor; Glutamatergic; Neuroscience; Neurotransmission; Receptor; Biology; Excitatory postsynaptic potential; Postsynaptic potential; Pharmacology; Cell biology; Inhibitory postsynaptic potential; Biochemistry","score_opus":0.35261253727455466,"score_gpt":0.45377469932888326,"score_spread":0.1011621620543286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214611031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99308443,0.000988943,0.000013966062,0.0012321131,0.0012667963,0.00046006372,0.000003446701,0.00010957062,0.0028406994],"genre_scores_gemma":[0.7532047,0.23541075,0.000012219915,0.011048239,0.0000988505,0.00009298695,4.5574984e-7,0.000011974994,0.00011984748],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970154,0.0011849967,0.0002237023,0.0007452928,0.00030688115,0.0005237129],"domain_scores_gemma":[0.9989766,0.00058015186,0.000056057528,0.0002512674,0.00001612742,0.00011982848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035503297,0.00021041828,0.00020195883,0.00017522143,0.00020432111,0.00004477684,0.00039135656,0.0001364089,0.0007259654],"category_scores_gemma":[0.00036515662,0.00013707597,0.00009361423,0.000471754,0.00028658134,0.00013498074,0.000025967898,0.0004392962,0.00018388813],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005000855,0.00048213336,0.0008610422,1.2944109e-7,9.885965e-7,0.000021015903,0.000057409805,0.000005921307,0.9701426,0.0014864994,0.00052318745,0.02591897],"study_design_scores_gemma":[0.0009885794,0.0010688496,0.0016021784,0.0000023374675,5.630841e-9,0.000011190638,0.000019932713,0.000015748643,0.6333254,0.0002267714,0.36262682,0.00011219887],"about_ca_topic_score_codex":0.0000037677903,"about_ca_topic_score_gemma":2.1538733e-7,"teacher_disagreement_score":0.36210364,"about_ca_system_score_codex":0.00003907844,"about_ca_system_score_gemma":0.000036002562,"threshold_uncertainty_score":0.7948812},"labels":[],"label_agreement":null},{"id":"W4224219978","doi":"10.1080/14712598.2022.2066471","title":"Onasemnogene abeparvovec for the treatment of spinal muscular atrophy","year":2022,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"","keywords":"Spinal muscular atrophy; Medicine; Physical medicine and rehabilitation; Pathology; Disease","score_opus":0.1591708778901365,"score_gpt":0.40619282643085386,"score_spread":0.24702194854071735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224219978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8464454,0.14242542,0.0007328457,0.006696823,0.0005277925,0.0028475863,0.00004124545,0.000045001594,0.00023789593],"genre_scores_gemma":[0.75058544,0.24567308,0.00028041878,0.0018656077,0.00027139994,0.0011798268,0.00006467677,0.000017727441,0.00006186197],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99890506,0.0001356657,0.00017435239,0.00028376243,0.00028016223,0.00022101845],"domain_scores_gemma":[0.9993713,0.00013796249,0.00004475798,0.00033748668,0.000039435756,0.00006908322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001366156,0.00014001428,0.000247651,0.000045251123,0.0002262754,0.000004739832,0.00015025464,0.000045307548,0.0006458337],"category_scores_gemma":[0.000018061442,0.00006958092,0.00039008507,0.00012901553,0.000121774945,0.0000047950425,0.00002558389,0.000076680975,0.0000051395236],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012528157,0.004464445,0.00091760827,0.0000039613255,0.00043538932,0.000011327027,0.00035019292,0.00007306876,0.13618945,0.0016170316,0.0017791538,0.8416302],"study_design_scores_gemma":[0.0034574976,0.030576764,0.0047321394,0.000003772679,8.5900837e-7,0.000010701391,0.00019047034,0.000091466885,0.016355865,0.000100467405,0.9444003,0.00007969235],"about_ca_topic_score_codex":0.0000187638,"about_ca_topic_score_gemma":1.3747349e-7,"teacher_disagreement_score":0.9426212,"about_ca_system_score_codex":0.000055402114,"about_ca_system_score_gemma":0.000044576267,"threshold_uncertainty_score":0.7071426},"labels":[],"label_agreement":null},{"id":"W4229749993","doi":"10.1517/eobt.3.2.319.21151","title":"Biotherapeutic approaches to pancreatic cancer","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Pancreatic cancer; Cancer; Medicine; Computational biology; Cancer research; Biology; Internal medicine","score_opus":0.45762131177354465,"score_gpt":0.4377060633269027,"score_spread":0.019915248446641942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229749993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91329825,0.038700536,0.0009513295,0.016534766,0.00056214805,0.001948554,0.000007812186,0.00019818773,0.027798403],"genre_scores_gemma":[0.8369395,0.1415976,0.0032721264,0.016532684,0.0003880356,0.0006928113,0.000015164317,0.00002808976,0.00053398474],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841887,0.00028707768,0.00023012017,0.00042672726,0.00022139364,0.00041579083],"domain_scores_gemma":[0.999075,0.00024979285,0.000038085178,0.00032621436,0.000034436514,0.00027647425],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033814882,0.00021448624,0.0005147453,0.0000998531,0.00011093234,0.000014018373,0.000121570614,0.0002221544,0.0024100982],"category_scores_gemma":[0.00012595477,0.00012285974,0.00011545689,0.00025866265,0.00014355358,0.000018004976,0.000013866741,0.00019882269,0.00022295235],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007847277,0.0043040034,0.46150956,0.000017186205,0.001101628,0.000037864364,0.002449281,0.000011754603,0.06860794,0.0591964,0.0127446735,0.38217244],"study_design_scores_gemma":[0.0025022863,0.004298583,0.068591096,0.000077406374,0.0000010775123,0.000023755218,0.00019286381,0.00005721664,0.007050601,0.0007162713,0.9162322,0.00025663347],"about_ca_topic_score_codex":0.000029169389,"about_ca_topic_score_gemma":5.828682e-7,"teacher_disagreement_score":0.90348756,"about_ca_system_score_codex":0.000105277904,"about_ca_system_score_gemma":0.00010558961,"threshold_uncertainty_score":0.99850184},"labels":[],"label_agreement":null},{"id":"W4238774925","doi":"10.1517/eobt.3.8.1291.21293","title":"6th World Congress on Inflammation","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Inflammation; Medicine; Immunology","score_opus":0.04287538238884352,"score_gpt":0.3101675836512783,"score_spread":0.26729220126243475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238774925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9506571,0.0075237537,0.00015362492,0.0011146875,0.0024543884,0.00054509315,0.000006423233,0.00007067537,0.037474222],"genre_scores_gemma":[0.95197845,0.04312367,0.00010759627,0.0035421108,0.00038502627,0.00008433081,0.00020459683,0.00001934926,0.00055486767],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99893916,0.00019015138,0.00019176365,0.0003393268,0.00010274692,0.00023683306],"domain_scores_gemma":[0.99951184,0.000027236687,0.00006760519,0.00030290347,0.000040590432,0.000049842394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016429968,0.00019572391,0.00014134918,0.00005425738,0.000108922,0.00002252708,0.00015301473,0.00017607443,0.0002925038],"category_scores_gemma":[0.00008283269,0.00013503588,0.00011212664,0.00009599666,0.000080235004,0.0000034036452,0.00001629561,0.000104121624,0.00009679275],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012791603,0.00028827923,0.0012696823,8.3442274e-7,0.00007536526,0.0000016100081,0.00007088411,0.0000710916,0.89774877,0.014366404,0.014915312,0.06991259],"study_design_scores_gemma":[0.00069113873,0.0008513026,0.0006379413,0.00000677914,3.4588364e-8,9.003861e-7,0.00003347293,0.0000020722978,0.34859172,0.0001796618,0.6488594,0.00014562982],"about_ca_topic_score_codex":0.0000016513326,"about_ca_topic_score_gemma":9.572041e-7,"teacher_disagreement_score":0.63394403,"about_ca_system_score_codex":0.000011209163,"about_ca_system_score_gemma":0.000017768132,"threshold_uncertainty_score":0.5506603},"labels":[],"label_agreement":null},{"id":"W4249444689","doi":"10.1517/eobt.3.2.215.21149","title":"Adult stem cell therapy for heart failure","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Heart failure; Stem-cell therapy; Stem cell; Medicine; Cell therapy; Intensive care medicine; Internal medicine; Biology; Cell biology","score_opus":0.05079476180649813,"score_gpt":0.32692137217583367,"score_spread":0.27612661036933556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249444689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9533512,0.034384303,0.0022870095,0.004051424,0.0010086371,0.0023602706,0.00006109212,0.000107936285,0.002388151],"genre_scores_gemma":[0.8750988,0.11538513,0.0021077064,0.0058347653,0.00051476434,0.00045600065,0.00018765326,0.000047422454,0.00036774328],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813646,0.00031323876,0.00023297111,0.00065443874,0.00018492572,0.00047798324],"domain_scores_gemma":[0.9991402,0.00007570188,0.00006006432,0.00044731452,0.00013032442,0.000146407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029418393,0.00027704632,0.00023691962,0.000042848005,0.00015966919,0.00003511393,0.0003019149,0.00037516007,0.00013689876],"category_scores_gemma":[0.000033815075,0.00018415978,0.00024592408,0.00009507861,0.00009863845,0.0000035253931,0.000029589824,0.00013315344,0.000051359082],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089550327,0.00039757328,0.0006238245,0.0000015526714,0.00003308198,4.5979885e-7,0.00002994974,0.000006541497,0.95500606,0.00061084196,0.032898143,0.009496452],"study_design_scores_gemma":[0.0012827297,0.0019961826,0.00013495696,0.0000038557437,2.5933398e-8,0.0000025947897,0.000049631995,0.000004052763,0.44363266,0.00006929841,0.55266535,0.000158621],"about_ca_topic_score_codex":0.0000027331223,"about_ca_topic_score_gemma":3.8659013e-7,"teacher_disagreement_score":0.5197672,"about_ca_system_score_codex":0.000018085806,"about_ca_system_score_gemma":0.000045982644,"threshold_uncertainty_score":0.7509818},"labels":[],"label_agreement":null},{"id":"W4255248734","doi":"10.1517/eobt.4.1.107.25251","title":"18th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer","year":2004,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Government (linguistics); Library science; Gerontology; Medicine; Political science; Environmental ethics; Family medicine; Philosophy","score_opus":0.0865523282519976,"score_gpt":0.39436392432464834,"score_spread":0.30781159607265074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255248734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98128605,0.016123652,0.00008362478,0.0011239948,0.00058245315,0.0004419436,0.00023085182,0.000007969717,0.00011947165],"genre_scores_gemma":[0.90251654,0.09594142,0.00040224727,0.00057392655,0.0002723475,0.00014831043,0.000118293174,0.0000070756637,0.000019865382],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999072,0.00003940071,0.00018865897,0.00033376095,0.00017070652,0.00019545924],"domain_scores_gemma":[0.9994561,0.000033976463,0.00011148787,0.00021301993,0.00014404426,0.00004136494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021030346,0.00012654321,0.00014523252,0.000017469829,0.000119306555,0.000013374463,0.00038493995,0.00013947634,0.000038589493],"category_scores_gemma":[0.00005134686,0.000064098014,0.00035291185,0.00009260871,0.0003738881,0.0000032303158,0.00007741751,0.000059093047,5.7248604e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012789171,0.00047513426,0.0053624096,8.0252767e-7,0.00021434051,8.550812e-8,0.00016788761,0.00004648135,0.9598724,0.0003976652,0.0023380984,0.029845763],"study_design_scores_gemma":[0.0021207999,0.0012948182,0.0046829833,0.000020134565,8.8750305e-8,5.68748e-7,0.00008561063,0.0000038194585,0.6504495,0.00038674017,0.34087166,0.000083256644],"about_ca_topic_score_codex":0.000095539595,"about_ca_topic_score_gemma":0.000007846758,"teacher_disagreement_score":0.33853355,"about_ca_system_score_codex":0.000035100802,"about_ca_system_score_gemma":0.00010785618,"threshold_uncertainty_score":0.2613841},"labels":[],"label_agreement":null},{"id":"W4307840943","doi":"10.1080/14712598.2022.2142039","title":"Hypersensitivity reactions to biologics in children","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Desensitization (medicine); Intensive care medicine; Population; Premedication; MEDLINE; Multidisciplinary approach; Pediatrics; Psychiatry; Internal medicine","score_opus":0.28195861148547285,"score_gpt":0.43985698454054195,"score_spread":0.1578983730550691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307840943","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028330865,0.98598045,0.0000065053086,0.00057435536,0.0011744119,0.002641603,0.00009997853,0.0002775093,0.008961872],"genre_scores_gemma":[0.00023696077,0.9950594,0.00022462089,0.0018687741,0.0007364816,0.00074099936,0.0009994484,0.00005789257,0.00007546107],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99687725,0.00070607115,0.00065337174,0.0010090921,0.00026500179,0.0004892316],"domain_scores_gemma":[0.9981252,0.0006477632,0.00021506778,0.0007147174,0.000027564489,0.000269697],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044714747,0.0006072095,0.0018126818,0.0005604206,0.00018238272,0.000017230266,0.00024306941,0.00066500995,0.00030344728],"category_scores_gemma":[0.00038181277,0.00038893116,0.00074689963,0.0009817248,0.00009186757,0.000035491703,0.00012630601,0.0013493316,0.00037264725],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032712815,0.00076540577,0.000031405576,0.000015132503,0.00013185013,0.000016818281,0.000034513392,0.0000011210866,0.00006039303,0.00021279129,0.00020935932,0.9984885],"study_design_scores_gemma":[0.00050650485,0.00052322116,0.0014901197,0.00087551936,0.0000023907726,0.0003483611,0.000057834597,5.320085e-7,0.0000049459027,0.000015923577,0.9957409,0.0004337729],"about_ca_topic_score_codex":0.000072868745,"about_ca_topic_score_gemma":5.9777744e-7,"teacher_disagreement_score":0.99805474,"about_ca_system_score_codex":0.0007039003,"about_ca_system_score_gemma":0.00017960153,"threshold_uncertainty_score":0.99985623},"labels":[],"label_agreement":null},{"id":"W4362506413","doi":"10.1080/14712598.2023.2199123","title":"Stem cell therapy for salivary gland regeneration after radiation injury","year":2023,"lang":"en","type":"editorial","venue":"Expert Opinion on Biological Therapy","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Regeneration (biology); Salivary gland; Stem cell; Medicine; Stem-cell therapy; Pathology; Radiation therapy; Cell therapy; Cell biology; Biology; Internal medicine","score_opus":0.057802180412068624,"score_gpt":0.34222793755110653,"score_spread":0.2844257571390379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362506413","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037107556,0.04835786,0.0005664321,0.0018197572,0.9417398,0.0022683803,0.0006465071,0.00047283713,0.00041766043],"genre_scores_gemma":[0.0017627634,0.467165,0.000119655735,0.0017161367,0.51936454,0.0014431713,0.007738484,0.00008948254,0.00060079386],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977302,0.00018122717,0.00047964315,0.00079234864,0.0004305753,0.00038602436],"domain_scores_gemma":[0.9979919,0.0010108976,0.00019403038,0.0004692396,0.00017668097,0.00015721757],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00032901586,0.00049181754,0.0006370467,0.0001886538,0.00019355111,0.00006211788,0.00014943328,0.001469589,0.0002812847],"category_scores_gemma":[0.00008227031,0.000311227,0.0004075054,0.00021639251,0.00006367514,0.00005643071,0.00002115457,0.00043801294,0.00009804901],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011319593,0.00043820834,0.00016087852,0.000007842193,0.00008909841,0.000002455822,0.00012847182,0.0000017173418,0.00078600884,0.000026968253,0.90437025,0.08266849],"study_design_scores_gemma":[0.004778492,0.0065533626,0.000614404,0.00006795945,0.0000014403231,6.061338e-7,0.000047389924,0.00003594369,0.0009455979,0.00017760624,0.9863811,0.0003960743],"about_ca_topic_score_codex":0.000025160265,"about_ca_topic_score_gemma":7.1204016e-7,"teacher_disagreement_score":0.4223753,"about_ca_system_score_codex":0.00009737884,"about_ca_system_score_gemma":0.00015721352,"threshold_uncertainty_score":0.99993396},"labels":[],"label_agreement":null},{"id":"W4385619728","doi":"10.1080/14712598.2023.2245321","title":"How can clinical safety and efficacy concerns in stem cell therapy for spinal cord injury be overcome?","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Stem cell; Spinal cord injury; Neural stem cell; Mesenchymal stem cell; Stem-cell therapy; Medicine; Induced pluripotent stem cell; Embryonic stem cell; Regenerative medicine; Neuroscience; Cell therapy; Biology; Pathology; Spinal cord; Cell biology","score_opus":0.3079596881650936,"score_gpt":0.4851213653748526,"score_spread":0.177161677209759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385619728","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002764276,0.9922722,0.000048515092,0.0006710132,0.0007545859,0.0029916707,0.0004030211,0.000047243266,0.000047488407],"genre_scores_gemma":[0.0006697123,0.9952493,0.00007009615,0.00075883046,0.0012224306,0.00047710378,0.0011036332,0.00009715677,0.00035178382],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99564147,0.0010758127,0.0008943893,0.0014434772,0.00026354118,0.00068133936],"domain_scores_gemma":[0.99813783,0.00052905217,0.00034310116,0.00066957105,0.00007089785,0.00024951703],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010344904,0.0006975197,0.0016947651,0.00014364618,0.00012957327,0.00008770313,0.00071086426,0.0013872371,0.000016363043],"category_scores_gemma":[0.00009520628,0.0004536514,0.00074781606,0.00023860064,0.0003335493,0.000004296871,0.00023918162,0.00060077594,0.00000866794],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005716347,0.00035291785,0.000032048214,0.00013268826,0.00013902427,0.0000061606997,0.000008865137,1.411657e-7,0.00062586257,0.00005194178,0.001645316,0.99128866],"study_design_scores_gemma":[0.002491874,0.013422346,0.00012704461,0.000660542,0.0000010001655,0.000005699757,0.000026986303,0.0000021738776,0.00036150106,0.000011273273,0.9823309,0.00055865967],"about_ca_topic_score_codex":0.000011660836,"about_ca_topic_score_gemma":0.0000029443966,"teacher_disagreement_score":0.99073005,"about_ca_system_score_codex":0.000081445454,"about_ca_system_score_gemma":0.00022483262,"threshold_uncertainty_score":0.99990916},"labels":[],"label_agreement":null},{"id":"W4388796117","doi":"10.1080/14712598.2023.2285996","title":"The endosomal-lysosomal system in ADC design and cancer therapy","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Endosome; Rab; Transferrin receptor; Epidermal growth factor receptor; Computational biology; Cancer; Cancer research; Medicine; GTPase; Biology; Transferrin; Cell biology; Biochemistry; Internal medicine; Intracellular","score_opus":0.4938790619789927,"score_gpt":0.5135073950707947,"score_spread":0.019628333091802008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388796117","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040443578,0.9929979,0.000016479413,0.000878068,0.0011252522,0.004338571,0.000024875675,0.00024276129,0.00033567156],"genre_scores_gemma":[0.000048090493,0.9927924,0.000087345994,0.00051099254,0.0013731999,0.004876543,0.00004655016,0.00011855216,0.00014630084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99496037,0.0017986381,0.00086285133,0.0009900889,0.0005767222,0.0008113034],"domain_scores_gemma":[0.9961557,0.0025600935,0.00022772222,0.00072978844,0.00007312344,0.00025358863],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014866347,0.0006799805,0.0019608333,0.00024347914,0.00024457264,0.00009052467,0.0005693337,0.00081601675,0.00015154149],"category_scores_gemma":[0.00015020052,0.00030782763,0.00041970698,0.00070704264,0.0003488702,0.000026609096,0.000106124484,0.0010748382,0.00013734763],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006940017,0.00010126947,0.000035118876,0.0003060949,0.0002027732,0.000052768708,0.00008324095,5.230285e-7,0.000022792978,0.0005791196,0.0023275209,0.9955948],"study_design_scores_gemma":[0.0013976743,0.0016812158,0.00010658977,0.010801955,0.0000011614484,0.00005192365,0.00007610505,0.00002443667,0.000027701779,0.000031196985,0.98546433,0.00033569543],"about_ca_topic_score_codex":0.00014038573,"about_ca_topic_score_gemma":0.0000021451604,"teacher_disagreement_score":0.9952591,"about_ca_system_score_codex":0.0005699676,"about_ca_system_score_gemma":0.00049076165,"threshold_uncertainty_score":0.99993736},"labels":[],"label_agreement":null},{"id":"W4389792976","doi":"10.1080/14712598.2023.2296126","title":"An evaluation of rozanolixizumab-noli for the treatment of anti-AChR and anti-MuSK antibody-positive generalized myasthenia gravis","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Myasthenia gravis; Antibody; Medicine; Immunology; Acetylcholine receptor; Internal medicine; Receptor","score_opus":0.1486298224363761,"score_gpt":0.4292359436668372,"score_spread":0.28060612123046114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389792976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988077,0.008526653,0.00013479253,0.0011309745,0.00026303783,0.0016813587,0.000080164136,0.000056104964,0.000049945927],"genre_scores_gemma":[0.8830759,0.11563554,0.00024403818,0.00021671645,0.00024469488,0.00016904881,0.00038583294,0.000019673183,0.000008575885],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984037,0.0002752104,0.00036913602,0.0003874282,0.0003215732,0.00024290691],"domain_scores_gemma":[0.998905,0.00022540294,0.00016945468,0.00038934234,0.00022634502,0.00008447794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050956855,0.00024097375,0.0005820997,0.000112907146,0.00013826696,0.000013103137,0.00011527287,0.00015907765,0.000091018694],"category_scores_gemma":[0.00003525031,0.00011842821,0.00021677183,0.00023907176,0.00021855898,0.000032305867,0.000012272154,0.000050121213,0.0000033904207],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023966478,0.0014795425,0.0053712325,0.0000063093494,0.0003401853,0.0000021784053,0.0024666407,0.000031477888,0.73516,0.00324326,0.00017124155,0.24933131],"study_design_scores_gemma":[0.021380028,0.029022895,0.57150567,0.00017796288,0.000024634623,0.000027522752,0.0011407004,0.00915902,0.30209857,0.0015460014,0.06345572,0.0004612806],"about_ca_topic_score_codex":0.000072269286,"about_ca_topic_score_gemma":6.166665e-7,"teacher_disagreement_score":0.5661344,"about_ca_system_score_codex":0.0000333564,"about_ca_system_score_gemma":0.00004063188,"threshold_uncertainty_score":0.48293623},"labels":[],"label_agreement":null},{"id":"W4397047590","doi":"10.1080/14712598.2024.2357382","title":"Anti-CD38 monoclonal antibodies in multiple myeloma with gain/amplification of chromosome arm 1q: a review of the literature","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Daratumumab; CD38; Monoclonal antibody; Multiple myeloma; Antibody; Cancer research; Medicine; Immunology; Biology; Genetics; Stem cell","score_opus":0.16356094872052226,"score_gpt":0.4215744358332648,"score_spread":0.2580134871127425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397047590","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008333947,0.995262,0.0000021771616,0.00056188204,0.00017066635,0.0028125313,0.00020997327,0.00003203741,0.00011533281],"genre_scores_gemma":[0.0026646568,0.9952346,0.00026652342,0.00028256662,0.00018386333,0.00040946124,0.0008894615,0.00003802891,0.000030847543],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99722457,0.0005348479,0.0008311721,0.0006254221,0.00047045856,0.0003135047],"domain_scores_gemma":[0.99829215,0.00036866235,0.00038405374,0.0007033641,0.00014864682,0.00010310517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035217154,0.00052234286,0.0021847708,0.0002223899,0.000047041412,0.000015964783,0.0003399781,0.0003839317,0.00010476707],"category_scores_gemma":[0.00024816892,0.00020189788,0.00068155635,0.0009064527,0.00028154333,0.000032151638,0.000076905526,0.0005970018,0.000019153546],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060264923,0.0016067673,0.00085541885,0.022044217,0.00071698095,0.00005019059,0.00020291547,1.4038899e-7,0.0003859384,0.00028910945,0.00083819666,0.97240746],"study_design_scores_gemma":[0.0011819367,0.0016072881,0.0019341401,0.2589287,0.000010752873,0.00007674311,0.000013071564,0.000004835844,0.0003051593,0.000025603747,0.7356923,0.00021947327],"about_ca_topic_score_codex":0.000012556034,"about_ca_topic_score_gemma":5.3910304e-7,"teacher_disagreement_score":0.972188,"about_ca_system_score_codex":0.00010621221,"about_ca_system_score_gemma":0.0002054628,"threshold_uncertainty_score":0.8233157},"labels":[],"label_agreement":null},{"id":"W4399883248","doi":"10.1080/14712598.2024.2321360","title":"Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open‑label, single-dose phase I study","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Celltrion","keywords":"Pharmacokinetics; Medicine; Biosimilar; Bioequivalence; Syringe; Immunogenicity; Pharmacology; Open label; Safety profile; Adverse effect; Anesthesia; Internal medicine; Antibody; Immunology","score_opus":0.12781426508065188,"score_gpt":0.4271629290048784,"score_spread":0.29934866392422654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399883248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.682299,0.284662,0.0013179238,0.009173263,0.006146947,0.012683872,0.0017591977,0.00067216234,0.0012856348],"genre_scores_gemma":[0.8995632,0.09672629,0.00065131055,0.0019451274,0.00010783466,0.00030220905,0.0001452945,0.00004001778,0.00051870296],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955891,0.0019306083,0.00094319024,0.00094602164,0.00010199704,0.00048913306],"domain_scores_gemma":[0.9975991,0.0016098697,0.00019511818,0.00041472682,0.00006917763,0.000111983456],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010722257,0.00053142523,0.0014331245,0.00012224507,0.0001983189,0.000110872694,0.00057855697,0.00033813698,0.002424127],"category_scores_gemma":[0.00030079897,0.00028240058,0.00019489616,0.00031827192,0.00077524973,0.0000810819,0.00028914493,0.00043656354,0.000014749501],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3247708,0.0063337917,0.000037086484,0.000016915224,0.0014480896,0.000036802357,0.0006970986,1.4168258e-7,0.42388076,0.00035582672,0.010660476,0.23176222],"study_design_scores_gemma":[0.23945858,0.019261358,0.000056381097,0.0001863967,0.000020058427,0.00006165642,0.0002804277,0.00020514641,0.11366157,0.00010667183,0.6260844,0.0006173779],"about_ca_topic_score_codex":0.000047542853,"about_ca_topic_score_gemma":0.0000017810843,"teacher_disagreement_score":0.6154239,"about_ca_system_score_codex":0.00005582937,"about_ca_system_score_gemma":0.000069650196,"threshold_uncertainty_score":0.9999628},"labels":[],"label_agreement":null},{"id":"W4399896975","doi":"10.1080/14712598.2024.2371049","title":"How close are we to a success stratification tool for improving biological therapy in ulcerative colitis?","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Ulcerative colitis; Medicine; Intensive care medicine; Clinical trial; Colitis; Internal medicine; Disease","score_opus":0.06058328736767934,"score_gpt":0.34182203433071473,"score_spread":0.2812387469630354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399896975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98400164,0.0058314847,0.0022587995,0.005001075,0.000634465,0.0019672178,0.00014386846,0.000102174796,0.000059307145],"genre_scores_gemma":[0.96288663,0.031845596,0.0004773962,0.0020468866,0.00087515207,0.0014553276,0.00033678382,0.000029045348,0.000047200814],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99797195,0.00031383263,0.00029788676,0.0008958033,0.00012398398,0.00039654897],"domain_scores_gemma":[0.99925995,0.0000986841,0.000075837386,0.00034732284,0.000094202835,0.00012401678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035907148,0.0003278731,0.0002445105,0.000086397595,0.00011383559,0.00019915197,0.0002982133,0.0003951248,0.000048003338],"category_scores_gemma":[0.00015222783,0.00022071121,0.00018742021,0.00014937218,0.000105454914,0.000015836029,0.00004590745,0.0001454587,0.00001071664],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009258233,0.00051009184,0.0026942012,0.0000132752375,0.00008119107,0.00003322112,0.00041458473,0.0000237487,0.7281666,0.008053022,0.0030511112,0.24770072],"study_design_scores_gemma":[0.0034229315,0.006320084,0.18950807,0.0001384023,3.8857928e-7,0.00000777468,0.0006349677,0.00034584865,0.117929764,0.0024968158,0.6780076,0.0011873405],"about_ca_topic_score_codex":0.0000041286517,"about_ca_topic_score_gemma":0.000011000698,"teacher_disagreement_score":0.6749565,"about_ca_system_score_codex":0.000055909866,"about_ca_system_score_gemma":0.000071876726,"threshold_uncertainty_score":0.9000342},"labels":[],"label_agreement":null},{"id":"W4400462617","doi":"10.1080/14712598.2024.2378090","title":"Systematic review: effectiveness and safety of switching between originator infliximab and biosimilar infliximab in patients with inflammatory bowel disease","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Pfizer","keywords":"Biosimilar; Infliximab; Medicine; Inflammatory bowel disease; Adverse effect; Intensive care medicine; Ulcerative colitis; Disease; Internal medicine; Pharmacology","score_opus":0.03492524527650228,"score_gpt":0.34824673445929305,"score_spread":0.3133214891827908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400462617","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010750527,0.9949048,0.000011664665,0.00008879745,0.00026262054,0.0034402553,0.00015432939,0.00005109769,0.0000113476335],"genre_scores_gemma":[0.0009856041,0.99810725,0.000046631936,0.00031886093,0.00003933017,0.00032176578,0.00013567969,0.00004115574,0.0000037313205],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.995077,0.002383753,0.0012124568,0.00084801705,0.00010723673,0.00037152818],"domain_scores_gemma":[0.9975251,0.0013796503,0.00046966586,0.00045758838,0.0000653156,0.00010268931],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012420112,0.0007570373,0.0033585087,0.0002517674,0.00008603235,0.000025099684,0.00030709736,0.00078485097,0.000029490448],"category_scores_gemma":[0.00032050954,0.00036591353,0.00032462957,0.0003011192,0.00037957684,0.000060299106,0.00016909257,0.0007447197,0.000010323032],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029014463,0.00090157025,0.009750668,0.5515539,0.0036337997,0.000019417934,0.00013013657,7.837143e-8,0.00003225667,0.0015915717,0.00023823383,0.4292469],"study_design_scores_gemma":[0.0025966577,0.0015419121,0.008414841,0.542623,0.00014879763,0.00000548697,0.00000887026,5.184969e-7,0.000019378394,0.00012647129,0.44366598,0.0008481289],"about_ca_topic_score_codex":0.0000023086009,"about_ca_topic_score_gemma":1.0173216e-7,"teacher_disagreement_score":0.44342774,"about_ca_system_score_codex":0.00009038397,"about_ca_system_score_gemma":0.00007627386,"threshold_uncertainty_score":0.9998793},"labels":[],"label_agreement":null},{"id":"W4400958298","doi":"10.1080/14712598.2024.2383882","title":"The potential for medical therapies to address fistulizing Crohn’s disease: a state-of-the-art review","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Crohn's disease; Disease; Intensive care medicine; Internal medicine","score_opus":0.054839421885677274,"score_gpt":0.38407368583395946,"score_spread":0.3292342639482822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400958298","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003524045,0.99271804,0.00008838772,0.0019191678,0.0017137147,0.003154868,0.0002957025,0.00003313769,0.000041740324],"genre_scores_gemma":[0.000025781937,0.9920671,0.000034418237,0.00390607,0.0009775499,0.002309406,0.00038280027,0.00006844878,0.00022845386],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99693805,0.00068944186,0.0007728096,0.0007494725,0.00043048413,0.0004197268],"domain_scores_gemma":[0.99829066,0.0001449768,0.00025816943,0.0009138436,0.00010839461,0.00028396357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073829736,0.0005536705,0.0008066487,0.00003639499,0.00024929154,0.00005899269,0.0012262084,0.00033812725,0.000078789744],"category_scores_gemma":[0.0005640693,0.00023812581,0.0014356108,0.00014940565,0.00027860404,0.0000024831493,0.0003098381,0.00027823527,0.00004905998],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005740502,0.00009838187,0.0000010920679,0.0013221072,0.00033542464,0.00001971179,0.000014507938,6.5209935e-7,0.000030228735,0.00022654094,0.09760306,0.89977425],"study_design_scores_gemma":[0.00022002787,0.00021513911,0.00007112604,0.010697713,0.000010468171,0.0000055475953,0.0000036409372,0.0000019664633,0.000011100313,0.000110500856,0.98831487,0.00033789038],"about_ca_topic_score_codex":7.0604125e-7,"about_ca_topic_score_gemma":0.0000011098266,"teacher_disagreement_score":0.89943635,"about_ca_system_score_codex":0.000035481604,"about_ca_system_score_gemma":0.0003983512,"threshold_uncertainty_score":0.97104883},"labels":[],"label_agreement":null},{"id":"W4402455324","doi":"10.1080/14712598.2024.2404079","title":"Mosunetuzumab for the treatment of follicular lymphoma","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Follicular lymphoma; Medicine; Cancer research; Lymphoma; Oncology; Internal medicine; Rituximab; Biology; Immunology","score_opus":0.23548741695875694,"score_gpt":0.44401641511800954,"score_spread":0.2085289981592526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402455324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033508157,0.99432176,0.0000089560535,0.0005868409,0.0010375889,0.0036579901,0.00011792699,0.00007386684,0.00016157245],"genre_scores_gemma":[0.000064488515,0.9933098,0.00012812029,0.00035043803,0.00094021315,0.004591667,0.0004563301,0.000049282608,0.00010966027],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982956,0.00010456744,0.0005490226,0.0005884113,0.00018721393,0.00027520265],"domain_scores_gemma":[0.998272,0.0008046484,0.00017608136,0.0006097034,0.000040930016,0.00009664456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000980179,0.0005940909,0.0018751805,0.00008481512,0.000086464206,0.000022952321,0.00017286031,0.0004330326,0.000109751934],"category_scores_gemma":[0.00001877847,0.00020287234,0.002135418,0.00018348593,0.000111779766,0.000008329013,0.000016962937,0.000047941438,0.00007925367],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002537787,0.0022006948,0.0000028951815,0.00014579041,0.0017530442,0.000013692352,0.000072202034,7.81602e-8,0.0000012945735,0.0012161627,0.0035957885,0.9907446],"study_design_scores_gemma":[0.0027065969,0.010690396,0.000023927207,0.0025037928,0.000056906792,0.000038405593,0.000015880563,0.0000052421165,0.00007384996,0.000063546475,0.98361814,0.00020331623],"about_ca_topic_score_codex":0.000022377504,"about_ca_topic_score_gemma":1.5289437e-7,"teacher_disagreement_score":0.9905413,"about_ca_system_score_codex":0.0004585982,"about_ca_system_score_gemma":0.00015598012,"threshold_uncertainty_score":0.8272894},"labels":[],"label_agreement":null},{"id":"W4403791186","doi":"10.1080/14712598.2024.2422998","title":"Recent developments and industry interest in gene therapy for Duchenne muscular dystrophy","year":2024,"lang":"en","type":"editorial","venue":"Expert Opinion on Biological Therapy","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Duchenne muscular dystrophy; Muscular dystrophy; Genetic enhancement; Medicine; Adverse effect; Intensive care medicine; Bioinformatics; Gene; Internal medicine; Biology; Genetics","score_opus":0.07155911960616099,"score_gpt":0.34584290525654365,"score_spread":0.2742837856503827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403791186","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49392736,0.13707264,0.0000397704,0.00084635464,0.36635014,0.0013640433,0.00022974984,0.00005759198,0.0001123438],"genre_scores_gemma":[0.028314864,0.7948557,0.00027362345,0.001329205,0.17061353,0.0006949679,0.0037996187,0.00006850788,0.000049949747],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978614,0.00019077386,0.00037134357,0.0010595451,0.000114521165,0.00040245373],"domain_scores_gemma":[0.99923867,0.00012267435,0.00010613897,0.00033559566,0.00009210458,0.00010482821],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0002765428,0.00049432606,0.00044636804,0.00009833968,0.00008244565,0.000039407765,0.00033218172,0.002870492,0.00005400081],"category_scores_gemma":[0.00022073292,0.00034974402,0.00016139673,0.0001003267,0.00017056175,0.000003579695,0.00012267209,0.0007643479,0.00000783467],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005986832,0.00054376316,0.000075076925,0.00001202947,0.0003341496,0.000004983735,0.00009648741,0.0000029483597,0.09555529,0.00013047163,0.7560125,0.14124545],"study_design_scores_gemma":[0.0022293502,0.0024719918,0.00033198224,0.00006148492,2.9809584e-7,9.346834e-7,0.000031986026,0.0000017800437,0.009211705,0.0006570165,0.98455423,0.0004472141],"about_ca_topic_score_codex":0.000009914856,"about_ca_topic_score_gemma":0.0000026025998,"teacher_disagreement_score":0.6577831,"about_ca_system_score_codex":0.00003805314,"about_ca_system_score_gemma":0.00013551499,"threshold_uncertainty_score":0.99989545},"labels":[],"label_agreement":null},{"id":"W4407086441","doi":"10.1080/14712598.2025.2456485","title":"Navigating the landscape of immune checkpoint inhibitors and novel immunotherapies in melanoma: long-term outcomes, progress, and challenges","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Melanoma; Immunotherapy; Nivolumab; Immune checkpoint; Immune system; Medicine; Ipilimumab; Term (time); Cancer research; Pembrolizumab; Immunology","score_opus":0.11995718681064713,"score_gpt":0.39524859417414226,"score_spread":0.2752914073634951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407086441","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047987415,0.99046963,0.00000125785,0.002680278,0.0003739867,0.0015697132,0.000019268233,0.000040379262,0.000046758316],"genre_scores_gemma":[0.0028452638,0.99621964,0.000067709516,0.00024944,0.00015237396,0.00034499817,0.00008113037,0.000030649466,0.000008793484],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976913,0.00024335047,0.0010276443,0.0005546392,0.00019367122,0.00028939339],"domain_scores_gemma":[0.99843603,0.0005788701,0.0004600353,0.00044154047,0.000036006015,0.00004752714],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000692792,0.0005515521,0.00189295,0.00010596733,0.00009312713,0.000029695899,0.00022806095,0.00052034203,0.00003991124],"category_scores_gemma":[0.000053884112,0.00025693545,0.00047493982,0.00025224383,0.0005149508,0.00003234701,0.00010062471,0.0006399835,6.610988e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006804577,0.00033126364,0.0021155735,0.0009688167,0.00043153757,0.0000033780636,0.00046139702,5.5311995e-9,0.00012198756,0.00009979408,0.000006631594,0.99477917],"study_design_scores_gemma":[0.0070082173,0.0031863637,0.07081991,0.05447104,0.000011716909,0.00010198829,0.0004289543,0.0000010411802,0.00019478214,0.000032461452,0.86304086,0.0007026596],"about_ca_topic_score_codex":0.00003680928,"about_ca_topic_score_gemma":0.0000023004704,"teacher_disagreement_score":0.9940765,"about_ca_system_score_codex":0.00005385775,"about_ca_system_score_gemma":0.00008865816,"threshold_uncertainty_score":0.99998826},"labels":[],"label_agreement":null},{"id":"W4408341556","doi":"10.1080/14712598.2025.2477192","title":"State of the art of the molecular hyperselection to guide treatment with anti-EGFR antibodies in RAS WT mCRC: implications for clinical practice and future perspectives","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pivotal (Canada)","funders":"","keywords":"Antibody; Clinical Practice; Medicine; Cancer research; Immunology; Family medicine","score_opus":0.12063140703017454,"score_gpt":0.48610959772964424,"score_spread":0.3654781906994697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408341556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020529386,0.98539215,0.00001851265,0.008618594,0.00021174643,0.0031103198,0.000070895425,0.000010511135,0.0005143208],"genre_scores_gemma":[0.0009197173,0.99733436,0.00044889387,0.00046243388,0.00012424035,0.00061495084,0.000017278437,0.000010822051,0.00006731145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986347,0.00029071668,0.00044610267,0.00040530603,0.00008890606,0.00013427144],"domain_scores_gemma":[0.9985722,0.00063993275,0.00026790603,0.0003225844,0.00016513339,0.000032283177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017044714,0.00026429878,0.0010738401,0.00006220111,0.00009681869,0.000006292054,0.000106520914,0.00012871793,0.0000033924978],"category_scores_gemma":[0.00018403358,0.0000952247,0.0003702059,0.0003304791,0.00018548497,0.000014410995,0.00004064259,0.00012922427,2.2643185e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008893328,0.00088630855,0.0011713342,0.00008906612,0.0007291423,5.126293e-7,0.00057778624,4.224185e-7,0.000044206103,0.0006347137,0.0005597693,0.9944174],"study_design_scores_gemma":[0.0010514124,0.0045658024,0.013511688,0.0012923917,0.000028276752,0.000009885221,0.0005525309,1.903141e-7,0.000057007008,0.000030024345,0.97880274,0.00009805664],"about_ca_topic_score_codex":0.000028856433,"about_ca_topic_score_gemma":0.000008725753,"teacher_disagreement_score":0.9943193,"about_ca_system_score_codex":0.00016723463,"about_ca_system_score_gemma":0.00019009698,"threshold_uncertainty_score":0.38831505},"labels":[],"label_agreement":null},{"id":"W4408393364","doi":"10.1080/14712598.2025.2480258","title":"IL23p19 therapies for moderately-to-severely active ulcerative colitis","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Ulcerative colitis; Medicine; Vedolizumab; Internal medicine; Tofacitinib; Gastroenterology; Disease; Rheumatoid arthritis","score_opus":0.09232761844520763,"score_gpt":0.39198695492837554,"score_spread":0.2996593364831679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408393364","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019293763,0.9923118,0.0006182071,0.0001507184,0.0009124866,0.003795494,0.000937209,0.000070590715,0.0010105796],"genre_scores_gemma":[0.00013275791,0.9889773,0.00043695758,0.0030695172,0.0010851494,0.003931438,0.0019273111,0.000066306275,0.00037325406],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969669,0.00066335424,0.0005262482,0.0011686886,0.00015554746,0.0005192747],"domain_scores_gemma":[0.99851763,0.00024227897,0.0002229242,0.0006282987,0.00018527517,0.00020359994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021867499,0.00079688476,0.0011439632,0.00012966046,0.00024751946,0.0000676216,0.0005842743,0.00096640654,0.000112502625],"category_scores_gemma":[0.00020868034,0.0005386006,0.0008850445,0.00014903011,0.00013496718,0.000004983567,0.00013040188,0.0002318321,0.00004936423],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008532411,0.00021007653,4.3387487e-7,0.00015273417,0.0005023406,0.000005486386,0.00009819008,0.0000026704622,0.00004399003,0.0013798719,0.010269904,0.9788019],"study_design_scores_gemma":[0.00074506545,0.0011571872,0.00026738926,0.0010730374,0.000002486122,0.000002996948,0.000034384047,0.000002015162,0.0003194226,0.0002418711,0.99546444,0.00068972853],"about_ca_topic_score_codex":0.0000024343722,"about_ca_topic_score_gemma":0.0000017399449,"teacher_disagreement_score":0.9851945,"about_ca_system_score_codex":0.0000937937,"about_ca_system_score_gemma":0.00037426376,"threshold_uncertainty_score":0.99970657},"labels":[],"label_agreement":null},{"id":"W4410261758","doi":"10.1080/14712598.2025.2500962","title":"Second-line strategies after anti-TNF failure in chronically active, moderate-to-severe ulcerative colitis: a retrospective, multicentre cohort study","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Ministry of Innovation; National Research, Development and Innovation Office; Nemzeti Kutatási, Fejlesztési és Innovaciós Alap; Innovation Fund; Szegedi Tudományegyetem; United European Gastroenterology; European Crohn's and Colitis Organisation","keywords":"Ulcerative colitis; Medicine; Retrospective cohort study; Cohort; Internal medicine; Cohort study; Infliximab; Inflammatory bowel disease; Tumor necrosis factor alpha; Gastroenterology; Disease","score_opus":0.015234076884882413,"score_gpt":0.3058804994429039,"score_spread":0.2906464225580215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410261758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951818,0.0005027552,0.00013238682,0.0003424925,0.0002658721,0.0022325634,0.0000922756,0.00005016255,0.0011996976],"genre_scores_gemma":[0.9935106,0.0026621325,0.00013748313,0.002279501,0.00021164911,0.00093978463,0.00013722015,0.000023322753,0.000098310265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974371,0.0005262382,0.00039900653,0.0010080844,0.00018099365,0.00044858205],"domain_scores_gemma":[0.99907666,0.000037655525,0.00007978088,0.000494322,0.00017093103,0.00014064343],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022316123,0.0004117648,0.00042749674,0.000099996694,0.00012221298,0.00008752059,0.00030895806,0.00035211508,0.0004808265],"category_scores_gemma":[0.00009268623,0.00031597045,0.0001382491,0.00019874863,0.00012626116,0.000018445375,0.00013732971,0.00027629774,0.000023660114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1377661,0.011160493,0.6982676,0.000029333496,0.0018083291,0.0005261221,0.0033357504,0.0022596323,0.1244761,0.003130471,0.007133268,0.010106843],"study_design_scores_gemma":[0.003925815,0.0014697147,0.9727401,0.000045232246,6.992578e-7,0.0000014560245,0.0011155211,0.00006663605,0.004738267,0.00015834153,0.015326258,0.0004119598],"about_ca_topic_score_codex":0.0000148627405,"about_ca_topic_score_gemma":0.00039516867,"teacher_disagreement_score":0.27447253,"about_ca_system_score_codex":0.00014534309,"about_ca_system_score_gemma":0.00019914717,"threshold_uncertainty_score":0.99992925},"labels":[],"label_agreement":null},{"id":"W4414026299","doi":"10.1080/14712598.2025.2557626","title":"Efficacy and safety of biosimilars in gastroenterology: a focus on inflammatory bowel disease management","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Biosimilar; Inflammatory bowel disease; Medicine; Gastroenterology; Internal medicine; Disease; Inflammatory Bowel Diseases; Intensive care medicine","score_opus":0.06055974414817065,"score_gpt":0.3647163946971899,"score_spread":0.30415665054901925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414026299","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008040347,0.99620235,0.000024000594,0.0008444082,0.0006724227,0.0014221387,0.000121148485,0.00004770973,0.0005854043],"genre_scores_gemma":[0.00022700478,0.9975343,0.0001491981,0.0016604185,0.00004898839,0.00018966205,0.00011402872,0.000018998733,0.00005741862],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99616075,0.0015306656,0.0008982314,0.00087411044,0.000060626466,0.0004756479],"domain_scores_gemma":[0.9981951,0.0009103025,0.00027277812,0.0005253349,0.000020598252,0.00007586581],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005227475,0.0006167632,0.0016288196,0.00039989673,0.00007952973,0.000009911457,0.00045255414,0.000901873,0.00023657657],"category_scores_gemma":[0.00010506421,0.00036376703,0.00045949646,0.00021597816,0.0005222047,0.000015870832,0.00020653296,0.0006304575,0.000018572999],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005299668,0.00081645575,0.00015694332,0.0003793447,0.00044799654,0.000015633323,0.000014733849,2.6691214e-7,0.000022289474,0.0032134913,0.0014814716,0.9881517],"study_design_scores_gemma":[0.0025910425,0.0015172958,0.0029061849,0.0067614513,0.000008588047,0.0000034111163,0.000009050465,3.424934e-7,0.00003166577,0.00025275687,0.9856142,0.00030402496],"about_ca_topic_score_codex":0.0000012645238,"about_ca_topic_score_gemma":3.238897e-7,"teacher_disagreement_score":0.9878477,"about_ca_system_score_codex":0.00006694451,"about_ca_system_score_gemma":0.00004048523,"threshold_uncertainty_score":0.99988145},"labels":[],"label_agreement":null},{"id":"W4415325193","doi":"10.1080/14712598.2025.2577752","title":"Improving care for children with juvenile idiopathic arthritis: the role of IL-6 inhibitors in a patient-centered approach","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children’s Health Research Institute; London Health Sciences Centre; Western University","funders":"Fresenius Kabi","keywords":"Oligoarthritis; Tocilizumab; Disease; Refractory (planetary science); Bridging (networking); Complex disease; Arthritis","score_opus":0.04256535268733067,"score_gpt":0.32880076810499925,"score_spread":0.28623541541766856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415325193","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048536243,0.9942111,0.000021938706,0.00004455066,0.000098557786,0.0047935653,0.00006394638,0.00003660899,0.00024440864],"genre_scores_gemma":[0.0049121752,0.9921517,0.00009168852,0.00012996561,0.00014351502,0.0019586068,0.000574568,0.00003237728,0.000005417545],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976826,0.00035631578,0.0008260247,0.00053244544,0.00024917806,0.00035346724],"domain_scores_gemma":[0.9989091,0.00013191332,0.00034007238,0.00047264804,0.000093210445,0.000053034022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029501837,0.000392511,0.001782783,0.000196616,0.000111060035,0.00001811679,0.00030138087,0.00045032304,0.000014401901],"category_scores_gemma":[0.00011845579,0.00018443668,0.0004818019,0.00033326316,0.00015438079,0.000028615535,0.0000788664,0.00054761866,0.0000020312439],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041255055,0.00033186984,0.00012458432,0.0005416235,0.000094103365,9.918397e-7,0.00051208225,3.171807e-7,0.000022063772,0.00007523269,0.00006287873,0.9978217],"study_design_scores_gemma":[0.0022402604,0.0035776272,0.000066385765,0.013743946,0.0000024444519,0.000013858693,0.0012863228,0.000006357605,0.00012256598,0.000014889242,0.9786813,0.00024403627],"about_ca_topic_score_codex":0.000042352938,"about_ca_topic_score_gemma":0.0000011422455,"teacher_disagreement_score":0.99757767,"about_ca_system_score_codex":0.00010158143,"about_ca_system_score_gemma":0.00040731695,"threshold_uncertainty_score":0.75211096},"labels":[],"label_agreement":null},{"id":"W4416866620","doi":"10.1080/14712598.2025.2597848","title":"An evaluation of guselkumab for the treatment of ulcerative colitis","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Golimumab; Ulcerative colitis; Clinical trial; Clinical efficacy; Combination therapy; Clinical endpoint","score_opus":0.07990704056397012,"score_gpt":0.3965135112182138,"score_spread":0.3166064706542437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416866620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913506,0.005567673,0.00088084536,0.00026760978,0.00029725482,0.0012432942,0.00006498736,0.000008199568,0.00031956285],"genre_scores_gemma":[0.9738578,0.02494042,0.00012302544,0.00030732504,0.00013763359,0.00046888043,0.000146568,0.000004812404,0.000013489963],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918705,0.00025900983,0.00017129576,0.00019891262,0.00009207951,0.000091679685],"domain_scores_gemma":[0.99935025,0.00006584391,0.000072945775,0.00028819783,0.00019995401,0.000022801429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025874175,0.00010273609,0.00011807105,0.000019916031,0.00006132247,0.0000047275066,0.00012314155,0.00010423302,0.000047150756],"category_scores_gemma":[0.000050600876,0.000056152527,0.0001167448,0.00003738958,0.000108015956,0.0000016449883,0.000006336091,0.000013738704,4.975077e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017906718,0.0026916566,0.0018472534,0.0000045900397,0.0005569101,3.9796313e-7,0.0007587438,0.00058007817,0.43725553,0.009916643,0.0022757975,0.52620566],"study_design_scores_gemma":[0.005396427,0.007813788,0.14852351,0.00001746084,0.0000029802586,2.8449173e-7,0.00032148906,0.0010552481,0.5564377,0.0011019347,0.27916938,0.00015985007],"about_ca_topic_score_codex":0.000005491849,"about_ca_topic_score_gemma":0.0000030413514,"teacher_disagreement_score":0.52604586,"about_ca_system_score_codex":0.000025171441,"about_ca_system_score_gemma":0.000075039155,"threshold_uncertainty_score":0.22898336},"labels":[],"label_agreement":null},{"id":"W4417073551","doi":"10.1080/14712598.2025.2601053","title":"Natural killer cell therapies in cancer: innovations, challenges, and future directions","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University College of the North","funders":"","keywords":"Immunotherapy; Cancer immunotherapy; Natural killer cell; Cancer; Cell; Chimeric antigen receptor; Cancer treatment; Cell therapy","score_opus":0.04228165378890512,"score_gpt":0.3129518251061232,"score_spread":0.27067017131721804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417073551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.072064914,0.8813621,0.000006769987,0.021056013,0.020091452,0.00029058498,0.0000015578345,0.00012571475,0.0050009154],"genre_scores_gemma":[0.2865842,0.7090077,0.000014199587,0.002667684,0.00013187775,0.000111526475,0.000055510744,0.0000051551183,0.0014221715],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990573,0.00021885488,0.00021934208,0.00030269113,0.000019682417,0.00018210911],"domain_scores_gemma":[0.99963015,0.00012073549,0.00005565104,0.00014505767,0.000040291256,0.000008139404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113035465,0.00016941917,0.00019743716,0.00019594743,0.000168764,0.000012263353,0.00009284701,0.00028146178,0.0007442293],"category_scores_gemma":[0.000012666997,0.00011290673,0.00005264422,0.00020345963,0.000094909316,0.00006320506,0.000023984128,0.00037108475,0.000035159494],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008310802,0.00046591082,0.0004285973,0.0000019523518,0.00008800332,2.9580434e-7,0.0012857784,4.0240351e-7,0.09790647,0.014007176,0.01742398,0.8675603],"study_design_scores_gemma":[0.0011552994,0.0002322708,0.030236147,0.00002553343,1.1682707e-7,0.000002206187,0.00089967053,0.000001573525,0.008990496,0.00017734017,0.9581532,0.00012615605],"about_ca_topic_score_codex":0.000058056066,"about_ca_topic_score_gemma":0.0000075779376,"teacher_disagreement_score":0.9407292,"about_ca_system_score_codex":0.000051456835,"about_ca_system_score_gemma":0.000017715101,"threshold_uncertainty_score":0.81487894},"labels":[],"label_agreement":null},{"id":"W4417314564","doi":"10.1080/14712598.2025.2604057","title":"Cell population data as predictive biomarkers for biologic therapy response in psoriasis","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"National Key Research and Development Program of China; Natural Science Foundation of Hunan Province; National Natural Science Foundation of China","keywords":"Psoriasis; Population; Biological response modifiers; Biologic Agents; Biomarker; Clinical trial; Cell; Cell therapy","score_opus":0.0950750619438016,"score_gpt":0.3562980083849614,"score_spread":0.2612229464411598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417314564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9280724,0.064493425,0.00025631333,0.0016533437,0.0028554266,0.0016222236,0.0003263018,0.00018855518,0.0005320019],"genre_scores_gemma":[0.8927256,0.10195133,0.00027587297,0.0015502597,0.00010219224,0.00048610303,0.0027185716,0.000016147227,0.00017395697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970172,0.0012163215,0.00041865138,0.000884916,0.000040004725,0.00042292586],"domain_scores_gemma":[0.9976561,0.0014379328,0.00013452103,0.00070091226,0.00004343504,0.000027118083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084590033,0.00035400543,0.00044494955,0.0002753024,0.00022522948,0.000019438747,0.0006110625,0.00068493624,0.0002654652],"category_scores_gemma":[0.00024347103,0.00022795709,0.00016063181,0.00034714703,0.00014297901,0.000083057836,0.00008964769,0.00014801625,0.00007203327],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1877029,0.0021868846,0.019897657,0.0000026273005,0.0007304092,0.000003797561,0.00042961325,0.000008815793,0.2724393,0.0011749276,0.012792483,0.5026306],"study_design_scores_gemma":[0.015003366,0.0087138545,0.2091535,0.00006607953,0.000002081241,0.00000328964,0.00046087822,0.00003295954,0.07207527,0.0023500684,0.69160223,0.0005364047],"about_ca_topic_score_codex":0.00013550672,"about_ca_topic_score_gemma":0.0000022810393,"teacher_disagreement_score":0.67880976,"about_ca_system_score_codex":0.00009383844,"about_ca_system_score_gemma":0.000055857363,"threshold_uncertainty_score":0.92958206},"labels":[],"label_agreement":null},{"id":"W4417497569","doi":"10.1080/14712598.2025.2606897","title":"Ranibizumab biosimilar (Oceva) – real-world experience from India (RORE study)","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Electrovaya (Canada)","funders":"","keywords":"Biosimilar; Ranibizumab; Population; Clinical trial; Pharmacogenetics; MEDLINE","score_opus":0.09086108873478276,"score_gpt":0.39661812815289293,"score_spread":0.30575703941811017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417497569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9027239,0.048434243,0.00056898553,0.009208851,0.010105514,0.002596382,0.00017532526,0.00086623663,0.02532058],"genre_scores_gemma":[0.9431206,0.044816416,0.00066873786,0.010211092,0.00020526284,0.0001780807,0.00009321647,0.000018996234,0.00068756985],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99683005,0.0010026073,0.0005526345,0.0009845252,0.00008603193,0.00054414506],"domain_scores_gemma":[0.9983277,0.0007422443,0.00012387609,0.0006766299,0.00006578123,0.00006378415],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040442278,0.0004464451,0.00068110635,0.00020173665,0.00034460952,0.000042971693,0.0006904612,0.00059619197,0.0036012144],"category_scores_gemma":[0.00014479796,0.00027417648,0.00024853277,0.00059123005,0.00051634543,0.000051193063,0.00015981904,0.00051462895,0.0001412644],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009109007,0.007138268,0.114691556,0.0000031325758,0.0014448742,0.000034922152,0.0031054576,9.320729e-7,0.43404415,0.018753564,0.06355545,0.34811866],"study_design_scores_gemma":[0.003433872,0.0016180873,0.14332104,0.000053332114,0.0000014495896,0.0000011749083,0.000976199,0.0000033703434,0.08306164,0.001380983,0.76570994,0.0004389122],"about_ca_topic_score_codex":0.0001855799,"about_ca_topic_score_gemma":0.000008832667,"teacher_disagreement_score":0.7021545,"about_ca_system_score_codex":0.00007367494,"about_ca_system_score_gemma":0.000041380496,"threshold_uncertainty_score":0.99997103},"labels":[],"label_agreement":null}]}